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Abstract 
Periodontal diseases are highly prevalent in population of all ages. They are initiated by 
bacterial accumulation at the interface of bone and soft tissue leading to the loss of gingival 
tissue attachment to the root surface, that may eventually lead to tooth loss. Regenerative 
approaches to treat periodontitis lesions offer exciting possibilities; in particular, guided 
tissue/bone regeneration (GTR/GBR) approaches are promising for periodontal tissues 
regeneration in periodontal loss because, through the insertion of a physical barrier, they can 
exclude unwanted epithelial and gingival connective tissue cells from the healing area and 
allow bone tissue cells to repopulate the bony defect. 
In the past few decades, different resorbable and non-resorbable membranes have been 
developed. Expanded polytetrafluoroethylene (ePTFE) membranes are the “gold standard” 
for GTR/GBR applications. However, they are non-resorbable and they need a second 
surgical operation to repair dehiscence. Although membranes based on biodegradable 
synthetic polymers avoid a second surgical operation, they show drawbacks concerning their 
capacity of space maintenance, early/late absorption, mechanical properties and bacterial 
infection during degradation. On the other hand, collagen membranes have advantages 
related to biological properties of collagen itself but are characterized by low mechanical 
strength. Thus, the “ideal” membrane for use in periodontal regenerative therapy has yet to 
be developed. 
The main purpose of this thesis was the design of biologically active products, with 
improved osteoconductive and antimicrobial properties, for GTR/GBR applications in 
periodontal diseases. 
In a more traditional approach, a commercially available membrane (based on PTFE) was 
surface modified by environmentally friendly technique to tailor the surface properties, 
allowing rapid bone re-growth and exerting antimicrobial action. Binding ability of 3,4-
dihydroxy-DL-phenylalanine (DOPA) to samples of any type, size and shape was exploited 
to improve PTFE film surface properties. In particular, a hydroxyapatite nanoparticles 
(HAp) coating was applied by DOPA polymerization on PTFE membrane surface in the 
presence of HAp nanoparticles, with the aim to promote the bone re-growth properties of 
PTFE membranes. Chemical composition analysis by XPS and FTIR-ATR analyses 
demonstrated the successful deposition of polyDOPA and HAp on PTFE coated with a 
combination of DOPA and HAp. Morphological and topographical characterizations further 
XVII 
 
confirmed the total surface coverage of the substrates by the coatings causing an increase in 
surface roughness (39.8 ± 5.2 nm for PTFE films vs 236.5 ± 12.0 nm for polyDOPA/HAp 
coated films) and wettability (110.8 ± 2.8° for PTFE films vs 46.1 ± 12.4° for 
polyDOPA/HAp coated samples). The coating stability was also studied by incubating 
coated PTFE films in PBS: the HAp coating was still present after 14 days of incubation, 
with a reduced surface roughness and an unchanged hydrophilicity. Finally, MC3T3-E1 pre-
osteoblastic cells cultured on polyDOPA/HAp coated films showed a pronounced increase 
of cell proliferation and cellular adhesion. 
Regarding the antimicrobial action, silver nanoparticles (AgNPs) have been selected as 
antimicrobial agents due to their good antimicrobial efficacy against bacteria, viruses and 
other eukaryotic micro-organisms. The successful deposition of AgNPs on PTFE film 
surface, through the functional groups of DOPA, has been demonstrated by physico-
chemical and morphological analyses. Nanoparticles exhibited a diameter around 68 nm and 
were homogeneously distributed on the surface, with only some agglomerates. In vitro cell 
tests with fibroblast NIH 3T3 cells showed an inhibition of cells proliferation on PTFE films 
functionalized with AgNPs after 3 days of culture, while good cell adhesion was observed 
with cells randomly distributed on sample surface and extensively spread. Finally, the 
antimicrobial efficiency was demonstrated against Staphylococcus aureus (S. aureus) and 
Ag release was sustained for at least 14 days. These findings suggested that the mussel-
inspired coated PTFE membrane could find potential application as GTR/GBR strategy for 
the treatment of periodontal diseases. 
In a highly innovative approach, a bi-layered bioabsorbable membrane was developed, by 
the assembly of a compact and a porous layer. The rationale of having a periodontal 
membrane with a multi-component structure relies on the idea that GTR/GBR membranes 
can be considered an interface-implant between gingival connective tissue/epithelium and 
alveolar bone tissue. Thus, developing a multi-component structure membrane with 
compositional and structural gradients that meet the local functional requirements could 
represent a challenge. The multifunctional membranes represent the next generation of 
GTR/GBR membranes for periodontal tissue engineering. 
Binary blends of poly(DL-lactide-co-ε-caprolactone) (PLCL) and poly(DL-lactide-co-
glycolide) (PLGA) with various compositions (100/0, 75/25, 50/50, 25/75, 0/100 wt/wt) 
were prepared by solvent casting technique as compact layer of the bi-layered membrane. 
Morphological analysis of fractured sections of PLCL/PLGA blend films did not evidence 
phase separation between blend components and the behavior of blend glass transition 
XVIII 
 
temperatures as a function of composition suggested some degree of blend compatibility. On 
the other hand, the elastic modulus of PLCL/PLGA blends showed a negative deviation 
from the additive law of mixture. In vitro cell tests with fibroblast NIH 3T3 cells showed 
improved cell adhesion and growth on PLCL/PLGA 25/75 blend. Thus, due to its 
biocompatibility, its superior mechanical properties (E = 10.2 ± 0.6 MPa, σmax = 0.8 ± 0.0 
MPa, and εmax = 548.8 ± 57.9%) and compatibility between the components, PLCL/PLGA 
25/75 blend was selected for this application. Compact films were then surface modified via 
layer-by-layer (LbL) technique to enhance fibroblast cell response and confer antibacterial 
efficacy. A surface priming treatment was applied and optimized before depositing LbL 
coating. PLCL/PLGA 25/75 films were pre-functionalized through aminolysis by using the 
following parameters: C = 0.08 g/mL, t = 8 min and T = 37 °C. Then, multilayered 
chondroitin sulfate/chitosan (CHS/CH) coatings were deposited on the aminolysed films. 
The feasibility of multilayer coating was confirmed by QCM-D analysis. Further 
confirmations of LbL build up on blend films derived from water contact angle 
measurements, which showed that the contact angle jumped alternatively between 45° and 
65° depending on the outmost layer component. FTIR-ATR analysis evidenced the 
appearance of absorbance peaks characteristics of CHS and CH, namely a broad peak 
between 3600 cm
-1
 and 3200 cm
-1
 attributed to the stretching vibrations of the N-H/O-H, a 
wide band in the 1650-1600 cm
-1
 region associated to amide I stretching vibration, and a 
peak at around 1550 cm
-1
 arised from amide II bending vibration. FTIC-labelled CH was 
also employed to follow LbL built up by fluorescence microscopy analysis. In vitro cell tests 
demonstrated the ability of coated samples to improve NIH 3T3 fibroblast adhesion and 
proliferation. Biocompatibility properties increased with increasing the layer number and 
were superior in the case of CH-terminating layers. However, no antibacterial activity was 
observed for films coated with 16 layers. 
Three dimensional sponge-like composite membranes fabricated by freeze-drying, with a 
similar composition to that of natural bone, and based on β-tricalcium phosphate (TCP) 
dispersed in a chitosan/gelatin (CH/G) network cross-linked with genipin (GP) and 
disodium phosphate salt (DSP) were developed as porous layer of the bi-layered device. 
Three kinds of membranes were developed (CH/G, CH/G+GP-DSP and CH/G/TCP+GP-
DSP) and characterized in terms of their cross-linking degree (Kaiser test), morphology 
(SEM analysis), chemical structure (EDS and FTIR-ATR analyses), thermal stability (TGA 
analysis), tensile mechanical behavior, stability in water (water absorption and dissolution 
tests), and biological response by in vitro cell tests using MG-63 human osteoblast-like 
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cells. Successful double cross-linking of CH/G network was confirmed by the performed 
characterizations. All membranes showed a typical foam-like morphology with 
interconnected pores having an average diameter of 100-200 μm. Both cross-linking and 
TCP presence caused a marked increase of membrane stability in water solution, as well as 
of tensile modulus and maximum tensile strength (respectively, 14.9 ± 5.1 MPa and 0.6 ± 
0.0 MPa for CH/G, and 29.4 ± 2.7 MPa and 0.8 ± 0.1 MPa for CH/G/TCP+GP-DSP.). In 
addition, compared to uncross-linked samples, CH/G+GP-DSP and CH/G/TCP+GP-DSP 
membranes showed improved cell response, in terms of cell viability and morphology. 
Finally, the assembly process of the compact and porous layer was developed based on the 
insertion of an intermediate adhesive layer composed by a 
polyvinylpyrrolidone/polyethylene glycol (PVP/PEG) 70/30 (wt/wt) blend. Preliminary 
characterizations of the bi-layered membrane were carried out. Morphological analysis did 
not show changes in compact and porous layer structure due to the presence of PVP/PEG 
70/30 adhesive. The final device showed an elastic modulus of about 61 MPa in dry 
condition that markedly decreased in wet state (to about 5 MPa). Finally, qualitative analysis 
of membrane manageability revealed its ability to adapt to mandible conformation after 
immersion in physiological solution. Despite the need for additional tests, the bi-layered 
membrane appeared promising for GTR/GBR applications. 
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Introduction to the Thesis Format 
This thesis is divided in IV sections, containing globally 8 chapters (six of them describing 
the experimental work performed): the content of each section is summarized below. 
Section I (Chapter 1) gives an overview of the current state of the art on guided tissue/bone 
regeneration membranes for periodontal applications, focusing on all the scientific and 
technological aspects which have been demonstrated to be crucial for a successful approach 
within this field, as well as some brief insights on future trends. 
Section II describes the preparation and characterization of non-absorbable 
polytetrafluoroethylene membranes, surface modified with hydroxyapatite (Chapter 2) and 
silver nanoparticles (Chapter 3). The main aim of this part of the work was to prepare 
membranes with enhanced bioactivity, by the addition of inorganic phase, and antimicrobial 
activity, by the addition of silver. 
Chapter 2 is focused on the development and characterizations of non-degradable 
polytetrafluoroethylene membranes coated with bioactive hydroxyapatite by an 
environmentally friendly technique, with the aim to tailor the surface properties, allowing 
rapid bone re-growth. 
Chapter 3 is focused on the preparation and characterization of an antimicrobial coating on 
polytetrafluoroethylene membrane, in order to eliminate pathogens in the treated site. Silver 
nanoparticles have been selected as antimicrobial agents due to their good antimicrobial 
efficacy against bacteria, viruses and other eukaryotic micro-organisms. 
Section III describes the preparation and characterization of an innovative bi-layered 
absorbable membrane (Chapter 7), based on a compact (Chapter 4 and 5) and a porous layer 
(Chapter 6). 
Chapter 4 is focused on the preparation and characterization of different compositions of 
poly(DL-lactide-co-ε-caprolactone)/poly(DL-lactide-co-glycolide) blends with the aim to 
select the one with the best mechanical behavior and biocompatibiliy for the perspective 
application. 
Chapter 5 is focused on the preparation and characterization of nanostructured coating via 
the Layer-by-Layer technique on the previously blend substrate selected, with the aim to 
improve cell response and antimicrobial activity. A surface priming functionalization 
method was also studied. 
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Chapter 6 is focused on the preparation and characterization of sponge-like membranes by 
the freeze-drying method, having a similar composition to that of natural bone and 
containing bioactive β-tricalcium phosphate, able to stimulate biomineralisation. The 
organic phase is based on gelatin and chitosan. The scaffolds are fully characterized in their 
physiochemical, structural, mechanical and biological properties. 
Chapter 7 is focused on the development of the assembly method for the compact and 
porous layers, previously developed. A biomedical glue based on polyvinylpyrrolidone and 
polyethylene glycol blend was selected and preliminary characterizations were performed 
on the final bi-layered membrane. 
Section IV (Chapter 8) presents the main achievements of the experimental work developed 
within the scope of the present thesis drawing the general conclusions and indication for 
future work. 
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1 
Guided Tissue Regeneration membranes 
for periodontal applications: 
State of the Art and future trends 
 
1.1 Introduction 
The aging population is one of the main reasons we need to advance the understanding of dental 
biomaterials. The progressive aging of population will cause an increase in the number of 
surgical and restorative procedures related to either oral rehabilitation, with the placement of 
dental implants and ceramic crowns, or to periodontal regeneration, which often requires the 
use of membranes for guided tissue regeneration (GTR) and grafting materials. 
Periodontitis is one of the most destructive pathologies that affect the integrity of the 
periodontal system and lead to damage of the periodontal tissues and, ultimately, tooth loss [1]. 
The development of periodontal disease is affected by individual conditions, such as life-style 
and genetics. It often starts in middle age and its incidence increases with age and is accelerated 
by systemic disorders such as diabetes, osteoporosis, cardiovascular and respiratory disease, and 
metabolic deficiencies. Data from the National Institute of Dental and Craniofacial Research 
(NIDCR, National Institutes of Health, United States) have revealed that nearly 90% of the 
adult population more than 70 years old present at least a moderate level of periodontal-related 
diseases [1, 2]. 
Clinical and/or surgical intervention is needed to reestablish healthy periodontal tissues. During 
the last decade, various regenerative surgical procedures have been proposed and examined for 
the regeneration of those part of the tooth-supporting apparatus which have been lost due to 
periodontitis, including alveolar bone, cementum, periodontal ligament and gingival. These 
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treatments have encompassed the utilization of a wide variety of surgical approaches, barrier 
membranes, a series of bone grafts and other osteoconductive/inductive materials or protein 
mixtures, exogenous growth factors, cell-based technologies and genes from recombinant 
technology. Among these approaches, periodontal tissues regeneration has achieved a 
significant success following the use of GTR strategies. Nonetheless, results are variable and 
reliant on patient age, defect size, and other demographic and lifestyle effects [3, 4]. 
GTR was first developed in the early 1980s by Nyman and Karring with the aim to regenerate 
lost periodontal tissues [5]. GTR is based on the concept that specific cells contribute to the 
formation of the different specific tissues. Melcher described selective cell repopulation of 
defects as a tool to enhance healing [6]. Exclusion of fast-growing epithelium and connective 
tissue from a periodontal wound for 6-8 weeks allows cells of the slower growing tissues, 
including osteoblasts, cementoblasts, and periodontal ligament cells, to fill the space adjacent to 
the tooth. 
Soon, GTR found applications in other areas, including the regeneration of bone tissue. The 
term guided bone regeneration (GBR) was introduced as a corollary of GTR by Nyman and 
Gottlow, who applied occlusive barriers in periodontal healing studies to stop the cell migration 
from gingival connective tissue and epithelium to the periodontal defect, which can interfere 
with tissue regeneration. Subsequently, Buser et al. [7] introduced the principle of GBR, applied 
in clinical dentistry to promote bone regeneration using a barrier membrane allowing the re-
population of the osseous wound space. Since then, membrane barriers and bone grafting 
materials in GBR technique have been extensively investigated in periodontal regenerative 
medicine and dental implant therapies to enhance new bone formation for the placement of 
implants [8, 9]. 
1.2 Anatomy of the periodontium 
The periodontium (pert = around, odontos = tooth) is an intricate system comprising the 
following tissues (Fig. 1.1): (1) the dentogingival junction (part of the gingival facing the 
tooth), (2) the periodontal ligament, (3) the root cementum, and (4) the alveolar bone (bone 
lining the tooth socket). 
The main function of the periodontium is to attach the tooth to the bone tissue of both mandible 
and maxilla and preserve their position, and to maintain the integrity of the surface of the 
masticatory mucosa of the oral cavity [10]. Additionally, it assures proper function and 
dissipation forces, preventing injury to teeth, mandible, and maxilla [11]. 
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The periodontium, also called “the attachment apparatus” or “the supporting tissue of the teeth”, 
constitutes a development, biologic, and functional unit which undergoes certain changes with 
age and is, in addition, subjected to morphologic changes related to functional alterations and 
modifications in the oral environment. It is important to understand that each of the periodontal 
components has its highly specialized structure which directly defines its function. Indeed, 
proper functioning of the periodontium is only achieved through structural integrity and 
interaction between its components [12]. 
 
Fig. 1.1 Schematic illustration showing a longitudinal section through dento-gingival part of a tooth and its periodontal 
tissue apparatus. 
 
1.2.1  Dentogingival junction 
The dentogingival junction is an adaptation of the oral mucosa that consists of an epithelial 
layer and an underlying connective tissue layer. The epithelium may be differentiated as 
follows: 
- oral epithelium, which faces the oral cavity; 
- oral sulcular epithelium, which faces the tooth without being in contact with the tooth 
surface; 
- junctional epithelium, which provides the contact between the gingiva and the tooth. 
The connective tissue, called lamina propria, is the predominant tissue component of the 
dentogingival junction and is divided into superficial and deep compartments. The major 
components of the connective tissue are collagen fibers (around 60% of connective tissue 
volume), fibroblasts (around 5%), vessels and nerves (around 35%) which are embedded in an 
amorphous ground substance (matrix). 
The junctional epithelium plays a crucial role since it essentially seals off periodontal tissues 
from the oral environment. Its integrity is thus essential for maintaining a healthy periodontium. 
Periodontal disease sets in when the structure of the junctional epithelium starts to fail, an 
excellent example of how structure determines function [10, 12]. 
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1.2.2  Cementum 
The cementum is a specialized mineralized tissue covering the root of teeth. It has many 
features in common with bone tissue. However, the cementum contains no blood or lymph 
vessels, has no innervations, does not undergo physiologic resorption or remodeling, but is 
characterized by continuing deposition throughout life. Like other mineralized tissues, it 
contains collagen fibers embedded in an organic matrix. Its mineral content, mainly consisting 
of hydroxyapatite (HAp), is about 65% by weight, slightly higher than that of bone (60%). 
Cementum has different functions: it attaches the periodontal ligament fibers to the root and it 
contributes to the process of repair after damage to the root surface [10]. Three types of 
cementum exist, distinguished on the basis of the presence or absence of cells and the origin of 
the collagen fibers of the matrix. Acellular extrinsic fiber cementum (primary cementum or 
acellular cementum) is found in the coronal and middle portions of the root; its thickness is 
around 10 μm. It develops very slowly and is defined acellular because cells are only found on 
its surface. The presence of an elevate number of main periodontal ligament fibers attached to 
the acellular cementum (where they are called Sharpey‟s fibers) underlines its important role in 
tooth attachment to the alveolar bone. The overall degree of mineralization of acellular 
cementum is about 45–60%: the innermost layer is the less mineralized while the outer layers 
are characterized by the presence of alternating bands with high and low mineral content that 
run parallel to the root surface. 
Cellular intrinsic fiber cementum (secondary cementum or cellular cementum) is distributed 
along the apical third or half of the root and in furcation areas; it can grow up to 100 μm or 
more. As cellular intrinsic fiber cementum is also produced as a repair tissue that fills resorptive 
defects and root fractures, it may also be found further coronally. Collagen produced by 
cementoblasts (intrinsic collagen fibers) and the presence of cementoblasts entrapped in lacunae 
within the matrix they produce (cementocytes) are the characteristic features of cellular intrinsic 
fiber cementum. The heterogeneous collagen organization, its rapid speed of formation, and the 
presence of cells and lacunae may be the reason why this cementum variety is less mineralized 
than acellular extrinsic fiber cementum. 
Cellular intrinsic fiber cementum constitutes the intrinsic component of cellular mixed stratified 
cementum, which possesses a stratification that is derived from consecutively deposited, 
alternating layers of acellular extrinsic fiber cementum and cellular intrinsic fiber cementum. 
Cellular mixed stratified cementum is always present in human teeth and it may serve as a 
means to adjust the tooth position to new requirements [12]. 
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1.2.3  Periodontal ligament  
The periodontal ligament is the soft, richly vascular and cellular connective tissue situated 
between the cementum covering the root of the tooth and the bone forming the socket wall. 
Similar to all other connective tissues, the periodontal ligament consists of cells and an 
extracellular compartment comprising collagenous and non-collagenous matrix constituents. 
The cells include osteoblasts and osteoclasts, fibroblasts, epithelial cells, monocytes and 
macrophages, undifferentiated mesenchymal cells, and cementoblasts and odontoclasts. The 
extracellular compartment consists mainly of well-defined collagen fiber bundles embedded in 
an amorphous background material, known as ground substance. The width of the periodontal 
ligament is approximately 0.25 mm and it maintains its width more or less over time. 
The presence of a periodontal ligament permits forces, elicited during masticatory function and 
other tooth contacts, to be distributed to and resorbed by the alveolar bone. The periodontal 
ligament is also essential for the mobility of the teeth, which is determined to a large extent by 
the width, height, and quality of the periodontal ligament. Importantly, it is a cell reservoir for 
tissue homeostasis and repair⁄regeneration. 
Finally, the periodontal ligament has the capacity to adapt to functional changes. When the 
functional demand increases, the width of the periodontal ligament can increase by as much as 
50%, and the fiber bundles also increase markedly in thickness. Conversely, a reduction in 
function leads to narrowing of the ligament and a decrease in number and thickness of the fiber 
bundles. These functional modifications of the periodontal ligament also implicate 
corresponding adaptive changes in the bordering cementum and alveolar bone [12]. 
1.2.4  Alveolar bone 
The alveolar process is defined as the parts of the maxilla and mandible that form and support 
the sockets of the teeth. It consists of outer cortical plates (buccal, lingual, and palatal) of 
compact bone, a central spongiosa, and bone lining the alveolus (alveolar bone). The cortical 
plate and bone lining the alveolus meet at the alveolar crest. 
The cortical plates consist of surface layers (lamellae) of fine-fibered bone supported by 
Haversian systems. They are generally thinner in the maxilla and thickest on the buccal aspect 
of mandibular premolars and molars. The trabecular (or spongy) bone occupying the central 
part of the alveolar process also consists of bone disposed in lamellae, with Haversian systems 
present in the larger trabeculae. Yellow marrow, rich in adipose cells, generally fills the 
intertrabecular spaces, although sometimes there can also be some red or hematopoietic 
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marrow. Trabecular bone is absent in the region of the anterior teeth and, in this case, the 
cortical plate and alveolar bone are fused together [12]. 
Together with the root cementum and the periodontal membrane, the alveolar bone constitutes 
the attachment apparatus of the teeth, the main function of which is to distribute and resorb 
forces generated by mastication and tooth contacts [10]. Because the tooth is constantly making 
minor movements and alveolar bone must respond to the functional demand placed on it by the 
forces of mastication, the bone of the socket wall is constantly remodeled and its structural 
organization varies along the wall [13]. The organization of the alveolar process is yet another 
example of structure-function relationship in the periodontium. 
Whereas the overall formation and regulatory events in alveolar bone are the same as at other 
anatomical sites, alveolar bone is distinctive because it turns over very rapidly and it is lost in 
the absence of a tooth. These two characteristics suggest that local regulatory mechanisms are 
particularly important in the case of alveolar bone. They also clearly demonstrate the 
interdependence of the periodontal tissues and underlines the important fact that the periodontal 
tissues function together as a unit [12]. 
The remodeling process of alveolar bone is essentially similar to that of bone in general [13]. 
However, resorption is asynchronous, so that periodontal ligament attachment is lost only 
focally and for short periods of time. During tooth migration, the distribution of force is such 
that bone lost by resorption on one surface of the tooth socket is balanced by bone formation 
along the opposite surface. This bone balance together with the continued deposition of 
cementum throughout life act to maintain a more or less constant relationship between the root 
surface and that of the alveolar socket. 
1.3 Periodontal diseases 
The performance of the periodontium depends upon its structural integrity and interactions 
among its components [12]. Periodontal disease can progressively destroy the periodontium, 
ultimately resulting in tooth loss. 
The term periodontal disease usually refers to the common inflammatory disorders of gingivitis 
and periodontitis that are caused by pathogenic microflora in the biofilm or dental plaque that 
forms adjacent to the teeth on a daily basis [14]. In 1999, the International Workshop for a 
Classification of Periodontal Diseases and Conditions classified the periodontal diseases in 
eight main categories [15]: 
I. Gingival diseases 
II. Chronic periodontitis 
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III. Aggressive periodontitis 
IV. Periodontitis as a manifestation of systemic diseases 
V. Necrotizing periodontal diseases 
VI. Abscesses of the periodontium 
VII. Periodontitis associated with endodontic lesions 
VIII. Developmental or acquired deformities and conditions. 
Gingivitis, the mildest form of periodontal disease, is caused by the bacterial biofilm (dental 
plaque) that accumulates on teeth adjacent to the gingival (gums). However, gingivitis does not 
affect the underlying supporting structures of the teeth and is reversible [14]. On the contrary, 
inflammation that extends deeper into the tissue and causes loss of supporting connective tissue 
and alveolar bone is known as periodontitis. It results in the formation of soft tissue pockets or 
deepened crevices between the gingival and tooth root, and, with time, in tooth mobility, 
drifting, and ultimately tooth loss. Severe periodontitis can result in considerable loss of 
function of the dentition, occasional pain and discomfort, and in aesthetic problems [1, 16]. 
Gingivitis and periodontitis are infectious diseases that afflict a high percentage of the 
population, even at younger ages. In its FY2003 Fact Sheet, the American Association for 
Dental Research reports that 48% of adults aged 35–44 years have inflammation of the gingiva 
(gingivitis), and 22% destructive periodontal disease, a major cause of tooth loss. In addition, 
evidence has been mounting that chronic periodontal diseases are linked with major systemic 
diseases, such as cardiovascular and pulmonary diseases [17, 18]. Although bacteria are 
essential for periodontitis to develop, the fact that it develops to variable degrees in different 
individuals suggests a multifactorial etiology. All forms of periodontitis, however, appear to 
have a common series of underlying events leading to tissue breakdown and tooth attachment 
loss. 
Bacteria are necessary for periodontal disease to take place but a susceptible host is also needed. 
The immune-inflammatory response that develops in the gingival and periodontal tissues in 
response to the chronic presence of plaque bacteria results in destruction of structural 
components of the periodontium leading, ultimately, to clinical signs of periodontitis. An 
individual‟s risk for periodontal disease could be linked to gingival inflammation in response to 
plaque accumulation [19]. The host response is essentially protective, but both hypo-
responsiveness and hyper-responsiveness of certain pathways can result in enhanced tissue 
destruction [20]. 
Both the host and bacteria in the periodontal biofilm release proteolytic enzymes that damage 
tissue. They release chemotactic factors that recruit polymorphonuclear leucocytes into the 
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tissues; if sustained, these cells release various enzymes that break down tissues. Hundreds or 
even thousands of microbial antigens evoke both humoral antibody-mediated and cell-mediated 
immune responses. These responses are usually protective, but a sustained microbial challenge 
in the presence of the risk factors (i.e., smoking, genetic polymorphisms, diabetes) results in the 
breakdown of both soft and hard tissues, mediated by cytokine and prostanoid cascades [1]. 
Once a periodontal pocket forms and becomes filled with bacteria, the situation becomes largely 
irreversible. Gingival epithelium proliferates to line the pocket and even if treatment resolves 
the inflammation and some bone and connective tissue are regenerated, complete restoration of 
the lost tooth support is impossible. Without adequate treatment, active periodontitis leads to 
tooth loss. 
As mentioned before, different factors contribute to the cause of periodontal diseases. 
1) Oral microorganisms 
The mouth, like all external surfaces of the body and the gut, has a substantial microflora living 
in symbiosis with a healthy host. The microflora of the mouth contains over 500 different 
species of aerobic and anaerobic bacteria and the junctional epithelium provides a very efficient 
barrier against periodontal pathogens and their products. These organisms grow on tooth 
surfaces as complex, mixed, interdependent colonies in biofilms, and are attached and densely 
packed against the tooth [21]. As dental plaque matures to a state that is associated with 
periodontal disease, the number of gram-negative and anaerobic bacteria increases [22]. 
Bacterial counts above the gums (supragingival) on one tooth surface can exceed 1·109 bacteria. 
Below the gum, the number of bacteria ranges from 1·103 in a healthy shallow crevice to more 
than 1·108 in a periodontal pocket [23]. Certain clusters of bacterial species commonly cohabit 
subgingival sites and are reproducibly associated with disease. These putative pathogens 
include Porphyromonas gingivalis, Tannerella forsythensis, and the spirochaete Treponema 
denticola. Infection of periodontal tissues with these and other organisms is accompanied by the 
release of bacterial leucotoxins, collagenases, fibrinolysins, and other proteases [24]. 
Actinobacillus actinomycetemcomitans is another species commonly associated with disease, 
especially in young adults [25]. 
2) Genetics 
Rare syndromes affecting phagocytes, the structure of the epithelia, connective tissue, or teeth, 
could have severe periodontal manifestations. Haim-Munk and Papillon-Lefèvre syndromes are 
rare autosomal recessive disorders associated with periodontitis onset at childhood and early 
loss of both deciduous and permanent teeth. Other disorders that have severe periodontal 
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manifestations include Chédiak-Higashi, Ehlers-Danlos (types 4 and 8), Kindlers, and Cohen 
syndromes [1]. 
3) Tobacco and alcohol use 
Oral smokeless tobacco can lead to gingivitis, loss of tooth support, and precancerous gingival 
leucoplakia at the site of quid placement [26]. The risk of periodontal disease in long-term 
smokers is equal to that of lung cancer, and smoking has a strong negative effect in response to 
periodontal treatment and other oral surgical interventions [27]. By contrast with tobacco use, a 
small but significant association exists between alcohol consumption and loss of periodontal 
support [28]. 
4) Nutrition 
Historically, specific, overt nutritional deficiencies have been associated with periodontal 
disease. Vitamin C deficiency leads to scurvy with decreased formation and maintenance of 
collagen, increased periodontal inflammation, hemorrhage, and tooth loss [29]. 
5) Diabetes 
People with type 1 diabetes at all ages and adults with type 2 diabetes have more widespread or 
severe periodontal disease than individuals without diabetes. Although people with well-
controlled diabetes do not seem to be at increased risk of periodontal disease respect to people 
without diabetes, those with poorly controlled diabetes are at raised risk for periodontitis and 
progressive bone loss [30]. Diabetes is associated with impaired wound healing, exaggerated 
monocyte response to dental plaque antigens, and impaired neutrophil chemotactic responses, 
all of which can lead to increased local tissue destruction [31, 32]. 
6) Impaired host response 
As an inflammatory disease, severe periodontal disease and loss of tooth-supporting tissues 
often occur if the individual‟s host response or immune function is impaired. Various systemic 
diseases such as leukaemia, thrombocytopenia, and leucocyte disorders such as agranulocytosis, 
cyclic neutropenia, and leucocyte adhesion deficiency could be associated with increased 
severity of periodontal disease [1]. 
Gingival recession is another periodontal problem that affects millions of people worldwide 
[33]. It is a multifactiorial condition (i.e., periodontal disease, trauma, gender, and tobacco 
consuption) found primarily in adult patients regardless of oral hygene [34, 35]. It is a result of 
apical migration of the gingival margin that leads to root surface exposure [35]. 
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1.4 Prevention and treatment of periodontal diseases 
Prevention of gingivitis and periodontitis is based on the control of their causal and risk factors. 
The most widely accepted risk factor is the periodontal biofilm that forms on the teeth in the 
absence of effective oral hygiene [1]. 
Tooth brushing and the use of dental floss and other devices to remove plaque from the teeth 
are the most common ways of disrupting or removing the periodontal biofilm from teeth. 
Although these methods are effective if used every day, they require motivation and dexterity. 
Mouthwashes and dentifrices containing antibacterial drugs have been used as adjuncts for 
controlling the biofilm. These combinations contain various biocides, surfactants, polymers, or 
other components that can reduce the biofilm and are generally not associated with the 
emergence of a resistant microbiota [36]. 
After all oral hygiene procedures are ceased, the biofilm begins to develop on the teeth within 
24 h and causes gingivitis in 10–21 days. Thorough tooth cleaning returns the gingiva to a 
healthy condition in about 1 week [37]. Control of the periodontal biofilm with professionally 
administered oral hygiene can slow or stop periodontitis and tooth loss for many years [38]. 
Treatment for gingivitis and periodontitis should establish periodontal health, arrest the 
progression of disease, prevent recurrence of disease, and preserve the dentition in a state of 
health, comfort, and function. This goal can be accomplished by various non-surgical and 
surgical therapies, depending on the specific treatment objective [1]: for patients with early or 
moderate disease, non-surgical treatment is often sufficient; for patients with advanced disease, 
a variety of types of periodontal surgery can be used. 
The different strategies of periodontal therapy aim to (1) reduce and/or eliminate inflamed 
tissues caused by bacterial plaque, (2) correct defects or anatomical problems due to the disease, 
and (3) regenerate new periodontal tissues [39, 40]. 
The cornerstone of periodontal therapy is anti-infective non-surgical treatment aimed at 
controlling the biofilm and other prominent risk factors. Dental plaque and calculus deposits 
adherent to the tooth both supra- and subgingivally can be removed by use of various manual or 
powered instruments [41]. In some cases this non-surgical therapy may also be combined with 
adjunctive antimicrobial therapy. In addition, long-term outcomes of treatment are dependent 
on the patient‟s commitment to maintaining a high standard of regular oral hygiene in order to 
prevent bacterial recolonization of the affected lesions [16, 42]. 
This non-surgical therapy can reduce tissue inflammation and pocket depths and improve 
clinical periodontal attachment. The tissues typically heal by repair, being characterized by 
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tissue shrinkage, fibrosis, and limited bone remodelling, but without any appreciable coronal 
regeneration of the lost tissues present [1, 16].  
While this treatment may be very effective in preventing future progression of disease and 
therefore any ultimate tooth loss, there are a number of limitations of this treatment outcome 
[16]. 
1) The treatment may have very limited impact on the existing mobility of teeth in view of 
the lack of regeneration of lost tissues. 
2) The treatment results typically in large amounts of gingival recession, which is both 
unsightly and may result in increased tooth sensitivity and susceptibility to root caries. 
3) It is postulated that, without restitution of the original anatomy, the site may be more 
susceptible to recurrence of disease in the future. 
An important long-standing aim of periodontal treatment has been to devise therapeutic 
interventions that would allow the clinician to regenerate the lost periodontal tissues. 
Periodontal regeneration requires the coordinated formation of new alveolar bone, dental 
cementum, and functionally oriented periodontal ligament interposed between these two tissues. 
In this contest, four particular issues are posed [16]: 
1) the requirement for the coordinated formation of the three tissues of the periodontal 
ligament; 
2) the potential role of bacterial contamination during healing; 
3) the specific requirement for dental cementum formation, a tissue that is not seen in other 
parts of the body; 
4) the requirement for coronal regeneration of tissues towards the overlying superficial 
tissues. 
The achievement of predictable periodontal regeneration has proved to be a remarkably elusive 
goal for clinical periodontists in most clinical circumstances. 
1.5 Biology of periodontal healing and regeneration 
Previous research on periodontal healing has provided a basic understanding of the mechanisms 
favoring periodontal tissue regeneration. A number of valuable findings at both the cellular and 
molecular levels was revealed and subsequently used to engineer the regenerative biomaterials 
currently available in periodontal medicine [43]. The rationale to consider when developing 
biomaterials and devices for periodontal healing and regeneration relies on the fact that, on one 
side, they will face the bone defect while, on the other side, they will face the gingival 
connective tissue/epithelium. Therefore, the implants should be designed to meet the local 
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functional requirements [44]: rapid wound healing and antimicrobial action on the side in 
contact with gingival tissue and rapid bone re-growth and osteointegration on the side in contact 
with bone tissue. 
1.5.1  Gingival wound healing process  
The biology and principles of wound healing in non oral sites, also apply to the healing process 
that take place following periodontal surgery. The sequence of healing after blood-clot 
formation is commonly divided into three phases: (1) inflammation, (2) granulation tissue 
formation, and (3) intercellular matrix formation and remodeling. These stages may overlap 
considerably and the time needed for completion of each stage may vary, depending on local 
and systemic factors [45, 46]. 
Traumatic injury causes capillary damage and hemorrhage and, as a result, a blood clot is 
formed. It has two functions: it temporarily protects the denuded tissues and it serves as a 
provisional matrix for cell migration [47]. The blood clot consists of all cellular components of 
blood (including red and white blood cells and platelets) in a matrix of fibrin, plasma 
fibronectin, vitronectin, and thrombondin [48].  
Within hours of injury, the inflammatory phase of healing initiates with polymorphonuclear 
leukocytes infiltration into the fibrin clot from the wound margins, followed shortly afterwards 
by macrophages [49]. The major function of the polymorphonuclear leukocytes is to debride the 
wound by removing bacterial cells and injured tissue particles through phagocytosis. The 
macrophages, in addition, have an important role in the initiation of tissue repair. Within 3 days, 
the inflammatory reaction moves into its late stage as the amount of polymorphonuclear 
leukocyte infiltrate gradually decreases while the macrophage influx continues. These 
macrophages contribute to the cleaning process through the phagocytosis of used 
polymorphonuclear leukocytes and erythrocytes. They release also a number of biologically 
active molecules, such as inflammatory cytokines and tissue growth factors, which recruit 
further inflammatory cells as well as fibroblastic and endothelial cells, thus playing an essential 
role in the transition of the wound from the inflammatory stage to the granulation tissue-
formation phase. 
The influx of fibroblasts and budding capillaries from the gingival connective tissue and the 
periodontal ligament connective tissue initiate the phase of granulation-tissue formation in the 
periodontal wound approximately 2 days after incision. The cell-rich granulation tissue next 
undergoes maturation and remodeling. Fibroblasts responsible for the replacement of the 
provisional extracellular matrix produce a new collagen-rich matrix. Approximately 1 week 
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following wounding, and once the collagen matrix has been synthesized, some fibroblasts 
undergo transformation into myofibroblasts and express α-smooth muscle actin. This 
transformation and synthesis is responsible for wound contraction. Endothelial cells, 
responsible for angiogenesis, migrate into the provisional wound matrix to form vascular tubes 
and loops, and as the provisional matrix matures, the endothelial cells undergo programmed cell 
death (apoptosis) and the number of vascular units is reduced [48, 50]. 
Maturation of the granulation tissue will lead to the final phase of healing where the reformed, 
more cell-rich tissue, undergoes maturation and sequenced remodeling to meet functional needs 
[45, 46]. 
There has been general observations that wounds in oral sites heal faster and with less scarring 
than extraoral wounds. It is probable that oral wound healing is enhanced partly because of 
factors present in the saliva and by the specific microflora of the oral cavity [51]. Generally, the 
healing of gingival epithelia and their underlying connective tissues concludes in a number of 
weeks. 
1.5.2  Bone regeneration process  
Bone possesses the intrinsic capacity for regeneration as part of the repair process in response to 
injury, as well as during skeletal development or continuous remodeling throughout adult life 
[52, 53]. Bone regeneration is comprised of a well-orchestrated series of biological events of 
bone induction and conduction, involving a number of cell types and intracellular and 
extracellular molecular-signaling pathways, with a definable temporal and spatial sequence, in 
an effort to optimize repair and restore function [53, 54]. Unlike in other tissues, the majority of 
bony injuries heal without the formation of scar tissue, and bone is regenerated with its pre-
existing properties largely restored, and with the newly formed bone being eventually 
indistinguishable from the adjacent uninjured bone [53]. 
Improved knowledge about the biological mechanisms and the temporal dynamics of new bone 
formation under the conditions of guided regeneration is critical. However, scientists and 
clinicians considered this knowledge a prerequisite to better understand the healing steps 
leading to regenerated and fully mature bone in order to be able to beneficially influence 
healing for further developments in the field and for increased predictability of the clinical 
outcomes [55]. 
Bone contains three main bone-specific cell types: osteocytes are mature cells that reside in 
bone lacunae, communicate with other osteocytes through long cellular processes, sense 
mechanical stress in bone, and send signals for bone remodeling as a result of mechanical 
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stress. The responding cells are osteoblasts, cells specialized to secrete the unique collagen-rich 
extracellular matrix in bone that enables mineralization; and osteoclasts, macrophage-like cells 
that degrade the bone structure through a combination of localized acidification (removes the 
minerals) and protease secretion (breaks down matrix). Osteoclasts tunnel through bone and are 
usually followed close behind by osteoblasts [56]. 
The type of bone being formed by applying the principle of GTR has been investigated in both 
animals [57-58 9] and human studies [60]. In all these experiments, a similar basic pattern of 
bone formation was observed. Initially, trabeculae of woven bone proliferated into the defect. 
Then, the bone volume increased with time and the primary intramembraneous trabecular 
scaffold underwent intense remodeling: numerous osteoclasts arose and began to eliminate the 
primitive woven bone, whereas a new generation of osteoblasts deposited mature lamellar bone 
layers on the woven bone remnants. As a consequence of the continuous remodeling of the 
primary bony network, most of the trabeculae contained only a small, intensely stained core of 
woven bone surrounded by thick bone layers of regular lamellar texture and thus comprised the 
secondary spongiosa. The continuous growth of the bone trabeculae resulted in the narrowing of 
the intertrabecular connective tissue and in the formation of primary osteons containing 
vascular channels. The presence of osteoid seams with overlying osteoblasts indicated 
continuation of the osteogenic process. At the defect borders facing the membranes, cortical 
bone was formed by continuous lamellar bone deposition. Finally, secondary osteons were 
formed replacing the previously formed cortical bone. 
The mechanism of bone healing depends on the size of the defect [55]. In cortical bone, circular 
defects of less than 200 μm had the potential to heal with concentric formation of lamellar bone 
[57]. In larger defects of 200 to 500 μm, bone healing was characterized by formation of a 
trabecular network of woven bone bridging the defect. Subsequently, the spaces between the 
trabeculae were filled with lamellar bone. In defects of 500 μm and larger, bridging by direct 
formation of bone did not occur. Following 3 weeks of healing, such defects exhibited a central 
area characterized by the presence of connective tissue. 
1.6 Current treatments for clinical periodontal regeneration 
Periodontal regeneration is defined as the regeneration of the tooth-supporting tissues including 
cementum, periodontal ligament and alveolar bone [61]. A number of different treatments have 
been developed to promote periodontal regeneration since the mid-1980s; they include bone 
replacement grafts, root surface biomodifications, cell-occlusive barrier membranes used in 
GTR/GBR procedures, and delivery of growth factors or gene therapies [62]. All of these 
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strategies aim to correct defects due to disease, and regenerate new periodontal tissues. In 
general, however, the clinical outcome of periodontal regenerative techniques depends on (i) 
patient-associated factors (i.e. plaque control, smoking habits, residual periodontal infection), 
(ii) effects of occlusal forces that deliver intermittent loads in axial and transverse directions, 
and (iii) factors associated with the clinical skills of the operator [63]. Consequently, both 
clinical and preclinical research continues to evaluate advanced regenerative approaches using 
new barrier membranes [64], cell-growth-stimulating proteins [65, 66] or gene delivery 
applications [67] in order to simplify and enhance the rebuilding of missing periodontal support. 
1.6.1  Bone replacement grafts  
Bone replacement grafts remain the most widely used therapeutic strategies for the correction of 
periodontal osseous defects; they provide demonstrable clinical improvements in periodontal 
osseous defects compared to surgical debridement alone [68]. 
Grafts can play a part in the correction of the osseous aspects of periodontal defects either by 
the process of osteoinduction or by osteoconduction [68, 69]. An osteoinductive material can 
induce bone formation by recruiting undifferentiated mesenchymal cells and causing them to 
differentiate into osteoblastic cells. An osteoconductive material acts principally as a 
scaffolding material for new bone formation to occur. 
Four major graft materials commonly used in clinics are autologous grafts, allografts, 
xenografts, and synthetic grafts or alloplasts. Autogenous bone grafts obtained either from 
intraoral sites or extraoral sites are thought of as “gold standard” with the ideal properties of 
grafts. They are a source of autogenous osteogenic cells as well as osteoinductive scaffolds. 
However, the volume of bone may be limited and the resorption may be unpredictable [70]. The 
autogenous bone collected during the surgery may also be contaminated by the microorganisms 
in the oral cavity [71]. 
To overcome these problems, a range of other bone graft materials have been utilized. 
Allografts are graft materials derived from a donor of the same species, which may be a fresh 
frozen bone (FFB), freeze-dried bone allografts (FDBA) or demineralized freeze-dried bone 
allografts (DFDBA). They can act as osteoconductive scaffolds and osteoinductive materials, 
due to the remaining proteins [72]. Xenografts are graft materials derived from another species, 
particularly bovine inorganic freeze-dried bone, widely used as osteoconductive scaffold 
materials [73]. However, a theoretical risk of disease transmission, such as prion disease in 
allografts and viral transmission in xenografts, remains. 
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Alloplastic bone substitute materials eliminate the problem of limited supply of autografts bone 
and risk of disease transmission from allografts and xenografts. Presently, six basic type of 
alloplastic materials are commercially available: porous and non-porous HAp, HAp cement, β-
tricalcium phosphate (TCP), polymers, and bioactive glasses. While clinical results of using 
alloplast grafts to treat periodontal disease appear promising, histologically the grafts remain in 
situ for long time and they are encapsulated by fibrous tissue rather than resulting in true bone 
formation and periodontal regeneration [74, 75]. Moreover, in clinical use, these materials 
appear to act largely as biocompatible space. 
1.6.2  Biomodification of the tooth-root surface 
A number of studies have focused on the modification of the periodontitis-involved root surface 
in order to advance the formation of a new connective tissue attachment. Root surface 
demineralization with citric acid has been used as a part of regenerative procedure. Citric acid is 
able to modify the root surface by “detoxifying” the surface and exposing collagen fibrils within 
the cementum or dentin matrix [76, 77]. Despite histological evidence of regeneration following 
root-surface biomodification with citric acid, the outcomes of controlled clinical trials have 
failed to show any improvements in clinical conditions compared with nonacid-treated controls 
[78, 79]. 
More recent studies [80, 81] indicate that the use of materials with less acidic pH, such as 
ethylenediaminetetracetic acid (EDTA), may also expose collagen fibers, thus promoting cell 
attachment without having damaging effect on the surrounding tissues. In recent years, 
biomodification of the root surface with enamel matrix proteins during periodontal surgery and 
following demineralization with EDTA has been introduced to promote periodontal 
regeneration. The application of enamel matrix proteins seems to promote periodontal 
regeneration as it initiates events that occur during the growth of periodontal tissues [82]. 
Moreover, enamel matrix derivatives have a key role also in periodontal wound healing [83], as 
reported in histological results from both animal and human studies [84]. 
Thus far, enamel matrix derivatives, either alone or in combination with grafts, have 
demonstrated their potential to effectively treat intraosseous defects and the clinical results 
appear to be stable long term [85]. 
1.6.3  Guided Tissue/Bone Regeneration  
The strategy of using barrier membranes with or without bone grafts has received great 
attention for restoring the function of a damaged or pathologically affected periodontium [4, 86-
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87 8]. In this context, two surgical techniques have been developed to restore/regenerate the 
different periodontal tissues, namely GTR and GBR. 
The use of an occlusive membrane interfacing with gingival connective tissue/epithelium and a 
PDL/alveolar bone tissue to promote periodontal tissue regeneration is called GTR while the 
restoration of deficient alveolar sites for posterior implant placement has been named GBR. 
Both techniques involve the placement of a membrane over a contained bony defect during 
surgery, based on the principles of space maintenance of the wound, excluding the gingival 
tissues from the healing area, allowing wound repopulation by appropriate progenitor cells, and 
clot stabilization to act as a scaffold for repopulating cells [89]. 
The types of barrier membranes evaluated in clinical studies vary in design, configuration and 
composition. A variety of membrane materials have been utilized. Originally GTR/GBR made 
use of expanded polytetrafluoroethylene (ePTFE) membranes. These membranes are highly 
biocompatible but are non-resorbable and require re-entry surgery a few weeks after treatment 
for their removal. Because of this limitation, a number of resorbable membrane types have been 
introduced [4, 87, 88]. These include membranes of polylactic acid (PLA), polyglycolic acid 
(PGA), bovine collagen membranes, and human cadaverous duramater-derived membranes. 
Clinical studies do not suggest any consistent difference in outcomes with any of these 
materials [90]. 
A deep analysis of GTR/GBR membranes in terms of required properties, materials employed 
in commercial products and research trends will be carried out in the next sections. 
1.6.4  Delivery of growth factors  
Wound-healing approaches using growth factors and bone mophogenetic proteins (BMPs) to 
target restoration of tooth-supporting bone, periodontal ligament and cementum have been 
shown to significantly advance the field of periodontal-regenerative medicine. Much of the 
research in growth factor application for periodontal regeneration has been focused on the use 
of BMPs. BMP-2 and BMP-7 have been shown to possess unique properties for inducing 
ectopic bone formation and new cementum formation [91, 92]. Other growth factors, mainly 
acting as a mitogen or differential factor on regenerating periodontal tissues, include: 
transforming growth factor-β (TGF-β), platelet-derived growth factor (PDGF), insulin-like 
growth factor (IGF), and fibroblast growth factor (FGF) [41]. 
Doses and delivery system for growth factors may play an important role in regenerative 
response. To achieve a therapeutic effect by the local release of exogenous growth factors, 
supraphysiological doses are required, together with a method for sustained growth factor 
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release [16]. Various delivery systems have been developed based on collagen sponges, 
membranes or gels, gelatin matrices with varying degrees of cross-linking [93-94 5], alloplastic 
calcium phosphate materials such as TCP and HAp [96], and resorbable polymers such as PLA 
[97]. Surface area, surface properties for cell-surface interactions, inflammatory and immune 
reactions, and degradation kinetics are of particular interest in growth factor systems.  
Bone and cementum formation occur in different time spans in animal models. This factor has 
to be considered during the growth factors delivery. The degradation kinetics of bioabsorbable 
carriers seem to influence the type of new tissue formation: a fast degradation and fast release 
of BMP induced bone formation to a greater extent, whereas cementum formation was 
significantly greater with the slow degrading and slow releasing BMP gelatin carrier [95]. 
Whether these findings apply to humans in an inflamed environment is unknown. Since limited 
human clinical data are available, more studies are still needed to fully evaluate the potential of 
growth factors for enhancing periodontal regeneration. 
1.6.5  Gene therapies 
Given the relative difficulty of producing sustained release of growth factors from a suitable 
carrier, and the large pharmaceutical doses of factors required, one alternative approach to 
growth factor delivery is the use of gene therapy for periodontal regeneration. The aim is to 
maximize the therapeutic outcome of periodontal-regenerative procedures [62]. Genetic 
approaches in periodontal tissue engineering show early progress in achieving delivery of 
growth-factor genes to periodontal lesions and gene-transfer methods may circumvent many of 
the limitations with protein delivery to soft-tissue wounds [98]. It has been shown that the 
expression of growth factors [99, 100] or soluble forms of cytokine receptors [101] by gene 
transfer provides greater sustainability than the application of a single protein. As a 
consequence, gene therapy may achieve greater bioavailability of growth factors within 
periodontal wounds and hence provide greater regenerative potential. 
Various gene-delivery methods are available to administer growth factors to periodontal 
defects. The delivery method can be tailored to the specific characteristics of the wound site. In 
order to overcome the short half-lives of growth factors in vivo, gene therapy using a vector 
encoding the growth factor is preferred to stimulate tissue regeneration. 
Two main strategies of gene vector delivery have been applied to periodontal tissue 
engineering: gene vectors can be introduced directly to the target site (in vivo technique) [99] or 
selected cells can be harvested, expanded, genetically transduced and then re-implanted (ex vivo 
technique) [100]. In vivo gene transfer involves the insertion of the gene of interest directly into 
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the body, anticipating the genetic modification of the target cell. Ex vivo gene transfer includes 
the incorporation of genetic material into cells exposed from a tissue biopsy with subsequent re-
implantation into the recipient. 
In proof of principle studies, cells have been transduced to express PDGF, BMP-7, BMP-2, and 
FGF-2 in vitro using adenovirus vectors, and transfected cells have been subsequently 
reimplanted into surgically created periodontal defects. These studies have demonstrated the 
potential of this technology to stimulate regeneration of the periodontal tissues [102, 103]. 
While this approach may offer promising prospects for the future, there are a number of critical 
issues, particularly related to safety of adenovirus vectors, that will need to be demonstrated 
prior to considering this type of approach in human studies. 
1.7 Commercially available membranes for GTR and GBR applications 
The rationale of GTR is to impede apical migration of the epithelium and gingival cells by 
placing a barrier membrane (resorbable or non-resorbable), which forms a space that allows the 
repopulation of PDL and alveolar bone cells onto the dental root surface [104]. 
The development of GTR was created in order to selectively guide tissue regeneration in the 
periodontium following periodontal disease. Following flap surgery in monkeys exposed to 
plaque for 6 months, a cellulose acetate laboratory filter or ePTFE was used by Gottlow et al. to 
successfully prevent gingival connective tissue from contacting the root surface during healing 
and to produce a space for tissue in-growth of the periodontal ligament [105]. After 3 months 
from implantation, histological analysis of explants evidenced that membranes exhibited 
improved bone re-growth. The results from this study confirmed the hypothesis that by 
selectively controlling the proliferation of the periodontal ligament cells and preventing contact 
from epithelium and connective tissues, the space-maintaining capability allowed improved 
regeneration of the attachment apparatus of the tooth. 
Subsequently, Buser et al. [7] introduced the basic principles of GBR, which is aimed at bone 
regeneration through a membrane avoiding connective tissue collapse into bone defect. The 
work from the above mentioned authors has been confirmed and reproduced in a number of 
animal and clinical studies on various periodontal defects including intrabony, furcation 
recession and supra-alveolar defects [106, 107]. 
As a medical application in dental implantology and to achieve better clinical outcomes, barrier 
membranes should fulfill some fundamental requirements [108-109 10]. 
1) Biocompatibility: the interaction between membrane and host tissue should not induce 
adverse effects. 
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2) Non-immunogenic and non-toxic 
3) Cell exclusion: the barrier membrane is used to prevent gingival fibroblasts and/or 
epithelial cells from gaining access to the wound site and forming fibrous connective 
tissue, that delay bone formation. 
4) Space-making: the ability to maintain a space for cells from surrounding bone tissue to 
migrate for stable time duration. 
5) Mechanical strength: proper physical properties to allow and protect the healing process, 
including protection of the underlying blood clot, avoiding the membrane collapse. 
6) Tenting: the membrane is carefully fitted and applied in such a manner that a space is 
created beneath the membrane, completely isolating the defect to be regenerated from the 
overlying soft tissue. It is important that the membrane be trimmed so that it extends 2 to 3 
mm beyond the margins of the defect in all directions. The corners of the membrane 
should be also rounded to prevent inadvertent flap perforation. 
7) Scaffolding: this tented space initially becomes occupied by a fibrin clot, which serves as a 
scaffold for the in-growth of progenitor cells. 
8) Stabilization: the membrane must also protect the clot from being disturbed by movement 
of the overlying flap during healing. It is therefore often, but not always, fixed into 
position with sutures, mini bone screws, or bone tacks. Sometimes, the edges of the 
membrane are simply tucked beneath the margins of the flaps at the time of closure, 
providing stabilization. 
9) Biodegradability: adequate degradation time matching the regeneration rate of new tissue 
to avoid a secondary surgical procedure to remove the membrane. 
Various types of materials have been developed, which can be grouped together as either non-
resorbable or resorbable membranes. The properties of commercially available membranes are 
discussed in the following paragraphs and summarized in Table 1.1. 
1.7.1  Non-resorbable membranes 
Non-resorbable membranes include expanded, high-density and Titanium-reinforced PTFE, and 
titanium mesh (Ti-mesh) [111] (Fig. 1.2). Although a number of animal studies involving a 
variety of defect configurations and human histological data after treatment of intrabony lesions 
with ePTFE membranes demonstrate high clinical attachment level (CAL) gain and residual 
probing depth [112], the requirement of a second surgical intervention to remove the barrier 4 to 
6 weeks after implantation is a significant drawback [113]. The need for a second surgery may 
injure and/or compromise the obtained regenerated tissue, since it is known that flap elevation 
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results in a certain amount of crestal resorption of the alveolar bone. Furthermore, the use of 
non-resorbable membranes involves extra surgical times, which leads to increased costs, patient 
discomfort and duration of the therapy. 
These undesirable characteristics are often weighed with the positive effects of using non-
resorbable membrane, which include effective biocompatibility and ability to maintain 
sufficient space in the membrane for longer periods compared to resorbable membranes, due to 
their ability to retain shape and structure in the tissues. They have a more predictable profile 
during the healing process for their adequate mechanical strength and they are easy to handle in 
clinics [110]. 
  
Fig. 1.2 Commercially available non-resorbable membranes: (a) Cytoflex® Tefguard®, (b) CytoplastTM, (c) CytoplastTM 
Ti-250, (d) Cytoflex® Mesh, (e) CytoplastTM Osteo-Mesh TM-300. 
 
1.7.2.1 PTFE-based membranes 
PTFE (Teflon
®
) is a synthetic fluoropolymer that relies on an extremely strong bond between 
carbon and fluorine for its non degradable, biologically inert properties. There is no known 
enzyme in the body capable of cleaving carbonfluorine bonds. Added rigidity of PTFE material 
can be achieved by reinforcement with fluorinated ethylene propylene, resulting in ePTFE 
(Gore-Tex
®
) [114]. Study by Buser et al. [7] was one of the first to report successful ridge 
augmentation with GBR in humans using an ePTFE membrane and tenting pins. 
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The first commercial membrane was first introduced in dentistry in 1984 and it was produced 
from ePTFE. However, the membrane had been used clinically for some previous years as a 
vascular graft material for hernia repair [115]. This membrane (Cytoflex
® 
Tefguard
®
, Fig. 1.3 a) 
is the gold standard of GTR and GBR treatments. 
The microstructure of ePTFE consists of solid nodes interconnected by fine, highly oriented 
fibrils, providing an unique porous structure. Both sides of the porous structure of ePTFE 
membrane have their own features [116]: on one side, an open microstructure collar of 1 mm 
thick and 90% porosity inhibits or retards the epithelium migration during the early phase of 
wound healing and promotes connective tissue in-growth [117]; on the other side, a 0.15 mm 
thick and 30% porous membrane provides the structural stability and the space for new bone 
growth, and acts to prevent fibrous in-growth. Effectiveness of ePTFE membranes was 
investigated in numerous clinical studies, that confirmed their excellent biocompatibility, 
leading to an average healing period after in vivo implantation of about 3–6 months [118, 119]. 
Drawbacks of ePTFE membranes are (i) the need for a second surgical procedure and (ii) 
membrane stiffness that may result in soft tissue dehiscence, allowing the exposure of the 
membrane to bacterial infection [120]. For these reasons, a membrane made of high-density 
PTFE (dPTFE) can be used alternatively. 
The dPTFE membrane (Cytoplast
TM
 TXT-200 and GBR-200, Fig. 1.3 b; TefGen-FD) was 
introduced by Bartee in 1993; it is a non-resorbable membrane having submicron (0.2 μm) 
pores [121]. The advantages of dPTFE membranes is that they do not require primary closure 
and preserve the full width of keratinized mucosa. Compared with the conventional ePTFE, the 
density of dPTFE membranes (i) prevents the infections and (ii) does not require second-stage 
surgery for retrieval because the membrane can be removed with a gentle tug, in a manner 
similar to that used for the removal of a suture. The successful use of this membrane was shown 
in animal and clinical studies. Marouf et al. [122] compared the patterns of bone healing 
obtained with Gore-Tex and TefGen-FD membranes. Clinically, they found that TefGen 
membrane was much easier to detach from the underlying bone than was the Gore-Tex 
membrane, which showed strict adherence to bone surface on removal. Macroscopically, a 
relatively greater speed and quantity of bone regeneration were observed in the defective 
cavities covered with Gore-Tex membrane than in those covered with TefGen membrane. 
1.7.2.2 Titanium mesh 
Creation and maintenance of a sufficient space underneath the barrier is an important factor for 
successful result. Titanium-reinforced PTFE (Ti-ePTFE; Cytoplast
TM 
Ti-250, Fig. 1.3 c) and 
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titanium barrier membranes (Cytoflex
®
 Mesh and CytoplastTM Osteo-Mesh TM-300, Fig. 1.3 d 
and e) were introduced as an option for GBR, because they provide advanced mechanical 
support which allows a larger space for bone and tissue re-growth. The exceptional properties 
of rigidity, elasticity, stability and plasticity make Ti-mesh an ideal alternative for ePTFE 
products as non-resorbable membranes [111]. 
Titanium-reinforced barrier membranes were first introduced by Jovanovic and Nevins who 
reported the superior regenerative ability of these membranes in respect to the conventional 
ePTFE ones [123]. The titanium reinforcement provides mechanical support to the overlying 
soft tissue preventing its collapse into the defect. Moreover, during the surgical procedure, 
titanium struts permit the surgeon to easily place the membrane under flaps with minimal 
dissection and flap reflection [124]. Since 1995, titanium membranes with microperforations 
(FRIOS BoneShield) have been used for GBR. The membranes are either triangular or oval. 
The mechanical properties of the membrane prevent its collapse providing the maintenance of a 
constant volume for regeneration. The membrane has a suitable microporosity preventing soft 
tissue penetration through the membrane and permitting diffusion of interstitial fluid [125]. 
Rakhmatia et al. [111] demonstrated that there are four main advantages of Ti-mesh membranes 
over their alternative PTFE membranes: (1) rigidity provides extensive space maintenance and 
prevents contour collapse, (2) elasticity prevents mucosal compression, (3) stability prevents 
graft displacement, and (4) plasticity permits bending, contouring and adaptation to any unique 
bony defect. The main disadvantage of Ti-mesh membranes is increased exposure due to their 
stiffness and also a more complex secondary surgery to remove them. 
1.7.2  Resorbable membranes 
A variety of resorbable membranes are currently available (Fig. 1.3). Their advantages are: 1) 
they allow a single-step procedure reducing patient discomfort and costs, 2) the shape and 
volume of the regenerated bone can be predefined-prefabricated, 3) they are radiolucent 
allowing imaging, and 4) their bioresorption eliminates potential surgical complications [126, 
127]. The main limitation of resorbable membranes is related to the resorption time, the degree 
of degradation and the effect of their degradation on tissue formation. The ideal membrane 
should be capable of being degraded or resorbed over time at the same rate that bone formation 
occurs. It is reported that an optimal persistence and stability of membranes in vivo should be 
guaranteed for at least 4-6 weeks until several months, to allow successful regeneration of 
periodontal system [128]. 
26 
 
There are two broad categories of bioresorbable membranes: the natural and the synthetic 
membranes. Natural membranes are made of collagen, whereas synthetic products are made of 
aliphatic polyesters [69]. 
The polyester-based membranes are biodegradable, allow tissue integration and are easier to 
handle surgically compared with non-resorbable membranes. However, their poor cell response 
is a drawback [86]. In contrast, collagen membranes have shown favorable regenerative results 
due to their excellent cell affinity and biocompatibility. Nevertheless, collagen based 
membranes show relatively poor mechanical and dimensional stability due to their rapid 
degradation and early collapse [129]. 
 
Fig. 1.3 Commercially available resorbable membranes: (a) Guidor® Matrix Barrier, (b) Vivosorb®, (c) Atrisorb®, (d) 
Epi-Guide® Bioresorbable Barrier Matrix, (e) Bio-Gide®, (f) Alloderm®, (g) BioMend®, and (h) Cytoplast® RTM 
Collagen. 
 
1.7.2.1 Synthetic resorbable membranes 
Synthetic resorbable membranes mainly consist of polyesters such as PGA, PLA, poly(ε-
caprolactone) (PCL) and their co-polymers. Aliphatic polyesters can be prepared reproducibly 
under strictly controlled conditions. The wide range of available polyester materials allows for 
the fabrication of a wide spectrum of membranes with different physical, chemical and 
mechanical properties. Another advantage is the ability of these polymers to completely 
degrade through hydrolysis and the degradation products are metabolized through the citric acid 
cycle [109]. 
The Guidor
®
 Matrix Barrier (Fig. 1.3 a) was the first resorbable membrane to be approved by 
the Food and Drug Administration for membrane techniques and it was the first used membrane 
for the regeneration of tissues in periodontology. It consists of PLA treated with 
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acetyltributylcitrate to achieve flexibility to guarantee close barrier adaptation to the bone 
defect. It has a matrix with two differently perforated layers (Fig. 1.4). The external layer, 
aimed at the integration of the overlying gingival flap, presents larger sized pores (with 
rectangular shape) to promote tissue integration and to allow gingival connective tissue 
penetration into the matrix. The inner layer presents lower sized pores (circular shape), able to 
retard tissue penetration but allowing nutrient permeation. The two layers are separated by 
many inner spacers forming an interspace into which tissue can grow. 
 
Fig. 1.4 Guidor® Matrix design: (1) external layer facing the gingival, (2) internal layer facing the tooth and (3) inner 
spacers to form an interspace (4) into which tissue can grow. 
 
According to the manufacturer, the barrier structure is not affected by the material degradation 
for at least the first 6 weeks, after which it slowly resorbs. A complete resorption occurs at 
approximately 12 months [130]. 
Poly(L-lactic acid) (PLLA) is one of two stereoisomers of PLA; it is used for the preparation of 
different bioabsorbable membranes, characterized by thermal plasticity, suitable mechanical 
properties and biocompatibility [131, 132]. PLLA presents the disadvantage to be absorbed 
completely after at least 4 years, while an ideal membrane should be absorbed within 1 year. To 
overcome this problem, copolymers of lactide and ε-caprolactone, glycolide, trimethylene 
carbonate, have been produced to reduce the resorption rate. 
Resolut
®
 is a commercially available product consisting of two layers: a poly(D,L-lactide-co-
glycolide) (PLGA) compact layer, that prevents epithelial cell penetration, and a porous 
network of PGA fibers, promoting tissue integration. Histological studies showed a similar 
effectiveness to non-resorbable membranes and complete resorption 5–6 months after 
placement [133, 134]. Fibers of polyglactin 910, a copolymer of glycolide and L-lactide (9:1 
wt/wt), were used to produce a woven mesh (Vicryl Periodontal Mesh
®
). The polyglactin 910 is 
inert (no reactions in the surrounding tissue during its adsorption were observed), not antigenic 
and preserves its physico-mechanical properties during the first 3–4 weeks [135]. Although 
animal studies indicated a lack of tissue integration and recession formation, clinical evaluation 
suggested a similar effectiveness as compared to that of other GBR membranes [133-136]. 
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Membranes based on copolymers of lactic acid and ε-caprolactone have been produced, 
showing a lower degradation time as compared to pure PLA membranes. PCL is characterized 
by higher hydrophobicity and lower water-solubility than PLA, PGA and their copolymers. A 
commercial product (Vivosorb
®
, Fig. 1.3 b), consisting of poly(DL-lactide-co-ε-caprolactone) 
(PLCL), was found to be biocompatible, non-cytotoxic, occlusive and space maintaining. It 
retains its mechanical properties up to 8 weeks, providing support and protection to the healing 
tissue; its period of resorption may take approximately 24 months [137]. 
Atrisorb
®
 membrane is the first liquid product adapted directly at the surgical site (Fig. 1.3 c): it 
consists of poly-DL-lactide acid dissolved in N-methyl-2-pyrrolidone. An irregular membrane 
is produced after polymer exposure to 0.9% saline solution for 4–6 min in a special cassette, in 
which it is possible to cut it into the desired shape. Membrane thickness is 600–750 μm, and it 
is positioned into the defect site by applying a moderate pressure. A histological complete 
resorption was observed 6–12 months after implantation. Clinical studies reported its efficacy in 
the treatment of periodontal defects [138, 139]. 
The Epi-Guide
®
 Bioresorbable Barrier Matrix is another membrane consisting of D-L polylactic 
acid (Fig. 1.3 d). It is a porous membrane with an unique three-layer technology, used as an 
adjunct to periodontal restorative surgery. The layer in contact with the gingival tissue is porous 
to promote fibroblast infiltration and attachment. On the contrary, the layer in contact with bone 
defects has a limited porosity that supports fluid uptake, helps adherence to the tooth surface, 
and inhibits fibroblast movement. Finally, the inner labyrinth layer creates pathways, while 
internal chambers enable collateral circulation and flow of interstitial fluid in the membrane. 
The Epi-Guide maintains its structure and functions for 5 months after implantation with a 
complete bioresorption between 6-12 months [140]. 
1.7.2.2 Membranes based on natural materials 
Natural polymers are characterized by their intrinsic biocompatibility, non-antigenicity, and 
bioresorption tuned by cross-linking treatment [141]. Membranes consisting of non-mineralized 
collagen have been shown in animal and human clinical trials to be as effective as other GTR 
membranes in inhibiting epithelial migration and in promoting new connective tissue 
attachment and new bone re-growth [142-143 44]. Drawbacks of collagen membranes are (i) loss 
of space maintenance in physiological condition, (ii) high cost, and (iii) risks of disease 
transmission to humans for animal-derived collagen [145]. 
Collagen is the predominant protein in alveolar bone and periodontal connective tissues. Some 
of the positive properties of collagen when used for GTR procedures include its hemostatic 
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function through its ability to aggregate platelets. This feature may facilitate early clot 
formation and wound stabilization, both of which are considered essential for successful 
regeneration [146]. In addition, collagen possesses a chemostatic function for fibroblasts, which 
may aid in cell migration to promote primary wound closure, an essential component for 
successful GTR outcomes [147]. Collagen is also well tolerated and easily manipulated and 
adapted [108]. 
Membranes based on natural materials are typically derived from human skin (Alloderm
®
), 
bovine achilles tendon (BioMend
®
 and Cytoplast
®
 RTM Collagen) or porcine skin (Bio-Gide
®
). 
The most important commercial collagen membrane is Bio-Gide
®
 (Fig. 1.3 e), which is based 
on Xenogenic collagen Type I from porcine skin and is characterized by a bi-layered structure 
with a dense and a porous layer (Fig. 1.5). The dense layer has a smooth surface able to avoid 
epithelial cell infiltration into bone defects, while the porous layer allows tissue integration. 
 
Fig. 1.5 Bio-Gide® membrane design. 
 
Taguchi et al. [8] have described a clinical study in which Bio-Gide
®
 membranes were inserted 
into artificial bone defects formed by drilling 20 4-week-old male Wistar rats. Alkaline 
phosphatase-positive cells and osteocalcin and osteopontin-immunopositive sialoproteins were 
observed after 14 days post-implantation, suggesting osteoblastic differentiation in the porous 
layer. Moreover, membrane was well integrated into the surrounding tissue. In addition, the 
compact layer of Bio-Gide
®
 membrane avoided invasion of epithelial and connective tissue, and 
maintained a free space where cells from the surrounding tissues could migrate. 
Alloderm
®
 (Fig. 1.3 f) is an acellular freeze-dried dermal matrix graft composed mainly of type-
I collagen derived from human cadaveric skin. It has been used in periodontal, plastic and 
reconstructive surgery since 1994. Borges et al. compared the effectiveness of the acellular 
dermal matrix as a membrane for GBR, with a bioabsorbable membrane. In seven dogs, the 
mandibular premolars were extracted; after 8 weeks, one bone defect was surgically created 
bilaterally and the GBR was performed. Each side was randomly assigned to the control group 
(bioabsorbable membrane made of glycolide and lactide copolymer) or the test group 
(Alloderm
®
 membrane). No statistically significant differences between the groups were 
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observed for any histomorphometric measurement. Clinically, both groups showed an increase 
in the thickness of keratinized tissue and a reduction in the width of keratinized tissue. 
Radiographically, an image suggestive of new bone formation could be observed in both groups 
at 8 and 16 weeks following GBR [148]. 
The use of Alloderm
®
 has several advantages because it does not contain cellular material, 
which eliminates the possibility of rejection because of the presence of major histocompatibility 
complex class I and II antigens. In addition, the unlimited supply, color match, and thickness, as 
well as no degradation if primary closure is not achieved, and formation of additional attached 
gingival tissue makes this material a good choice for membrane barrier techniques. 
Type I collagen membranes are also manufactured from bovine Achilles tendon. BioMend
® 
membrane (Fig. 1.3 g) is semi-occlusive with nano-sized pores and resorbable within 8 weeks. 
Cytoplast
®
 RTM Collagen membrane (Fig. 1.3 h) is characterized by (i) a multi-layer 
construction that allows tissue integration into outer layer, while preventing direct passage of 
bacteria and epithelial cells, and (ii) a longer and predictable resorption time (26–38 weeks) 
[110]. 
Oh et al. [149] compared two collagen membranes, Bio-Gide
®
 and BioMend
®
, for the treatment 
of implant dehiscence defects in eight mongrel dogs. The results of this study indicated that: (1) 
GBR treatment with collagen membranes may significantly enhance bone regeneration, 
manifested at late stage (16 weeks) of healing, and (2) space maintenance and membrane 
coverage were the two most important factors affecting GBR using bioabsorbable collagen 
membranes. 
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Table 1.1 Available commercial non-resorbable and resorbable membranes. 
 Commercial Name Material Properties Reference 
N
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M
e
m
b
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n
e
s 
Cytoflex Tefguard ePTFE 
Excellent biocompatibility 
Healing period of about 3-6 months 
118, 119 
Cytoplast TXT-200 dPTFE 
0.2 μm pores 
E ~ 16 MPa; σmax ~ 2 MPa; εmax ~ 545% 
No second-stage surgery 
121 
Cytoplast Ti-250 Ti-ePTFE 
Easy to place 
250 μm thick 
124 
Cytoplast Osteo-Mesh TM-300 Ti 300 μm pores 125 
R
e
so
r
b
a
b
le
 M
e
m
b
ra
n
e
s 
Guidor PLA treated with acetyltributylcitrate 
Bi-layer membrane 
Resorption: 6 weeks-12 months 
Easy to use 
130 
Resolut PLGA and PGA 
Bi-layer membrane 
Resorption: 10 weeks 
Good space maintainer 
σmax ~ 11.7 MPa 
133, 134 
Vicryl Polyglactin 910 
Resorption 4-12 weeks 
Inert and no antigenic 
135 
Vivosorb PLCL 
Resorption: 24 months 
Up to 8 weeks‟ mechanical properties 
Anti-adhesive barrier 
137 
Atrisorb Poly-DL-lactide and solvent 
Resoprtion: 6-12 months 
Liquid product 
600-750 μm thick 
138, 139 
Epi-Guide Poly-DL-lactic acid 
Three-layer membrane 
Resorption: 6-12 months 
140 
Bio-Gide Xenogenic collagen Type I from porcine skin 
Bi-layer membrane 
Resorption: 24 weeks 
At least 6 weeks bioactive 
σmax ~ 7.5 MPa  
8 
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Alloderm Type-I collagen from human skin 
Eliminates the possibility of rejection 
σmax = 9.4-21.5 MPa 
148 
BioMend Type-I collagen from bovine Achille 
Resorption: 4-8 weeks 
σmax = 3.5-22.5 MPa 
110 
Cytoplast RTM Type-I collagen from bovine Achille 
Multi-layer construct 
Resorption: 26-38 weeks 
E ~ 170 MPa; σmax ~ 8 MPa; εmax ~ 12% 
110 
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1.8 Current trends in the development of membranes for GTR/GBR 
Although a number of barrier membranes are already being used in clinical practice, novel 
membranes have been developed in an effort to overcome the limitations of the currently used 
membranes. The polymeric commercial products described previously are characterized by 
weak mechanical and osteoconductive/osteoinductive properties. The researchers are looking 
for different approaches to meet the demands of degradable GTR/GBR membranes in terms of 
mechanical properties and biocompatibility: 
1) the incorporation of bioactive inorganic fillers 
2) the production of multi-component structure 
3) the surface modification of synthetic polymers/copolymers to graft bioactive proteins or 
biomolecules. 
The use of polymers in combination with a bioactive inorganic filler is considered a suitable 
strategy for producing bone regenerative materials with physicochemical properties 
approaching those of bone and with good tissue compatibility, such as cell affinity, 
osteoconductivity and enhanced bone formation [150, 151]. Bioactive inorganic components, 
including calcium phosphates (i.e. HAp, TCP) and bioactive glasses/glass ceramics, are the 
most widely used inorganic fillers, while the polymeric components are natural and/or synthetic 
polymers. For example, Xianmiao et al. [152] prepared nano-hydroxyapatite and chitosan (n-
HAp/CH) composite membranes by solvent casting and evaporation methods. CH is a 
biocompatible, antimicrobial, and biodegradable natural polymer with outstanding biological 
properties for promoting osteogenesis. The surface of the composite membranes was rough and 
microporous, suitable for adhesion, crawl and growth of cells. The hydroxyapatite holds nano 
size in the composite membranes and its Ca ions and –OH groups could interact with –NH2 or –
OH groups of CH. Cell culture and MTT assays showed that n-HAp/CH composite membranes 
had no cytotoxic effect on cells and possessed good biocompatibility. Therefore, the n-HAp/CH 
composite membranes showed promising properties for GBR membrane applications. Synthesis 
of a new flexible and thermoplastic copolymer, such as poly(L-lactide-co-glycolide-co-ε-
caprolactone) (PLGC), and its conjugation with TCP has been carried out by Kikuchi et al. [12]. 
The bioactive composite films have been prepared by a heat-kneading method. The composites 
formed an electrostatic interaction between the TCP surface and ester C=O bond of the 
polymer, and the interaction maintained mechanical strength of the composites to the same or 
greater degree as the pure polymers. The composites had a pH maintenance effect and 
decomposed in 24 weeks after soaking in both physiological saline and phosphate buffered 
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saline (PBS). The GBR application of the membrane, in animal tests in beagle model, indicated 
good regeneration of mandibular bones. 
In several works, bioactive glass addition into PGA or PLA membranes has been shown to 
stimulate different biological processes, such as the enhancement of osteoblastic activity and 
new collagen production [153, 154]. In addition, differentiation of mesenchymal stem cells into 
bone-forming cells was observed by Blaker et al. [155] in composite porous membranes 
consisting of Bioglass
®
 and PLA. Bioactive glass increased significantly the bioactivity, in 
terms of formation of a bone-like mineral layer on the surface of membranes, which is an 
essential requirement for an implant to exhibit a bone-bonding behavior. The addition of nano 
bioactive glass ceramic (nBGC) particles into scaffold material has also been studied by 
Srinivasan and co-workers [156]. The scaffold has been developed from alginate, a natural 
polysaccharide with high hydrophilicity and biocompatibility, relatively economic and widely 
used in the food and pharmaceutical industry. The alginate/nBGC composite scaffolds were 
found to have suitable physico-chemical and biological properties to facilitate periodontal 
regeneration. They had a pore size of about 100-300 µm, controlled porosity and swelling 
ability, limited degradation and enhanced biomineralization, ideally controlled due to the 
presence of bioglass in the scaffold. Incorporation of nBGC helped to attain good protein 
adsorption, human periodontal ligament fibroblast and osteosarcoma cells attachment and 
proliferation onto the scaffolds. The periodontal ligament fibroblast also showed distinct 
osteoblast-like behavior with enhanced alkaline phosphatase activity. 
Advances in the science and technology of nanomaterials have led to increased enthusiasm for 
approaches such as electrospinning of biomimetic multifunctional growth-enhancing 
regenerative membranes for periodontal tissue engineering. Electrospun nanofibrous 
scaffolds/membranes mimic more closely the scales and morphologies of the extracellular 
matrix (ECM) proteins (fibers with diameters ranging from 50 to 500 nm). The thin fibers are 
characterized by large surface areas, possibility of functionalization for various applications, 
superior physico-chemical properties. Sui et al. [157] developed an electrospun PLLA/HAp 
hybrid membrane for bone tissue regeneration. Synthesized HAp nanoparticles were carefully 
dispersed in PLLA solution and nanosized PLLA/HAp hybrid fibers were electrospun to obtain 
hybrid membranes. The introduction of HAp nanoparticles increased the specific surface area 
and mechanical properties, slowed down the degradation rate of PLLA/HAp membrane, and 
maintained constant the pH value of the incubation solution during degradation, which 
facilitated osteoblast cell adhesion and growth on the hybrid membrane. HAp nanoparticles 
were also dispersed in PCL matrix [158]. The coupling agent γ-glycioxypropyltrimethoxysilane 
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known as A-187 was utilized to treat HAp nanoparticles to improve their dispersion in PCL 
matrix. To fabricate fibrous scaffolds mimicking the natural bone structure, electrospinning was 
adopted and two scaffolds were developed (HAp/PCL and A187-HAp/PCL). The good 
dispersion of HAp in PCL enhanced tensile strength and modulus of the scaffold. Furthermore, 
the surface modification of HAp using A-187 did not affect its bioactivity. Both scaffolds were 
in vitro bioactive, in fact HAp coating was observed on the scaffolds surface when they were 
soaked in 1.5 SBF, while no HAp formation was found on net PCL scaffold. Finally, the in 
vitro cellular assays suggested the electrospun fibrous scaffolds of A187-HAp/PCL and 
HAp/PCL were non-toxic to fibroblasts and osteoblasts. 
Lee at al. used the electrospinning technique to produce nanofibrous bioactive glass; then, the 
researchers introduced the bioglass nanofibers into a degradable polymer, PCL, to form a 
nanocomposite with a thin membrane form (Fig. 1.6) [159]. The nanocomposite membrane 
induced the rapid formation of apatite-like minerals on the surface when immersed in a 
simulated body fluid. Murine-derived osteoblastic cells grew actively over the nanocomposite 
membrane with cell viability significantly improved compared to those on the pure PCL 
membrane. Moreover, the osteoblastic activity, as assessed by the expression of alkaline 
phosphatase, was significantly higher on the nanocomposite membrane than on the pure PCL 
membrane. 
 
Fig. 1.6 Optical views of the pristine PCL and PCL-glass nanofiber nanocomposite prepared in membrane form [159]. 
 
Electrospinning could be also used for the production of barrier membranes with a multi-
component structure to obtain tuned mechanical and degradation characteristics. The rationale 
of having a periodontal membrane with a multi-component structure relies on the principle that 
one can tailor the properties of the different layers to meet the local functional requirements, 
enhancing bone re-growth while preventing the gingival tissue down-growth. A novel multi-
component membrane was designed and fabricated via multilayering electrospinning by Bottino 
et al. [126]. Researchers have proposed a multilayered membrane consisting of three layers 
(Fig. 1.7): a core layer (CL) and two functional surface layers (SL), interfacing bone and 
epithelial tissues. The CL comprised a neat PLCL layer surrounded by two composite layers 
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based on a gelatin/polymer ternary blend (PLCL:PLA/G). To obtain this membrane, a 
sequential multilayer electrospinning process was carried out in the order: PLA:G (type-B 
gelatin)+10 wt% n-HAp, followed by the core layers (namely PLCL:PLA:G, pure PLCL and 
PLCL:PLA:G), and finally PLA:GEL+25 wt% MET (metronidazole benzoate). n-HAp was 
loaded on the outer layer in contact with bone tissue to enhance bone formation, while the layer 
in contact with epithelial and gingival tissues was functionalized with MET, a common 
antibiotic used in periodontitis treatment preventing bacterial colonization [160]. 
  
Fig. 1.7 (A) Cross-section SEM micrographs of the FGM processed via multilayering electrospinning (B) Schematic 
illustration of the FGM [126]. 
 
The multi-component device exhibited an open porosity and interconnected structures formed 
by randomly oriented non-woven fibers. The majority of fibers had submicron diameters and 
displayed a topography that closely resembled the native ECM structure. In GBR, the 
mechanical properties of the membranes are of the utmost importance for the clinical success of 
the therapy. The mechanical properties of the CL were a major contributor to, and, therefore, 
predictor of, the in vivo mechanical performance of the FGM. Under hydrated conditions, the 
CL presented a high tensile strength (8.7 MPa) and tensile modulus (156 MPa) with a strain at 
failure of 375%. No delamination was observed in the CL membrane, indicating that the 
compositionally graded layers remained intact under physiological conditions. The multi-
component membrane exhibited a tensile strength of 3.5 MPa and a tensile modulus of 80 MPa 
with a strain at break equal to 297%. These results were comparable with those recently 
reported in the literature [4, 9] and suggested that addition of two SLs rich in protein decreased 
the tensile properties in both the dry and hydrated conditions. 
Other multi-component structures have been developed by Reis et al. [161] and Liao et al. 
[162]. In the first study, a semi-rigid PLGA/CaP (calcium phosphate) bilayered construct has 
been developed to promote periodontal regeneration. The device was characterized by a 
continuous outer barrier membrane and an inner topographically complex component (Fig. 1.8). 
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Fig. 1.8 Optical views of the membrane (A) and the macroporous (B) surfaces of the bilayered construct [160]. 
 
Researchers compared periodontal prophylaxis alone with prophylaxis and biomaterial 
implantation in the treatment of class II furcation defects in dogs. Healing occurred 
uneventfully and bone volumetric values, trabecular number and trabecular thickness were all 
significantly greater in the treated group; while trabecular separation was significantly greater in 
the control group. New cementum, bone, and periodontal ligament with Sharpey fibre insertions 
were only seen in the treated group. Although periodontal regeneration has been reported 
elsewhere, the advantages of employing bilayered PLGA+CaP construct are twofold: (1) it did 
not collapse into the defect and (2) its inner side was able to retain the blood clot throughout the 
buccal defect. 
Liao and co-workers selected nano-carbonated hydroxyapatite/collagen (nCHAC) as bioactive 
component and PLGA as barrier to prepare a novel three-layered membrane (Fig. 1.9). The 
nCHAC material facilitated reliable bone regeneration by inducing undifferentiated cells in the 
graft recipient site to become osteoblasts and form new bone. The composite also supplied a 
ready source of calcium for rapid mineralization. 
 
Fig. 1.9 (a) Schematic representation of three-layered membrane (b) The optical microscopy result of the section of the 
nCHAC/PLGA membrane [161]. 
 
This new mineralized collagen/PLGA membrane was considered to have many medical 
applications because of its flexibility, strong mechanical strength, easy manipulation character, 
excellent biocompatibility and controllable bioresorption. It could be used in medical 
applications such as for repairing periodontal defects, membranes for covering bone defect 
surgery and for bone substitutes, skin wound repair and healing, skin sealing, and as a carrier 
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for antibiotic, bone growth factors, skin growth factors, and so forth. Osteoblast cells were 
cultured on the three-layered composite membrane; primary results showed a positive response 
compared with pure PLGA membrane. 
The third strategy adopted by researchers to obtain membranes for GTR/GBR with improved 
biocompatibility properties, makes use of different surface engineering techniques to graft 
bioactive molecules accelerating ECM secretion and tissue regeneration. Biomacromolecules, 
such as proteins, polysaccharides, proteoglycans and their derivatives are known to act as 
biological cues for adherent cells. Therefore, if biomaterial surfaces are functionalized with 
these bioactive macromolecules, the biocompatibility can be significantly improved. 
Several approaches can be adopted to modify the surface properties of biocompatible polymers 
with biomacromolecules, such as covalent attachment, physical adsorption, and affinity bonding 
(Table 1.2). 
The surface modification techniques, as briefly summarized in Table 1.2, have been described 
in many reviews and book chapters (163-164 65). In particular, an exhaustive list of cross-linkers 
for the immobilization of bioactive molecules to a functionalized substrate has been reported by 
Goddard et al. (166). 
Table 1.2 Surface modification approaches. 
Modifications Mechanisms Methods 
Chemical grafting Covalent grafting of bioactive 
peptides, proteins and 
polysaccharides to improve cell 
adhesion and biocompatibility. 
Carbodiimide (87, 167-168 69), 
glutaraldehyde (170, 171), 
hydroxyethylmethacrylate (172, 173) 
Physical adsorption Non-covalent immobilization 
of bioactive macromolecules 
and growth factors (by 
hydrogen bonding, van der 
Waals interactions or 
electrostatic forces) to promote 
cell interaction and response, 
respectively.  
Layer-by-layer (LbL) self 
assembly and mussel inspired 
techniques belong to physical 
adsorption techniques. 
Physical adsorption (174-175176 77) 
Affinity bonding Streptavidin (avidin)/biotin non 
covalent interaction 
Surface functionalization with a biotin 
containing molecule, able to interact 
with streptavidin(avidin), then binding 
to a biotin-functionalized bioactive 
molecule (178). 
39 
 
Surface coating by the three above mentioned approaches is often proceeded by a surface pre-
functionalization step via surface chemical etching (in acidic or basic solution [179]), chemical 
functionalization (i.e. by aminolysis [173, 180]) or plasma treatment [181, 182]. 
Chemical etching involves the partial degradation of the surface material by the corrosive action 
of a liquid or gaseous acid or an alkali. Etching treatment of aliphatic polyesters results in the 
hydrolysis of exposed macromolecules, leading to the formation of carboxylic and hydroxylic 
moieties [166]. Aminolysis is another widely applied technique for surface functionalization of 
polyesters with amino groups, which allows the grafting of biomolecules. During the aminolysis 
reaction, a diamine reagent reacts with exposed ester groups of polyesters, reducing the 
molecular weight of surface macromolecules and forming amide bonds. As a result, amino and 
hydroxyl groups form on the material surface (183, 184). Plasma treatment can introduce 
hydroxyl, carboxyl and amino groups on polymer surfaces using different carrier reactive gases 
such as argon, oxygen, nitrogen, hydrogen, and ammonia. When these gases are exposed to 
plasma, they dissociate and react with the surface, creating different chemical functional groups 
on the surface. The plasma process results in a physical and/or chemical modification of the 
first few molecular layers of the polymer surface. The effectiveness of the treatment is 
determined by the plasma source gases, the configuration of the plasma system and the plasma 
operating parameters [163]. 
Some examples of successful surface modification strategies for GTR/GBR application are 
reported below, based on a pre-modification step, followed by surface functionalization. 
Park et al. have recently proposed a novel biocompatible and degradation-controlled membrane 
formed by two layers: a PLGA grafted hyaluronic acid (HYA) layer and a PLGA layer [87]. As 
a natural linear polysaccharide, HYA is biodegradable, biocompatible and non-immunogenic 
[185]. It is also known to be osteoconductive, to promote angiogenesis, and moderate immune 
responses. In this work, HYA was chemically modified with adipic acid dihydrazide (ADH) in 
the mixed solvent of water and ethanol, and grafted to PLGA, previously activated by N,n‟-
dicyclohexyl carbodiimide and N-hydroxysuccinimide. According to in vitro degradation tests 
in PBS, HYA-PLGA/PLGA (weight ratio of 1/2) film degraded relatively slowly compared to 
PLGA film and HYA coated PLGA film. The innovative membrane was also used to cover up 
bone defects in rats to study in vivo bone regeneration. Histological and histomorphometric 
analyses revealed that HYA-PLGA/PLGA film resulted in the most effective bone regeneration 
compared to other samples (control and PLGA films) with a regenerated bone area of 63.1% 
covering the bone defect area. 
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Chen and co-workers [171] developed a PLLA electrospun membrane aminolyzed with CH 
(PLLA-CH) to enhance both the biocompatibility and the degradation. To graft CH, the 
membrane was first aminolyzed in a 1,6-hexanediamine/isopropanol solution and then 
immersed in a glutaraldehyde solution to obtain the aldheyde PLLA electrospun membrane. 
The modification of CH promoted the hydrophilicity, enhanced the bioactivity, and accelerated 
the degradation rate of PLLA electrospun membrane. Moreover, the grafting process did not 
change membrane morphology: statistical analysis showed no significant difference in fiber 
diameter and pore sizes between PLLA and PLLA-CH membranes. In vitro cell culture showed 
that the modified membrane had a better biocompatibility and promoted osteoblast proliferation 
compared with pure PLLA. Besides, it could also prevent fibroblasts invasion. CH was also 
used as substrate for covalent immobilization of BMP-2, a prominent cytokine in osteogenesis, 
to develop a potential membrane for GBR. For the covalent grafting, 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide (EDC) was used to form covalent bonds between carboxyl 
groups of the growth factor and amine groups of CH. The films with covalently immobilized 
BMP-2 stimulated osteoblast attachment, proliferation, and differentiation in a dose-dependent 
manner. After 3 weeks of immersion in PBS , about 80% of the immobilized growth factor was 
retained on the films, and enabled its stimulation effect to persist for a longer period of time 
[167]. 
Nanocoatings can be also fabricated using (i) the layer-by-layer (LbL) self-assembly technique 
[186], one of the most rapidly growing strategies of generating thin films in the field of 
materials science, and (ii) the mussel-inspired technique [187], an innovative versatile and 
attractive method for surface modification of solid materials. A detailed discussion of this 
techniques in terms of assembly mechanism, advantages and applications in GTR/GBR will be 
carried out in the next sections. 
1.9 Layer-by-Layer deposition technique (LbL) 
Employed in a variety of biomedical applications, LbL deposition is a simple and versatile 
technique used for the fabrication of thin films and coatings. This method, proposed firstly by 
Decher et al. in 1991 [188, 189], is mainly driven by the electrostatic attraction between 
oppositely charged polyelectrolytes (PEs) [190]. Generally, LbL self-assembly proceeds as 
schematically reported in Fig. 1.10. A charged substrate is immersed in a solution of an 
oppositely-charged PE to electrostatically attract a first monolayer. A washing step follows to 
remove unbound material and to avoid contamination of the subsequent oppositely-charged PE 
solution, in which the substrate is then submerged to deposit the second PE layer. A washing 
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step is then performed again. These four steps are repeated several times to obtain a 
multilayered coating. LbL films can not only be developed using the dipping method described 
above, but can also be produced via spin-coating [191] or spray-coating [192] of alternating 
species. 
 
Fig. 1.10 A schematic illustration of the LbL film-deposition process, based on the alternating exposure of a charged 
substrate to solutions of positively and negatively charged PEs. A rinsing step is included between the two previously 
described adsorption processes, to remove excess as well as to prevent cross-contamination of the PE solutions. 
 
LbL film can be formed on nearly any 2D or 3D substrates and a wide range of charged species 
can be incorporated within LbL multilayers, including natural and synthetic polymers, proteins, 
DNA, drugs, dyes, inorganic nanoparticles, and carbon nanotubes [193194195196-197198199200]. At the 
beginning, only electrostatic interactions were utilised for LbL assembly. Subsequently, other 
interactions such as covalent bonding, hydrogen bonding, charge transfer, hydrophobic 
interactions, and coordination bonding [201202-203204 05] have been investigated to facilitate polymer 
association for ultrathin film deposition. 
Film properties such as thickness, mechanical stability, permeability, and surface roughness, 
chemistry and wettability can be fine tuned by altering the PEs, layer numbers, architecture and 
fabrication conditions employed (i.e. pH, ionic strength and PEs concentration) [206]. This 
flexibility makes LbL deposition an attractive method for a diversity of applications; it is also 
environmentally friendly and it allows room temperature processing and low-cost 
manufacturing [207]. 
1.9.1  Film growth and influencing factors  
The mass and thickness of multilayer films can grow either linearly or “exponentially” with the 
number of deposited bilayers, depending upon a number of factors. Linearly growing films are 
generally formed from strong PEs with a high charge density, such as poly(4-sodium styrene 
sulfonate) (PSS) and poly(allylamine) (PAH), which lead to films consisting of relatively 
immobile polymer chains. These linear films thus tend to be thinner, more mechanically rigid, 
and less permeable [208]. Exponential multilayers, by contrast, tend to be formed from weaker 
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PEs, especially biopolymers such as proteins and polysaccharides, and tend to be significantly 
thicker, more visco-elastic, and somewhat more permeable [209]. 
“Exponential” multilayer growth, as proposed by the model developed by Lavalle et al. [210], 
appears to be due to diffusion of one or more of the PEs into and out of the film system. An 
example, is represented by the poly(lysine) (PLL)/HYA system, where PLL is the freely 
diffusing PE and HYA can only interact with the outermost layers during a deposition step 
[211]. When a negatively charged HYA outer layer is brought into contact with a positively 
charged PLL solution, the PLL chains not only interact with this layer to adsorb and form PLL-
HYA complexes, but also diffuse down throughout the film. This free PLL interacts weakly 
with the film matrix and may even exchange with some of the bound PLL within the film. PLL 
diffusion into the film stops as the PLL-HYA complexes that form at the film surface invert the 
surface charge, thus creating an electrostatic barrier. When a buffer solution is introduced in the 
rinsing step, some of the free PLL diffuses back out. However, as this diffusion lowers the 
chemical potential inside the film, which in turn increases the height of the electrostatic barrier 
to be overcome by the remaining PLL chains, not all the free PLL leaves the film. As the 
oppositely charged HYA solution is brought into contact with the film for the next deposition 
step, the electrostatic barrier is removed, and some of the free PLL left within the film diffuses 
out to interact with the HYA at the film/solution interface. Thus the HYA that adsorbs in this 
step is not only proportional to the amount of PLL adsorbed in the last step, but is additionally 
dependant upon the amount of free PLL that diffuses to the film surface (Fig. 1.11). This, in 
turn, is related to the total thickness of the film. The mass increase of the film thus increases 
with total film thickness, becoming “exponential”. 
43 
 
 
Fig. 1.11 Drawing of the build up mechanism of PLL/HYA film. (A) At the end of a HYA deposition step with a 
negative electrostatic potential at the top of the film. (B) PLL interaction with the surface renders it positive; PLL 
chains can cross the energy barrier and diffuse down throughout the film. As they diffuse into the film, the chemical 
potential of free PLL chains increases and (C) diffusion stops as the PLL-HYA complexes that form at the film surface 
invert the surface charge, thus creating an electrostatic barrier. (D) During the rinsing phase with pure buffer, the free 
PLL chains can cross the electrostatic energy barrier in the reverse direction and diffuse back out. During this process, 
the chemical potential of these chains diminishes as well. (E) When this film is further brought in contact with a HYA 
solution, HYA chains interact with the outer PLL layer to form PLL/HYA complexes which form the new outer layer of 
the film. The positive electrostatic barrier totally disappears. The remaining free PLL chains can thus diffuse out of the 
film. (F) The diffusion process stops when all the free PLL chains inside of the film have diffused out of it [211]. 
 
While it is difficult to predict which growth regime will characterize a given PE pair, in general, 
linear film growth is associated with strongly interacting PEs which are highly exothermic, 
while exponential growth is linked to more weakly interacting PEs which are endothermic or 
weakly exothermic [212]. However, most PE systems can be made to transition from linear to 
exponential growth, or vice versa, given the right conditions. For example, linear films can be 
made to grow exponentially with an increase in solution salt concentration and many 
exponentially growing films transition to linear growth once a certain critical number of 
deposited bilayers is reached [213, 214]. 
Many factors influence the strength of PE interactions and thus whether a film system grows 
linearly or exponentially, including polymer charge density, the concentration and type of 
counter ions present in the depositing and rinsing solutions, the deposition time and 
temperature, solvent quantity, and solution pH [215]. 
The presence of salt ions in LbL deposition and rinsing solutions strongly influences the 
formation and resulting properties of multilayer films. The addition of salt in the deposition 
solution screens charges on the PE chains, minimizing repulsion interactions within chains and 
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thus leading to chain coiling. These coiled chains adsorb in extended “loopy” conformations 
which allow for greater PE surface density and thus thicker and rougher films [216]. Film 
thickness tends to increase proportionally to salt concentration, reaching a maximum at an 
optimal concentration which depends upon the given PE system [217]. The type of salt ions 
used also affects LbL film formation, with multilayer thickness generally varying as 
Li+<Na+<K+ and F->Cl->Br- [218, 219]. Generally, ions characterized by smaller and weaker 
hydration shells interact more strongly with PEs, promoting chain coiling and thicker and 
smoother surface. 
PE structure, molecular weight and charge density also play important roles in determining 
multilayer properties. For most PE system there is a minimum charge density required for LbL 
film formation [217]. Charge density in strong PEs is determined by chemical structure alone, 
while for weak PEs it is also highly dependant upon the solution pH. Generally, fully charged 
PE chains adsorb in a flat, spread out conformation due to intra-chain repulsion and increased 
chain-surface interactions, thus leading to thinner films. In this fully charged state, molecular 
weight appears to have little effect on film thickness for many PE system. Meanwhile, less 
charged PEs tend to coil and adsorb as thicker layer, with increased molecular weight, in this 
case, leading to thicker films [216, 220, 221]. 
While the broad range of factors influencing the formation and properties of LbL films may 
seem daunting, it also provides a great flexibility for multilayer design, enabling fine, nano-
scale tuning of film features. By carefully selecting the PE used, and the layer architecture and 
preparation conditions employed, multilayer films can be designed for a wide variety of 
biomedical applications, including modifying cellular and protein adhesion, and tunable drug, 
protein and gene delivery. 
1.9.2  Monitoring multilayer build up  
The combination of several techniques can be used to study the construction, disassembly or 
release of captured content from LbL polyelectrolyte multilayers (PEM). These methods can be 
divided into two groups. 
1) Ex-situ characterization 
The easiest way to follow multilayer build up is probably by UV/Vis spectroscopy that 
determines cumulative absorption attributed to stepwise deposition of UV-active colloids [222]. 
However it works only for materials having UV/Vis absorbance. Equivalent to measuring the 
optical absorbance, one can also determine the film thickness by ellipsometry or X-ray 
reflectometry. The first determines the distance-dependent change in polarization of a light 
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source as a function of reflection or transmission through a substance [223]. X-ray 
reflectometry measures the intensity of x-rays reflected and compares it with the value 
predicted by the law of Fresnel reflectivity; the deviations from the law can then be analyzed to 
obtain the density profile of the interface normal to the surface [224]. Very recently, nuclear 
magnetic resonance (NMR) was added to the “toolbox” of multilayer research [225, 226] and 
this deserves special attention as it gives access to important new data. In order to monitor the 
correct growth of the multilayer films, measure of static contact angle can be performed. The 
change of the surface wettability of multilayer films after each step of adsorption of polycations 
and polyanions layers can be evaluated. Usually contact angle analysis shows a “zig-zag” trend 
due to the alternate deposition of polycations and polyanions [227]. 
2) In situ characterization 
The characterization methods described above are straightforward and widely available, but 
they require the interruption of the deposition process to analyze samples. Moreover, analysis 
has to be performed in the dry state. It has been observed that films deposited from identical 
solutions under the same adsorption times and temperature show different film thickness for the 
same number of layers, depending on whether layers have intermittently been dried or not. In-
situ methods allow to follow the kinetics of adsorption and/or multilayer reorganization. 
Typical analysis in-situ methods are the zeta potential measurements, quartz crystal 
microbalance, surface plasmon spectroscopy, optical waveguide lightmode spectroscopy, 
scanning angle reflectometry, in situ atomic force microscopy (AFM) and attenuated total 
reflection fourier transform infrared spectroscopy (ATR-FTIR). Quartz crystal microbalance 
studies relate vibration dissipation (QCM-D) as a function of the step-wise amount of colloid 
adsorbed to a quartz crystal surface in real time. The dissipation values are then converted to the 
amount of material that was adsorbed per layer [228]. Electrophoretic particle mobility enables 
zeta potential measurements of charged, therefore efficiently coated, surfaces to study charge 
reversal and colloidal stability [229]. The surface texture and roughness of PEMs can be 
elucidated by AFM [230]. AFM can also aid studying the changes in wettability, contact angle 
and subsequently surface energy [228]. 
1.9.3  State of the art of LbL technique for gingival wound healing 
applications 
Beside the need to improve biocompatibility of GTR membranes, in recent years, the focus of 
many laboratories has been the design of membranes with antibacterial properties [11]. To this 
purpose, surface functionalizations of membranes with (a) controlled release system of biocides 
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[231, 232], (b) antibacterial polymer or peptides [233, 234], and (c) microbe-repelling or anti-
adhesive polymer [235, 236] have been developed to ensure the safety of implanted materials. 
The most common biocidal leaching materials used in PEMs are silver (Ag) and Ag ions [237-
238 39]. Although the mechanism of Ag effects is not completely clear, its multilevel 
antimicrobial mode has been well known [240], which ensures that Ag are proven biocides 
against a broad spectrum of bacterial strains, fungi, and viruses even at low concentrations 
[241]. 
One strategy for incorporating Ag into PEMs has involved treating the PEM film as a 
nanoreactor within which Ag ions can be incorporated directly during the assembly process and 
subsequently reduced to form Ag nanoparticles. By utilizing the excess charged groups 
naturally present in all PEMs, the ion-exchange/reduction approach can be extended to 
incorporate nanoparticles into PEMs fabricated from any polyelectrolyte. For example, Zan and 
Su [242] developed a facile approach for the fabrication of transparent antimicrobial coatings 
based on poly(diallyldimethylammonium chloride)/poly(styrene sulfonate) (PDDA/PSS) PEMs. 
In brief, a PDDA/PSS multilayer film was immersed in a silver nitrate (AgNO3) solution to 
introduce Ag ions into the PEM, which were converted into Ag nanoparticles in situ by treating 
with a freshly prepared sodium borohydride (NaBH4). The antibacterial efficacy of the films 
against Escherichia coli (E. coli) was assessed by the Kirby–Bauer method. The PEMs 
containing Ag in the ionic form exhibited high activities in short terms while the PEMs loaded 
with Ag nanoparticles showed lower initial bactericidal effects, but remained active after long 
periods of time. Combining the two Ag form, it could be possible to develop PEMs with high 
initial antimicrobial efficacy as well as long-term performance. A similar approach was also 
adopted by Agarwal and co-workers [243], who loaded Ag nanoparticles in PEM films of PAH 
and poly(acrylic acid) (PAA). 
Preformed silver nanoparticles have also been assembled into multilayers during the dipping-
assembly process [244]. 
In the context of metallic materials with antimicrobial properties, Zhou and co-workers [245] 
developed a potential long-term antibacterial coating through the alternate deposition of 
negatively charged gold nanoparticles (GNP) and positively charged lysozyme (Lys) on highly 
porous electrospun cellulose nanofibrous mats. Lys is a natural enzyme and, as part of the 
innate immune system, one of its major functions in vivo is against infection [246]. GNP have 
been extensively used in biological applications due to their biocompatibility, low size (<50 
nm) and ease of characterization [247], and they have been shown to exhibit good antimicrobial 
effects [248]. The antibacterial bioactivity against E. coli and Staphylococcus aureus (S. 
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aureus) of uncoated and LbL coated cellulose nanofibrous mats was determined. Uncoated 
cellulose mats hardly showed inhibitory effect while functionalized mats revealed significant 
antibacterial activity, which was enhanced with increasing the numbers of bilayers. 
In addition to Ag and GNP, releasable antibiotics have been incorporated into PEMs. 
Chlorhexidine (CX) is a promising candidate antimicrobial agent for incorporation into wound 
dressings. It is considered the “gold standard” antiseptic that is active against gram-
positive/gram-negative bacteria, facultative anaerobes/aerobes, molds, yeasts and viruses [249]. 
It exhibits both immediate bactericidal effect and excellent residual effect, which prevents 
reestablishment of microorganisms on the skin [250]. Agarwal et al. [251] functionalized the 
wound-contact surface of a synthetic biologic dressing with antibacterial nanofilms containing 
CX. The PEMs was composed of PAH and PAA, and cationic chlorhexidine acetate. In a full-
thickness „splinted‟ dermal wound-model in normal wild-type mice, the CX-functionalized 
dressing showed no decrease in either its adherence to the wound-bed or wound closure rate 
over 14 days. Significantly, CX/PEMs reduced viable counts of S. aureus by 3 log10 within 3 
days in murine wounds incubated with bacteria, compared to persistent bacterial colonization 
observed in wound treated with unmodified dressing. 
Another antibiotic commonly used to treat infections is gentamicin, an aminoglycoside 
antibiotic most effective against gram-negative bacteria, but also efficacious against certain 
gram-positive species such as S. aureus [252]. Chuang and co-workers [253] tried to develop an 
antimicrobial coating that can both discourage bacteria attachment to the implant surface and be 
able to release gentamicin into the surrounding tissues at a tunable dosage and rate. The 
researchers studied the possibility to construct a hydrolytically degradable thin film via the LbL 
deposition of poly(β-amino ester)s, HYA and gentamicin. The PME film demonstrated to have 
in vitro efficacy against S. aureus proliferation, comparable to those of positive controls of 
direct gentamicin administration. 
An alternative strategy that could be adopted to ensure the safety of wound healing dressing is 
the surface functionalizations of biomaterial with antibacterial polymer or peptides. Over many 
years, the cytotoxic properties of polycations in solution have been documented [254]; as a 
result, antibacterial strategies based on surface immobilized polycations have been widely 
explored [255, 256]. 
Among common synthetic polyelectrolytes, polyethylenimine (PEI) has intrinsic antibacterial 
property, as demonstrated in different studies [257, 258]. He and Chan [259] developed a stable 
PEM films by covalent LbL assembly of PEI, followed by in situ reduction of Ag ions. The 
covalent build up of PEI layers has been carried out through the use of a chemical cross-linker, 
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terepthalaldehyde (TA), while Ag nanoparticles were incorporated into PEI multilayers through 
in situ reduction of Ag
+
 by the pre-absorption of NaBH4. The antibacterial properties of PEI 
multilayer in the presence or absence of embedded Ag nanoparticles were measured by several 
standard assays. The live/dead bacterial assay showed that PEI multilayer film possessed 
considerable antimicrobial property against S. aureus and E. coli upon contact formation. The 
inclusion of Ag nanoparticles in PEI film not only increased to over 99% its contact killing 
efficiency but also led to the inhibition of the bacteria growth in suspended culture via the long-
term release of Ag
+
 into the liquid medium. 
Another synthetic polyelectrolyte with antibacterial property is the polyhexamethylene 
biguanide (PHMB), a positively charged polymer with a broad-spectrum of antimicrobial 
effects toward gram-positive and gram-negative bacteria, fungi, yeast, and human 
immunodeficiency virus type 1 (HIV-1) [260]. For biomedical applications, PHMB has been 
assessed as one of the most suitable antiseptic agents for clinical practice, due to its non- or 
low-toxicity to human cells [261, 262]. Tang and co-workers [263] developed a LbL 
nanocoating on PCL fiber surface composed of PHMB and PAA. The uniform coating showed 
excellent antibacterial ability, but had no toxicity on mammalian cells. PCL fibrous matrix with 
electrostatically self-assembled PHMB coating may provide a new anti-infective tissue scaffold 
for various biomedical applications. 
CH is a natural biocompatible cationic polysaccharide and a weak polyelectrolyte, whose 
antibacterial activity has received considerable attention in recent years. Although many 
mechanisms of action have been proposed, CH and its derivatives have been shown to bind to 
the negatively charged bacterial cell membrane and cause leakage, both when used in solution 
and when immobilized on surfaces [264]. Yu et al. [265] combined the widely described 
antimicrobial properties of Ag nanoparticles and CH to improve the antibacterial activity of a 
PLLA membrane. The polysaccharide PEMs included CH and dextran sulfate (DS)-stabilized 
silver nanosized colloid (DSS). The non-cytotoxic DS and dextrose served as stabilizer and 
reducing agent, respectively to form well-distributed Ag nanosized colloid (DSS). Bactericidal 
activity against Methicilin-resistant S. aureus was evidenced by PLLA-PEM membranes.  
Finally, Pinto et al. [266] explored the use of a negatively charged antibacterial agent as a 
possible surface active agent. The researchers have been able to incorporate the pseudo-
polyelectrolyte, poly(4-vinylphenol) (PVPh) onto multilayered systems with both weak and 
strong polycation, respectively PAH and PDDA. Phenol is a strong disinfectant that is used as 
the standard to which other antimicrobials are compared [267]. The study showed that the 
antimicrobial nature of PEM films was pH dependant. Both PAH/PVPh and PDDA/PVPh 
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systems were able to inhibit the growth of the Gram (+) bacteria, S. epidermidis, by 60–70%, 
respectively, when assembled at a pH of 10.5; however they both showed very little activity 
towards the Gram (−) E. coli bacteria. 
Designing a multifunctional surface by composition of anti-adhesion and contact killing 
polyelectrolytes may represent a viable chance to ensure the safety of wound healing dressing. 
For example, Wang et al. [268] developed a stable PEMs coating that combines the anti-
adhesion property of poly(vinyl pyrollidone) (PVP) and contact killing ability of CH. 
Adherences of S. aureus and E. coli on substrate with CH/PVP coating were significantly 
reduced. Bactericidal activity of CH/PVP coatings was good against E. coli and S. aureus and 
the addition of PVP increased its anti-adhesion property. In vitro cytotoxicity tests, cell 
morphology and activity evaluation of human umbilical vein endothelial cells showed that 
CH/PVP coatings had also good biocompatibility. Mei et al. [269] developed antibacterial 
polyacrylonitrile nanofibrous membranes by combining the anti-adhesive property of heparin 
(HE) with the antibacterial property of polyhexamethylene guanidine hydrochloride (PHGH). It 
was found that these LbL-modified nanofibrous membranes possessed high antibacterial 
activities against Gram-positive bacterium S. aureus and Gram-negative E. coli. 
In conclusion, PEMs can be tailored to leverage the key advantages of bacterial adhesion 
resistance, contact killing, and biocide leaching strategies. Moreover, the addition of biocide 
leaching to contact killing PEMs can significantly improve antibacterial efficacy. 
1.10 Mussel-inspired coatings: definition and state of the art 
In recent years, mussel adhesive proteins (MAPs) excreted by marine mussels have attracted 
much attention for their ability to form strong adhesive interaction with various substrates in 
wet environment [270]. 
Mussels are promiscuous fouling organisms and have been shown to attach to virtually all types 
of inorganic and organic surfaces [271], including classically adhesion-resistant materials such 
as PTFE. Clues to mussels‟ adhesive versatility may lie in the amino acid composition of 
proteins found near the plaque-substrate interface, which are rich in 3,4-dihydroxy-DL-
phenylalanine (DOPA) and lysine amino acids (Fig. 1.12) [272]. Proteins found in the mussel 
adhesive plaque, Mytilus edulis foot protein (Mefp), were largely characterized and six of them 
were identified to present a DOPA content ranging from 3 mol% (Mefp-2) to 30 mol% (Mefp-
5). 
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Fig. 1.12 (a) Photograph of a mussel attached to a mica surface, (b) schematic illustrations of the interfacial location of 
adhesive related proteins identified in the byssus of M. edilus [273], (c) amino acid sequence of Mefp-5 [274], (d) 
DOPA contains both amine and catechol functional groups found in Mefp-5 and was used as a molecular building block 
for polymer coatings. 
 
Specific adhesion mechanism of these small molecules to a large panel of surfaces is still not 
completely understood. It has been studied for many years and several proposals of interaction 
modes can be found in the literature [275]. However in all cases, covalent or strong non-
covalent interactions (hydrogen bonds or π–π stacking interactions for instances) can be found 
between catechol groups and inorganic substrates [276]. Inspired by the adhesive proteins 
secreted by mussels for attachment to wet surfaces, the interest for an attachment strategy based 
on catecholic chemistry [275] has increased, opening the door to the design of new 
(multi)functional platforms based on catechols. 
Lee at al. [277] proposed a convenient and versatile method for the surface modification of 
various solid materials by just immersing the substrate in a DOPA solution for a few hours, 
resulting in spontaneous deposition of a thin adherent polymer film (polyDOPA) whose 
thickness was a function of the immersion time and the polymerization temperature. Moreover, 
to avoid non-specific microparticle deposition on surfaces, stirring and/or vertical sample 
orientation was necessary. 
Although the exact polymerization mechanism is unknown at this time, it is likely to involve 
oxidation of the catechol to a quinone group which further participate in the functionalization 
process. In general, the polymerization process should include oxidation, intramolecular 
cyclisation and rearrangement of the DOPA structure as reported in Fig. 1.13. The reaction with 
other catechol/quinone and amine functions results then in a cross-linking polymer film [278, 
279]. 
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Fig. 1.13 The scheme of DOPA polymerization process. 
 
The polyDOPA coating is able to form on virtually all types of material surfaces: metals such as 
gold [280], platinum [281], stainless steel [282], nitinol [283] and titanium [284]; ceramics such 
as zirconia [285] and TCP [286]; synthetic polymers such as polyethersulfone (PES) [287], 
poly(vinylidene fluoride) (PVDF) [288], PLLA [289], PLGA [178]; natural polymers such as 
CH [290]. Then, the polyDOPA coating can further support a variety of secondary reactions, 
leading to tailoring of the coating for diverse functional uses. For example, the metal-binding 
ability of catechols [283, 291] present in the polyDOPA coating was exploited to deposit 
adherent and uniform metal coatings onto substrates by electroless metallization. This was 
demonstrated through deposition of silver metal nanoparticles via dip-coating of polyDOPA 
coated objects into silver nitrate solutions (Fig. 1.15 A). Based on these remarkable binding 
properties toward metal ions, different research groups have also used polyDOPA coatings as 
templates for the formation of HAp by co-precipitation of calcium and phosphate ions [282, 
292]. 
PolyDOPA coatings were also exploited to graft various (bio)macromolecules (Fig. 1.14 B, C) 
for the creation of functional ad-layers. Under oxidizing conditions, catechols react with thiols 
and amines via Michael addition or Schiff base reactions. These can either favor cell adhesion 
and improve blood compatibility by grafting heparin or bovine serum albumin (BSA) [293294-
295] or avoid protein adhesion with poly(ethylene glycol) (PEG) [296]. 
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Fig. 1.14 PolyDOPA coating and further derivatizations. 
 
In this contest, mussel-inspired coatings can be used to improve biocompatibility and/or 
osteoinductive/osteoconductive properties of GTR/GBR membranes by grafting bioactive 
compounds. Rim et al. [289] developed functionalized PLLA electrospun fibers using a mussel-
inspired surface coating (PD-PLLA) to regulate adhesion, proliferation and differentiation of 
human mesenchymal stem cells (hMSCs). They also examined the effect of the modified 
surface on the osteogenic differentiation of hMSCs. The homogeneous coating modulated 
hMSC responses in several aspects. Firstly, adhesion and proliferation of hMSCs cultured on 
PD-PLLA were significantly enhanced relative to those on PLLA. In addition, it enhanced 
osteogenic differentiation and calcium mineral deposition for up to 14 days of culture. These 
results suggested that the bio-inspired coating synthetic degradable polymer is a very promising 
tool to regulate stem cell function, which may serve as an effective osteoinductive material for 
engineering bone tissue in GBR applications. 
Insufficient osteoconductive ability and bacterial infections may lead to the failure of 
membranes for periodontal regeneration. Lee and co-workers [284] studied a functionalization 
method able to enhance osteoblast functions, while simultaneously decreasing bacterial 
infections. The coating has been developed on titanium (Ti) discs as schematically reported on 
Fig. 1.15. Substrates were first functionalized with heparin-dopamine by mimicking a mussel 
adhesion mechanism and, then, gentamicin sulfate (GS) and/or BMP-2 were sequentially 
immobilized to the heparinized-Ti (HE-Ti) surface. 
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Fig. 1.15 Schematic diagram for the immobilization of GS and BMP-2 to heparinized-Ti substrate [284]. 
 
Antimicrobial activity assay showed that the growth of S. aureus on GS/HE-Ti and GS/BMP-
2/HE-Ti was significantly lower compared to that on the pristine Ti and BMP-2/HE-Ti. In 
addition, in vitro cell test revealed that BMP-2/HE-Ti and GS/BMP-2/HE-Ti significantly 
enhanced alkaline phosphatase (ALP) activity and calcium mineral deposition of MG 63 
osteoblast cells. Taken together, GS/BMP-2/HE-Ti could achieve the dual functions of 
excellent antibacterial activity and osteoblast function promotion. Therefore, dual drug 
(antibiotics and osteoinductive protein)-eluting Ti substrates such as GS/BMP-2/HE-Ti could be 
a promising material for the enhanced osteointegration and implant longevity in periodontal 
applications. The same goal has been reached by Saidin et al. [282] through a multistep process 
of dopamine polymerization, Ag metallization and HAp biomineralisation on stainless steel 
(SS316L) substrates (Fig. 1.16). The SS316L substrates were first pre-treated and grafted with 
polydopamine through a self-polymerization technique. The Ag nanoparticles were then 
metallized on the polydopamine film at different immersion times in AgNO3 solution, followed 
by the formation of second polydopamine coating layer. Finally, HAp biomineralisation was 
performed in 1.5 Simulated Body Fluid (SBF) solution. The presence of Ag conferred 
antibacterial properties with 97.9% of bactericidal ratio against E. Coli after 24 h. Moreover, Ag 
was ionised up to 7 days which is crucial to prevent bacterial infection during the first stage of 
implant restoration. The functionalized films were stable with not significant alteration of their 
chemical composition, surface roughness and wettability properties after incubation in PBS for 
7 days. 
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Fig. 1.16 Schematic illustration of dopamine polymerization, Ag metallization and HAp biomineralisation on SS316L 
[282]. 
 
Finally, Chen et al. [297] took advantage of polyDOPA coatings ability to graft various 
biomacromolecules to improve cell response. A novel GBR membrane has been developed 
through the immobilization of a collagen/chitosan (COL/CH) composite on dopamine modified 
PLGA, to mimic ECM. The composite membrane retained mechanical properties from PLGA 
and biological properties from the COL/CH composites. However, diverse ratios of COL/CH 
displayed different microstructures and effects on cell behavior and proliferation (COL 
facilitated cell adhesion and spread while CH decreased both). A critical ratio of COL/CH (2:1) 
above which the addition of CH only slightly impacted cell proliferation was found. The results 
should be useful for combining versatile materials from different origins to construct GBR 
membranes and to further optimize the ratio of COL/CHI composites. 
Table 1.3 summarized the properties of membranes from literature discussed in previous 
paragraphs. 
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Table 1.3 Resorbable membranes from the State of the Art analysis. 
Material Fabrication Technique Structure Properties Reference 
n-HAp/CH Solvent casting Compact film 
Good biocompatibility 
σmax = 29.3-65.2 MPa; εmax = 6-18.5% 
152 
PLGC/TCP Heat-kneading Compact film 
Good regeneration of beagles‟ mandibular bones 
Resorption: 24 weeks 
σmax = 1-16 MPa 
12 
PLA/Bioglass Thermally induced phase separation Foam High bioactivity 155 
Alginate/nBGC Freeze-drying Porous scaffold 
Good biocompatibility 
Limited degradation after 4 weeks 
100-300 µm pores 
156 
PLLA/HAp Electrospinning Electrospun membrane 
Improved cells adhesion and growth 
Limited degradation after 8 weeks 
313 nm fiber diameters 
E ~ 118 MPa; σmax ~ 3 MPa; εmax ~ 6% 
157 
A187-HAp/PCL Electrospinning Electrospun membrane 
Good bioactivity 
Non-toxic to fibroblasts and osteoblasts 
E ~ 8 MPa; σmax ~ 5 MPa; εmax ~ 70% 
158 
PCL/Bioglass nanofibers Solvent casting Compact film 
Rapid formation of apatite-like minerals on the surface 
High osteoblastic activity 
260 µm thick 
159 
PLCL, PLA, G, HAp, MET Electrospinning Three-layer membrane 
Open porosity, interconnected structures 
E ~ 38 MPa; σmax ~ 2 MPa; εmax ~ 234% 
126 
PLGA/CaP Solvent-casting-leaching Bi-layer membrane 
No collapse into the defect 
Inner side able to retain blood clot throughout the buccal defect 
161 
nCHAC/PLGA Solvent casting Three-layer membrane Excellent biocompatibility 162 
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300-400 μm thick 
E ~ 1 GPa; σmax ~ 10 MPa; εmax ~ 249% 
HYA-PLGA/PLGA Solvent casting Bi-layer membrane 
Limited degradation after 8 weeks 
Effective bone regeneration 
87 
PLLA-CH Electrospinning Electrospun membrane 
Limited degradation after 6 weeks 
Good biocompatibility 
Prevent fibroblasts invasion 
115 nm fiber diameters 
280 nm pores 
171 
CH-BMP-2 Solvent casting Compact film 
Limited degradation after 3 weeks 
Osteoblast attachment, proliferation, differentiation 
E ~ 50 MPa; σmax ~ 6 MPa 
169 
PD-PLLA Electrospinning Electrospun membrane 
Enhanced cells adhesion and proliferation 
Enhanced osteogenic differentiation and calcium mineral deposition 
289 
PLGA-COL/CH Solvent casting Compact film 
COL/CH ratios different effects on cell behaviour 
E ~ 8 GPa; σmax ~ 50 MPa 
297 
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1.11 Factors influencing the success of GTR/GBR 
Factors that may limit regenerative healing after GTR/GBR surgery can be categorized into 
[298]: 
 barrier-independent factors (i.e. poor plaque control, smoking, occlusal trauma, 
suboptimal tissue health, mechanical habits that interfere with healing, inadequate 
overlying keratinized tissue and tissue thickness improper surgical technique, premature 
plaque colonization and early mechanical insult, loss of wound stability); 
 barrier-dependent factors (i.e. inadequate root-barrier seal, non-sterile technique, 
instability of membrane, premature membrane exposure/loss). 
Several studies have demonstrated the importance of patient selection, plaque control, and anti-
infective therapy in achieving consistently positive results with GTR procedures. Favorable 
clinical results have been most often observed in healthy, non-smoking patients demonstrating 
good plaque control and compliance with recommended oral hygiene measures [298]. The 
effects of bacterial contamination have been noted in a study of Selvig et al. [299], reporting an 
inverse relationship between observed plaque contamination of retrieved membranes and 
clinical attachment gain. Colonization of membranes with black pigmented species [300] and 
the presence of bacteria in samples treated with regenerative procedures correlates with a 
diminished healing response [301, 302]. However, a recent report conducted by Machtei et al. 
[303] indicates that membrane exposure had only a minimal effect on GTR results around 
natural teeth. 
Important defect-specific factors include the number of bony walls and the depth of the 
intrabony component. Gingival tissue thickness has also been linked to reduce clinical 
outcomes in GTR, including GTR-based root coverage procedures, with thin tissues achieving 
significantly less clinical improvements and percentages of root coverage [304, 305]. 
Identification of the influencing factors should lead to more predictable treatment outcomes 
following GTR procedures through better patient and defect selection. 
1.12 Thesis goal 
The main purpose of this work is the development of biologically active membranes and 
nanocoatings, with improved osteoconductive and antimicrobial properties, for Guided 
Tissue/Bone Regeneration applications in periodontal diseases. 
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Periodontitis is a chronic inflammatory pathology that can jeopardize the integrity of tooth 
support and ultimately, lead to tooth loss. To date, flap debridement and/or flap curettage and 
periodontal regenerative therapy with membranes and bone grafting materials have been 
employed with distinct levels of clinical success. 
Current resorbable and non-resorbable membranes act as a physical barrier to avoid connective 
and epithelial tissue down-growth into the defect, favoring the regeneration of periodontal 
tissues. As reported in this chapter, the ePTFE membranes are the “gold standard” for 
GTR/GBR applications. However, they have different disadvantages such as non-resorbability 
and the need for a second surgical operation to repair dehiscence. In this work, two different 
approaches were proposed to improve non-resorbable membranes properties and to avoid a 
second surgical operation, respectively by using surface-functionalized (i) high-density PTFE 
membranes and (ii) resorbable membranes, combining synthetic and natural biomaterials. 
Although membranes based on biodegradable synthetic polymers avoid a second surgical 
operation, they show drawbacks concerning their capacity of space maintenance, early/late 
absorption, mechanical properties and bacterial infection during degradation. On the other hand, 
collagen membranes have additional advantages related to biological properties of collagen 
itself (cell adhesiveness and biodegradability) but are characterized by low mechanical strength. 
It is clear that the “ideal” membrane for use in periodontal regenerative therapy has yet to be 
developed. Based on the State of the Art analysis, research efforts have been addressed to the 
preparation of (i) composites consisting of osteoconductive calcium phosphate ceramics and 
biodegradable polymers, (ii) multi-component membranes with specific properties at the 
interface between the implant and alveolar bone and epithelial tissues, and (iii) surface 
modification of synthetic polymers to graft bioactive proteins or biomolecules. The introduction 
of specific cell-adhesion molecules should lead to a specific tissue response on the membrane 
surfaces, the delivery or incorporation of antimicrobial substances might minimize the influence 
of bacterial contamination on regenerative outcome and the growth factor release from 
membranes should stimulate a better bone regeneration. 
In this contest, the thesis is aimed at the design of advanced products for GTR/GBR 
applications. 
The first part of the thesis follows a more traditional approach, where a commercially available 
membrane is surface modified by environmentally friendly technique to tailor the surface 
properties, allowing rapid bone re-growth and exerting antimicrobial action (Fig. 1.17). To this 
purpose, PTFE film surface is modified by a mussel-inspired coating method, involving the 
application of a thin film coating of DOPA on a substrate via dip-immersion and oxidative 
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polymerization. Based on it, the osteoconductive property of PTFE film is improved by the 
deposition of a HAp film, that may occur by binding of DOPA to the HAp nanoparticles during 
the DOPA polymerization process. Regarding the antimicrobial activity, the polyDOPA layer 
on PTFE film allows further deposition of silver nanoparticles, without the addition of reducing 
agents, surfactants, or energy-consuming steps. 
The physicochemical, morphological and biological properties of coated samples are then 
evaluated through different techniques, such as X-Ray photoelectron spectroscopy, scanning 
electron microscopy, atomic force microscopy, water contact angle measurements, and cell 
proliferation and adhesion. 
 
Fig. 1.17 Not-absorbable PTFE membranes surface modified by mussel-inspired coating methods to (a) allow rapid 
bone re-growth and (b) exert antimicrobial action. 
 
The second part of the thesis follows a highly innovative approach, where a bi-layered 
bioabsorbable membrane is developed, by the assembly of a compact and a porous layer (Fig. 
1.18). The purpose is to combine the approaches identified in the scientific literature, 
developing biologically active, osteoconductive and multi-component materials, mimicking  
native bone and gingival ECM.  The multifunctional membranes represent the next generation 
of GTR/GBR membranes for periodontal tissue engineering. 
This work is divided into three parts. 
1. Development of the compact layer: poly(DL-lactide-co-ε-caprolactone) and poly(DL-
lactide-co-glycolide) are selected as polymers to prepare binary blends. Different 
compositions are studied to find those with suitable mechanical and biological properties 
for the application. Then, a nanocoating is deposited on optimized blend film with the aim 
to tailor surface composition to enhance cell response and antimicrobial activity. To this 
purpose, a surface priming treatment is performed on substrates to allow the deposition of 
nanocoating and Layer-by-layer technique is used to obtained nanostructured coating. 
2. Development of the porous layer: sponge-like membranes based on TCP as the inorganic 
phase, stimulating the biomineralisation, and chitosan/gelatin blend as the organic phase, 
supporting cell adhesion and proliferation, are developed by freeze-drying. A double 
cross-linking process is introduced with the aim to improve membranes stability in 
physiological environment. Membranes are then characterized in terms of 
physicochemical, morphological and mechanical properties. 
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3. Development of the bi-layered device: a biomedical glue based on polyvinylpyrrolidone 
and polyethylene glycol blend is employed to assemble the two layers. Physicochemical 
and adhesion properties of glue are evaluated. Then, preliminary characterizations of the 
bi-layered membrane are carried out. 
 
Fig. 1.18 Functionalized bi-layered bioabsorbable membrane consisting of a compact and a porous layer, assembled 
with a biomedical glue. 
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2 
PolyDOPA mussel-inspired coating as a 
means for hydroxyapatite entrapment on 
polytetrafluoroethylene surface for 
application in Periodontal diseases 
 
Abstract 
Periodontal diseases are highly prevalent in population of all ages. They are initiated by 
bacterial accumulation at the interface of bone and soft tissue leading to the loss of gingival 
tissue attachment to the root surface. In this context, membranes made from expanded 
polytetrafluoroethylene (ePTFE) are considered the gold standard for guided tissue and bone 
regeneration. However these non-resorbable membranes suffer from weak 
osteoconductive/osteoinductive properties. Therefore, in this chapter a strategy for 
hydroxyapatite nanoparticles (HAp) coating on PTFE films was developed to improve PTFE 
osteconductive properties. Binding ability of 3,4-dihydroxy-DL-phenylalanine (DOPA) to 
samples of any type, size and shape, was used to firmly coat HAp nanoparticles on PTFE 
(PTFE-DOPA-HAp). PTFE films and PTFE coated with solely DOPA (PTFE-DOPA) or with 
HAp (PTFE-HAp) were also characterized. Chemical composition analysis by XPS and FTIR-
ATR demonstrated the successful deposition of polyDOPA and HAp on PTFE coated with a 
combination of DOPA and HAp. Morphological and topographical characterizations further 
confirmed the total surface coverage of the substrates by the coatings causing an increase in 
surface roughness and wettability. PTFE-DOPA-HAp films were also immersed in PBS to 
study coating stability: the HAp coating was still present after 14 days of incubation, with a 
reduced surface roughness and an unchanged hydrophilicity. MC3T3-E1 pre-osteoblastic cells 
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cultured on polyDOPA and polyDOPA/HAp coated film showed a pronounced increase of cell 
proliferation and cellular adhesion. These findings suggest that this environmentally friendly 
and mussel-inspired coated PTFE membrane could find potential application as scaffold for 
guided tissue/bone regeneration in periodontal diseases. 
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2.1 Introduction 
Periodontitis is a very aggressive pathology that affects the integrity of the periodontal system 
and lead to damage of the periodontal tissues [1]. Initiated and maintained by bacterial 
stimulation of a chronic inflammatory and immune response, tissue integrity is compromised 
with the loss of soft tissue attachment to the root surface and the loss of alveolar bone that 
results in the formation of a periodontal pocket around the tooth. The pocket acts as a reservoir 
supporting the growth of anaerobic bacteria, which ultimately may lead to tooth loss [2]. 
Periodontal disease are highly prevalent; data from the National Institute of Dental and 
Craniofacial Research (NIDCR, National Institutes of Health, United States) has revealed that 
nearly 90% of the worldwide adult population present at the least a moderate level of 
periodontal-related diseases [1, 3]. 
Since the mid-1980s, several therapeutic approaches have been developed to treat the diseases 
that affect the periodontium; all have been focused on periodontal tissues regeneration. They 
include bone replacement grafts, root surface biomodifications, guided tissue and bone 
regeneration (GTR/GBR), and delivery of growth factors or gene therapies [4]. Among them, 
GTR/GBR have become the most promising therapies and were widely used in clinical 
treatment for their convenience and effectiveness [5-
6
7]. 
GTR/GBR treatments of periodontitis are surgical procedures that involve the placement of an 
occlusive barrier membrane between the tooth and the gingival tissue, preventing epithelial and 
connective tissue down-growth into the defect and allowing the exposed root surface to be 
repopulated with regenerating cells, such as periodontal ligament cells and osteoblasts [6-
8
9]. 
Non-resorbable membranes were the first used in clinical treatments. They are inert and 
biocompatible, act as a cellular barrier, provide space for tissue regeneration, and allow tissue 
integration [10]. In this contest, membranes made from expanded polytetrafluoroethylene 
(ePTFE) are considered the gold standard of GTR/GBR treatments. Effectiveness of ePTFE 
membranes was investigated in numerous clinical studies, confirming their excellent 
biocompatibility [11, 12]. However, despite the excellent mechanical properties and the 
effective biocompatibility, non-resorbable PTFE membranes suffer of weak 
osteoconductive/osteoinductive properties. 
The use of bioactive inorganic compounds is considered an effective way of producing bone 
regenerative materials with physicochemical properties approaching those of bone and with 
good tissue compatibility, such as cell affinity, osteoconductivity and enhanced bone formation 
[13, 14]. Bioactive inorganic components, namely calcium phosphates and bioactive 
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glasses/glass ceramics, are the most widely used inorganic compounds. Hydroxyapatite (HAp) 
is a calcium phosphate ceramic with chemical composition similar to the mineral component of 
bone. Due to its proven osteoconductivity properties, it is extensively used as coating on 
commercially available metallic implants for orthopedic and dental applications to improve 
their osteoconductivity [15, 16].  
The application of HAp coating on PTFE is very challenging. As known, PTFE is a very inert, 
hydrophobic and adhesion-resistant material. Various methods used currently, such as UV-
induced graft [17], radiation graft copolymerization [18] or plasma-induced surface graft 
polymerization [19] require expensive equipment and complex process.  
Recently, a mussel-inspired coating method has been reported as a versatile surface 
modification technique that is effective irrespective of material type [20, 21]. The proteins 
secreted by mussels are found to serve as an adhesive layer in wet condition to introduce further 
modification on the surface. These proteins contain domains rich in 3,4-dihydroxy-DL-
phenylalanine (DOPA) and lysine amino acids as adhesive moieties [22]. Dreyer et al. showed 
that a thin film of DOPA on a substrate can be achieved via dip-immersion and oxidative 
polymerization, and the film properties can precisely be controlled by adjusting immersion 
time, solution concentration and temperature [23]. The dip-coated solid surface could further be 
modified and functionalized by the adduct formation between thiol- or amine- containing 
molecules and DOPA coating layer [24, 25]. 
Guided by these findings, herein, we report on an environmentally friendly technique to apply a 
HAp-nanoparticles coating on PTFE film through one-step DOPA application process in order 
to promote the bone re-growth properties of PTFE membranes. In our strategy, HAp coating on 
polymer films occurs by simultaneous binding of DOPA during its polymerization, to the HAp 
nanoparticles and to the PTFE substrates. Thus, the immobilization of HAp nanoparticles on 
PTFE surface could be achieved by their entrapment and/or conjugation with polyDOPA. We 
fully characterized the surface morphology and surface physicochemical properties of coated 
films using complementary analytical techniques including scanning electron microscope 
(SEM), atomic force microscopy (AFM), X-ray photoelectron spectroscopy (XPS), and water 
contact angle measurements. The stability of the coating was examined in phosphate buffer 
saline (PBS). We then evaluated the effect of HAp on the adhesion and proliferation of mouse 
preosteoblast MC3T3-E1 (subclone 14) cells. 
 
77 
 
2.2 Materials and methods 
2.2.1  Materials 
Model PTFE films (10 x 30 mm
2
) were kindly supplied by BIOMICRON s.r.l. Laboratory 
(Torino, Italy). The surface of the film was cleaned by immersion in ethanol/water (1/1 v/v) 
solution for 12 h at room temperature. Then, clean PTFE films were rinsed with large amount of 
demineralised water and dried at room temperature under a vented hood for 24 h. 
The monomer DOPA (Mw: 197.19 Da), the HAp (nanoparticles size < 200 nm; Mw: 502.31 Da) 
and Tris (CH2OH)3CNH2 (Mw: 121.14 Da) were purchased from Sigma-Aldrich (Milano, Italy) 
and used as received. 
2.2.2  Methods 
2.2.2.1 Surface treatment 
Clean PTFE films were immersed in three different solutions:  
1) 2 mg/mL of DOPA in 10 mM Tris buffer 
2) 10 mg/mL of HAp in 10 mM Tris buffer  
3) 2 mg/mL DOPA/10 mg/mL HAp in 10 mM Tris buffer. 
The pH was adjusted at 8.5 through HCl (1 M) dropwise addition. After 48 h of immersion at 
room temperature, the films were then rinsed three times with large amount of demineralised 
water to remove free DOPA and HAp, and dried at room temperature under a vented hood for 
24 h. The coated films were coded as follows: PTFE-DOPA, PTFE-HAp and PTFE-DOPA-
HAp. 
2.2.2.2  Surface analyses 
The static water contact angles of the sample surfaces were determined through a sessile drop 
method, using a 6 µl double distilled water droplet. Static contact angles of films were 
measured in air at room temperature in a VCA Optima (AST, Massachusetts, USA) instrument 
equipped with a VCA Optima XE software for data acquisition. 
Chemical composition of the functionalized films was investigated by XPS (K-Alpha
TM+
 
spectrometer, Thermal Scientific, Texas, USA) at a detection angle of 45°. The 
characterizations were performed in survey and high resolution spectra using standard 
aluminum (1486.6 eV) and magnesium (1253.6 eV) X-Ray sources, respectively. A surface area 
of 0.005 cm
2
 was analyzed at 150 W without charge compensation. Chemical analysis has been 
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carried out also in a Perkin Elmer Frontier Optical Spectrometer fitted with an attenuated total 
reflection sampler (FTIR-ATR, Massachusetts, USA). Spectra were recorded over the 400-4000 
cm
-1
 range at room temperature, using diamond crystal. 
The surface morphologies were visualized using scanning electron microscopy (FEI Inspect F-
50 FE-SEM, Oregon, USA) and compositional analysis (EDS). Each sample was coated with an 
ultrathin platinum as a conductive layer for better image quality. 
The topographic surfaces were imaged by AFM using the Nanoscope III (Digital Instruments, 
Veeco, California, USA) system in the tapping mode. Images were acquired in air at room 
temperature using a silicon probe with a nominal spring constant of 40 N/m and a nominal 
radius of curvature of 35 μm (model RTESP, Veeco). 10 x 10 and 5 x 5 μm2 areas were scanned 
at a rate of 1 Hz using the minimum amount of force required to obtain steady images. The root 
mean square roughness (Rrms) was calculated using Nanoscope v5.12r5 software on a 10 μm by 
10 μm area. 
Finally, the polyDOPA-HAp coating dissolution has been evaluated by immersing surface 
modified films in PBS (pH 7.4) at 37 °C for 7 and 14 days. The PBS medium was exchanged 
once every 2 days. At each dissolution time, samples were characterized through XPS, FTIR-
ATR, SEM and AFM analyses and water contact angle measurements. 
2.2.2.3  Cell culture  
Mouse preosteoblast MC3T3-E1 (subclone 14) cells were supplied by American Type Culture 
Collection (ATCC, Virginia, USA). Minimum essential media (α-MEM; Gibco, Invitrogen 
Corporation) supplemented with 10% Fetal Bovine Serum (FBS; Gibco, Invitrogen) and 1% 
penicillin/streptomycin (Invitrogen) was used to culture the osteoblasts. Cells were first 
expanded, and a concentration of 5 × 10
4
 was seeded on the model PTFE films and incubated at 
37 °C in a humidified atmosphere of 5% CO2 for 1 and 3 days. Cell Crown
TM
 inserts (Scaffdex, 
Tampere, Finland) were used to fix the films at the bottom of the wells prior to cell seeding. 
Cell proliferation was assessed using the colorimetric indicator Alamar Blue assay (Life 
Technologies, Ontario, Canada). Media was removed, samples were rinsed once in PBS 
(Sigma-Aldrich), and 300 µL of fresh medium containing a 10% solution of Alamar Blue was 
added to each well. The culture plates were wrapped in aluminum foil and incubated for 4 h at 
37 °C in a humidified atmosphere of 5% CO2. Absorbance of the extracted dye, which is 
proportional to the number of cells attached to the film, was measured spectrophotometrically 
with a microplate reader (Molecular Devices, SpectraMax i3 multi-mode detection platform, 
California, USA) at wavelengths of 570 and 600 nm. A calibration curve, generated from a 
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known number of osteoblast MC3T3 cells reacting with the Alamar Blue indicator, was used to 
quantify the number of cells attached on the films. 
2.2.2.4  SEM analyses 
Cell seeded films were washed two times with PBS, fixed in Parafolmaldehyde for 30 min at 
room temperature, washed again three times with PBS and dehydrated in 30%, 50%, 70%, 80%, 
90%, 95%, and 100% ethanol, respectively, for 15 minutes. After dehydration with ethanol, the 
films were immersed in amyl with a gradient of acetate:ethanol from 25:75; 50:50; 75:25 to 
100:0, for 15 min for each composition and then placed in a Critical Point Dryer. The samples 
were finally air dried under vacuum, coated with platinum, and examined with SEM (FEI 
Inspect F-50 FE-SEM). 
2.2.3  Statistical analysis  
All data are expressed as means ± standard deviation. Differences between means were 
analyzed by one-way ANOVA followed by a Tukey’s post hoc test. For in vitro cell assay, 
statistical analysis was performed using two-way ANOVA with the Bonferroni’s post test. All 
statistical analyses were performed with Prism, Graph Pad Software. 
2.3 Results and discussion 
2.3.1  Chemical composition 
The chemical composition collected from XPS spectra of PTFE, PTFE-DOPA, PTFE-HAp, and 
PTFE-DOPA-HAp samples (data not shown) are listed in Table 2.1. 
Table 2.1 XPS chemical composition of pristine PTFE film, DOPA powder, PTFE film coated with DOPA (PTFE-
DOPA), HAp (PTFE-HAp) and DOPA/HAp mixture (PTFE-DOPA-HAp). 
Sample Atomic percentage (mol%) C/N 
C1s O1s F1s N1s Ca2p P2p 
PTFE 30.8 0.7 68.5 - - - - 
DOPA (theoretic value) 64.3 28.6 - 7.1 - - 9.0 
PTFE-DOPA 51.4 15.2 28.7 4.5 - - 11.4 
PTFE-HAp 33.5 9.3 50.9 - < 1.0 < 0.5 - 
PTFE-DOPA-HAp 38.3 23.2 22.9 3.9 12.5 10.2 9.8 
 
XPS spectra of both PTFE and PTFE-DOPA indicated the presence of oxygen (O1s, 534 eV), 
carbon (C1s, 286 eV), and fluorine (F1s, 689 eV). However, pure PTFE film had no nitrogen 
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(N1s 400 eV) while on the film surface modified by self-polymerized DOPA (polyDOPA) the 
N1s could be detected. In addition after the coating of polyDOPA, the contents of carbon and 
oxygen increased remarkably (reaching values of 51.4mol% and 15.2mol% respectively), while 
the detected fluorine content decreased from 68.5mol% to 28.7 mol%. As a result, the C/N 
molar ratio for the PTFE-DOPA film was 11.4, in the same order of the theoretical value for 
pure DOPA (9.0). In general, the atomic percentages detected on the DOPA-modified PTFE 
film were in good agreement with theoretic values [22]. These indicated that the PTFE film was 
fully covered and the thickness of polyDOPA layer surpassed the detection deepness of XPS 
[26]. 
The immersion in a DOPA/HAp mixture solution resulted in the appearance of HAp 
characteristic elements: calcium (Ca2p, 348 eV) and phosphate (P2p, 136 eV). The high atomic 
percentage of calcium and phosphate indicated that a layer of HAp has been deposited on the 
PTFE surface. Moreover, surface atomic composition of polyDOPA/HAp coated PTFE was 
different from PTFE-DOPA film confirming the formation of a HAp layer on PTFE film. The 
contents of carbon, fluorine and nitrogen decreased to 38.3 mol%, 22.9 mol% and 3.9 mol%, 
respectively, while the detected oxygen content increased reaching a value of 23.2 mol%.  
In order to demonstrate the role of polyDOPA is critical to firmly attach the HAp to the surface, 
a PTFE film was immersed in a solution containing only HAp and used as control. The XPS 
spectra of PTFE-HAp film after rinsing the film to remove the access of HAp showed only a 
trace of calcium and phosphate (less than 1 mol%).  
To further investigate the chemical structure and molecule interaction, spectral deconvolution of 
C1s and O1s peaks was performed for PTFE, PTFE-DOPA, PTFE-HAp and PTFE-DOPA-HAp 
samples (Fig. 2.1). 
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Fig. 2.1 XPS high resolution spectra of O1s and C1s for PTFE, PTFE-DOPA, PTFE-HAp and PTFE-DOPA-HAp 
samples. 
 
As shown in Fig. 2.1, the C1s spectrum of unmodified PTFE film exhibited two main bands at 
292.3 and 284.9 eV associated to CF2 and C-C groups, respectively [27]. Compared to the 
unmodified PTFE film, some new satellite peaks assigned to C=O/COOH (288.2 eV), C-N/C-
OH (286.2 eV), and C-H (284.7 eV) bonds were observed in the deconvolution of the C1s core-
level spectrum of PTFE-DOPA samples. The C-C/C-H was attributed to an aromatic carbon 
chain in the polyDOPA structure, in between amine (C-N) and catechol groups (C-OH). During 
the polymerization process, the catechol was oxidized into quinone group (C=O) which further 
participated in the functionalization process. The polymerization process included oxidation, 
intramolecular cyclisation and rearrangement of the DOPA structure. The reaction with other 
catechol/quinone and amine functions was then resulted in a cross-linking polymer film [28, 
29]. The C-OH (532.6 eV) and C=O/COOH (532.1 eV) bands were also observed in 
deconvolution spectra of O1s of PTFE-DOPA films. It should be noted that the C-OH peak 
observed in all pristine PTFE spectra was associated with the interaction of ambient air with the 
PTFE samples before polyDOPA coating [28]. 
The relative percentage of C1s and O1s bands were influenced by the introduction of HAp 
agglomerates on the PTFE surface, which lead also to the generation of new band (1.9%) on 
O1s deconvolution spectrum at 534.7 eV due to phosphate bonds in HAp structure. Compared 
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to the literature values (531-531.5 eV) [30, 31], the binding energy observed for PTFE-DOPA-
HAp film was very high. This shift which is caused by calcium–phosphate, has been already 
noticed by Saidin et al. [32]. 
The deconvolution spectra of C1s for PTFE-HAp sample was almost similar to those of pristine 
PTFE with the exception of the presence of a small trace of HAp that introduced some changes 
on O1s spectra of PTFE-HAp. 
The successful introduction of polyDOPA and HAp on PTFE model film surface has been 
confirmed by FTIR-ATR analysis (Fig 2.2).  
 
Fig. 2.2 FTIR-ATR spectra of PTFE, PTFE-DOPA, PTFE-HAp and PTFE-DOPA-HAp films, compared with FTIR-
ATR spectra of DOPA HAp powder. 
 
DOPA spectrum showed many narrow peaks, characteristic of small molecules. Although weak, 
the absorption bands of catechol N-H at 3375 cm
-1
 and O-H at 3198 cm
-1
 could be observed 
[33]. The absorption band at 1659 cm
-1
 and at 1605 cm
-1
 were attributed to the stretching 
vibration of C=C bond on aromatic rings and N-H bending vibration, respectively [27]. 
The presence of new broad peaks in PTFE-DOPA spectrum at 3600 cm
-1 
and 3200 cm
-1
 as 
compared to unmodified PTFE film was attributed to the stretching vibrations of the N–H/O–H 
as a result of the surface coating of PTFE film by polyDOPA. The peak at 1600 cm
-1
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overlapping C=C vibrations of the aromatic ring and the N–H bending vibrations along with a 
peak around 1350 cm
-1
, related to the phenolic bending vibration are also indicative of the 
presence of polyDOPA on the surface of PTFE films.  
The immersion of PTFE film in a buffer solution containing DOPA and HAp nanoparticles led 
to marked changes in PTFE spectra and resulted in three new peaks at nearly 1420 cm
-1
, 1030 
cm
-1
 and 603 cm
-1
 characteristics of ν3 vibrational mode carbonate ions, and ν3 and ν4 phosphate 
vibrational bands as a result of HAp entrapment in DOPA layer on PTFE films. Similarly to the 
results obtained by XPS analyses, no peaks related to the presence of HAp could be detected on 
PTFE-HAp spectra when this inorganic phase deposited without the addition of DOPA 
confirming that DOPA is critical for introducing this osteoconductive material on PTFE 
membrane. 
2.3.2  Morphology 
Fig. 2.3 illustrates the surface morphology of coated and uncoated PTFE films as revealed by 
SEM. 
 
Fig. 2.3 Morphology of (a) PTFE, (b) PTFE-DOPA, (c) PTFE-HAp, and (d) PTFE-DOPA-HAp films. EDS analyses of 
(e) PTFE-HAp and (f) PTFE-DOPA-HAp surfaces. The arrows in Fig 3b inset show polyDOPA thin layer on the 
surface of PTFE-DOPA samples while in Fig 3c they indicate the agglomerates of HAp dispersed on the PTFE surface. 
 
Control PTFE film and those modified by polyDOPA or HAp were characterized by rough 
surface (Fig. 2.3 a, b and c). After the immersion in DOPA solution, a polyDOPA thin layer 
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covered the surface of PTFE-DOPA samples, as underlined by the inset in Fig. 2.3b (black 
arrows). The polyDOPA coating appeared uniformly distributed over the entire substrate 
surface. On the contrary, only some agglomerates of HAp nanoparticles could be observed on 
PTFE-HAp film (Fig. 2.3c, black arrows). The PTFE-DOPA-HAp film showed a coating layer 
of mineral crystal precipitations on the surface of PTFE film. The HAp layer was uniformly 
covering the entire sample surface, producing a high rough surface. Moreover, the SEM image 
of PTFE-DOPA-HAp film at a higher magnification (inset in Fig. 2.3d) showed a compact 
coating with a 3D-structure characterized by the presence of some pores, beneficial for bone 
integration [34]. Comparing the EDS spectra of PTFE-HAp and PTFE-DOPA-HAp films 
showing higher amount of Ca and P than PTFE-HAp film confirmed the presence of polyDOPA 
embedded HAp on the sample surface.  
2.3.3  Surface roughness and wettability properties  
Further characterizations on the film topography and wettability properties confirmed our SEM 
observations. Indeed, after the immersion of PTFE samples into the DOPA solution for 48 h, 
the surface roughness increased significantly (*** P < 0.01) (Fig. 2.4b). As reported by Xi et al. 
[22], this phenomenon is attributed to the coverage of polyDOPA layer on film surface. 
Conversely, the surface roughness slightly increased, but not significantly, in respect to PTFE 
films when HAp simply deposited on the PTFE. The PTFE immersion in a buffer solution 
containing DOPA and HAp nanoparticles markedly changed the film surface topography. 
PTFE-DOPA-HAp samples (Fig. 2.4d) exhibited significantly higher peaks than pristine PTFE, 
PTFE-HAp and PTFE-DOPA samples and reached over 200 nm after the adsorption of HAp 
nanoparticles (*** P < 0.01). The AFM results confirmed again that the use of polyDOPA as 
embedding layer is essential to deposit an effective amount of HAp on PTFE films. 
 
Fig. 2.4 AFM height mode images and root mean square roughness values (Rrms) of (a) PTFE, (b) PTFE-DOPA, (c) 
PTFE-HAp, and (d) PTFE-DOPA-HAp samples. 
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As expected, polyDOPA or/and HAp coating on PTFE affected also the film wettability, due to 
both changes in surface roughness and its chemical composition. The presence of hydrophilic 
functional groups (-NH and -OH) of polyDOPA and HAp coatings significantly increased the 
wettability properties of PTFE films. As reported in Fig. 2.5, contact angle of PTFE-DOPA 
samples reached a value of 69.9° ± 3.8° while the immersion in DOPA/HAp mixture solution 
decreased the contact angle of PTFE substrate to less than 50°. The surface wettability of 
PTFE-HAp sample was comparable to that obtained for unmodified PTFE, since the direct HAp 
deposition do not lead to significant change either in surface chemical composition or 
roughness (according to previous analyses). 
 
Fig. 2.5 Static contact angle measurements of PTFE, PTFE-DOPA, PTFE-HAp, and PTFE-DOPA-HAp films. 
Statistical analysis indicated the presence of statistically significant differences among contact angle values (*** P < 
0.01). 
 
As a result of rougher surface, the surface wettability was significantly increased for PTFE-
DOPA-HAp in comparison to all other samples. As known in the literature, a hydrophilic 
surface is important for protein absorption and proliferation of osteoblast cells [35]. Similarly, a 
rough surface will provide high surface area for protein absorption, that in turn create more 
anchoring points for osteoblast adhesion and thereby would accelerate bone growth onto an 
implant surface [36]. 
2.3.4  Cell proliferation and adhesion  
When compared to initial number of seeded cells The improved surface wettability and 
roughness promoted MC3T3-E1 cells’ proliferation on all samples as soon as day one of culture 
(Fig. 2.6).  
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Fig. 2.6 Alamar Blue assay results for cell proliferation on PTFE, PTFE-DOPA, PTFE-HAP, and PTFE-DOPA-HAp 
films as a function of time. The initial number of seeded pre-osteoblast MC3T3-E1 was 1 x 105 cells in 500 μl MEM-α. 
Petri dish was used as control (Ctrl). 
 
Interestingly, the cells responded more favorably to PTFE-DOPA rather than PTFE-DOPA-
HAp. We believed that in addition to improved surface wettability, the presence of bioactive 
functional groups such as OH- and NH2- (from polyDOPA coating) [37] was responsible for 
such an improvement. However, the overall cell proliferation on PTFE and PTFE modified 
surfaces was less than the cells on control Petri dishes. This is in alignment with Lincks et al. 
[38] observation where the authors reported a decreased osteoblast-like cells proliferation on Ti 
samples with high surface roughness and concluded that high surface roughness was 
responsible for this decrease at early stage of cell culture (day 1).  
After 3 days of culture, cells continue to proliferate on all samples. However, the growth rate 
was more pronounced, compared to control, on PTFE-DOPA-HAp films compared to others. 
This result indicates that the polyDOPA and HAp combination strategy allowed to significantly 
improve the proliferation of MC3T3-E1 cells comparing to PTFE or PTFE modified either by 
polyDOPA or HAp. 
The SEM micrographs of osteoblasts on the PTFE-based films after 1 and 3 days of culture 
were in good agreement with cell proliferation assay (Fig. 2.7). Higher number of adhered 
MC3T3-E1 cells were found on PTFE-DOPA and PTFE-DOPA-HAp films than on pure PTFE 
and PTFE-HAp samples as of day one. The cells where more spread with extended filopodia 
invading the surface of samples (Fig. 2.7 b1 and d1). At the day 3, the number of MC3T3-E1 
cells adhered on the surface markedly increased for PTFE-DOPA-HAp film (Fig. 2.7 d2), 
where cells stretched out, flattened covered most of the surface of the sample. A good cells 
adhesion could be observed also for PTFE-DOPA film (Fig. 2.7 b2), while MC3T3-E1 cells 
cultured on PTFE and PTFE-HAp samples remained rounded, often growing in clusters (Fig. 
2.7 a2 and c2). 
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Fig. 2.7 SEM morphology of preosteoblast cells grown on PTFE (a1, a2), PTFE-DOPA (b1, b2), PTFE-HAp (c1, c2) 
and PTFE-DOPA-HAp (d1, d2) films after seeding cells for 1 and 3 days, respectively denoted with numbers 1 and 2. 
Scale bar = 100 µm. 
 
The results from proliferation and adhesion tests confirmed that the combined DOPA and HAp 
coating played an important role in stimulating the proliferation and adhesion of MC3T3-E1 
cells and significantly improved the osteoblast response of PTFE.  
2.3.5  Coating dissolution 
As discussed, the polyDOPA/HAp coating was characterized by a high surface roughness. 
Thus, the polyDOPA/HAp coating would be expected to result in a faster rate of dissolution, as 
a greater surface area of the coating is exposed to the surrounding environment. 
Indeed, XPS results, indicated many changes in the surface composition of PTFE-DOPA-HAp 
films after incubation over 14 days in PBS (Table 2.2). While an increase in fluorine atomic 
percentage could be detected, the characteristic peaks of PTFE substrate, mainly carbon and 
oxygen content, were decreased. Nitrogen content linearly decreased with the increase of 
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incubation time in PBS, reaching a value of 0.8 mol%. The same happened for the atomic 
percentage of Ca and P, which markedly decreased to values of 6.9 mol% and 4.8 mol%, 
respectively, after 7 days of immersion; then, they remained almost constant after this period. 
Table 2.2 XPS chemical composition of PTFE-DOPA-HAp films after incubation in PBS at 37 °C for 0, 7 and 14 days. 
Sample Time 
(days) 
Atomic percentage (mol%) 
C1s O1s F1s N1s Ca2p P2p 
PTFE-DOPA-HAp 
0 38.3 23.2 22.9 3.9 12.5 10.2 
7 28.6 24.4 29.7 1.4 6.9 4.8 
14 31.9 16.5 40.6 0.8 5.8 4.4 
 
Deconvolution spectra of C1s and O1s were also characterized on PTFE-DOPA-HAp films at 
each dissolution time (Fig. 2.8). The polyDOPA and HAp release influenced the relative 
percentage of C1s bands. In fact, it could be observed the atomic percentage reduction of 
elements associated with the polyDOPA coating. On the contrary, no markedly changes could 
be detected for O1s bands, except the disappearance of the peak attributed to oxygen from the 
phosphate bonds in HAp structure. 
The results obtained with XPS analysis suggested that dissolution reactions were occurring in 
two steps: an extremely fast release of HAp during the first week of immersion and a much 
more gradual release during the next 7 days. 
 
Fig. 2.8. XPS deconvolution spectra of O1s and C1s for PTFE-DOPA-HAp samples after incubation in PBS at 37 °C 
for 0, 7 and 14 days. 
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The surface chemical composition of PTFE-DOPA-HAp films at each dissolution time has been 
also evaluated through FTIR-ATR analysis. Peaks associated to the coating were still visible in 
spectra of samples incubated in PBS and only slight changes in peaks intensity could be observe 
(data was not shown). 
A physical change in the surface morphology of the coating was observed through SEM 
analysis (Fig. 2.9). After immersion in PBS for 7 days, PTFE-DOPA-HAp films presented a 
surface morphology which was considerably different from the initial one. The coating was no 
longer covering the entire surface of the substrate and appeared smoother and thinner than the 
one before incubation in PBS. The results were the same for samples immersed for 14 days in 
PBS. 
In agreement with SEM analysis, the AFM images showed a gradual decrease of surface 
roughness as compared to PTFE-DOPA-HAp films at day zero in order to reach a Rrms value of 
about 111 nm after 14 days of incubation in PBS. However, this value remained higher than the 
Rrms value of uncoated PTFE. This change in surface roughness was not enough to affect the 
surface wettability as the PTFE-DOPA-HAp films incubated in PBS for 7 and 14 days have 
shown contact angle values (respectively (51.6 ± 7.6)° and (57.4 ± 11.1)°) comparable to the 
initial one ((46.1 ± 12.4)°) coated films. All taken together with XPS analyses support the 
hypothesis of a two-step dissolution process of polyDOPA/HAp coating.  
 
Fig. 2.9. AFM height mode images, root mean square roughness values (Rrms) and SEM micrographs of PTFE-DOPA-
HAp samples as a function of the immersion time in PBS at 37 °C. Statistical analysis indicated the presence of 
statistically significant differences among PTFE-DOPA-HAp 0 days and 7, 14 days (*** P < 0.01), and PTFE-DOPA-
HAp 7 days and 14 days (** P < 0.01). 
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It is widely suggested that the osteoconductive properties of HAp coatings arise as a direct 
result of their dissolution properties. Dissolution of HAp allows redistribution of Ca and P ions, 
which may be used by surrounding tissues in the manufacture of new natural bone [39, 40]. 
Thus, the burst release of HAp observed in this work during the first week of immersion in PBS 
would provide to osteoblast a high amount of Ca and P that could be useful to speed up the 
bone mineralization process. The second dissolution step, through the gradual HAp release, 
would maintain the osteoblast activity and the Ca and P ions in the surrounding environment. 
2.4 Conclusions 
In this chapter, the efficiency of mussel-inspired coating technique has been demonstrated. A 
HAp coating has been successful developed on PTFE highly hydrophobic and inert substrates, 
by entrapment and/or conjugation of HAp nanoparticles with polyDOPA. 
The polyDOPA/HAp coating covered the entire surface of the films, producing a very rough 
surface with improved wettability properties. Moreover, the coating was characterized by a 3D-
structure, able to enhance protein absorption and osteoblast proliferation, both very favourable 
for accelerating osteointegration and bone re-growth. Indeed, in vitro cell test with pre-
osteoblast MC3T3-E1 cells confirmed these observations. Cells proliferated very well on the 
PTFE-DOPA-HAp over 3 days. They were extremely well spread and formed long filopodia 
with firm attachment to the surface of PTFE-DOPA-HAp. There are two potential reasons for 
the improvement in the cellular activity of MC3T3-E1 on self-assembled polyDOPA/HAp 
composite coating: (1) the improved surface roughness, hydrophilicity and bioactive chemical 
cues from both polyDOPA and HAp; (2) the aid in protein adsorption of HAp. An investigation 
of the coating stability indicated a two-step dissolution process: an initial marked release of 
HAp in the first week, and a second phase of gradual release in the next 7 days.  
Taken together the results of this chapter, we believe that our coating strategy would lead to the 
development of PTFE substrates with improved osteoconductive properties for their use in 
tissue engineering. Such an improvement in PTFE is not only very useful for the treatment of 
periodontal diseases but also for many other pathology requiring the improved osteoconductive 
properties of PTFE. 
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3 
Self-polymerizing DOPA as a functional 
layer for the development of antimicrobial 
coating on PTFE barrier membranes for 
GTR procedures 
 
Abstract 
Regenerative approaches to treat periodontitis lesions offer exciting possibilities; however, they 
frequently fail to produce the desired clinical outcome due to infectious complications. Guided 
tissue regeneration (GTR) procedures, with currently available membranes, exhibit large 
variability in the surgical outcome due to bacterial infection following placement of the barrier 
membrane. In this chapter, an antimicrobial coating of polytetrafluoroethylene (PTFE) 
membrane has been developed in order to eliminate pathogens in the treated site. Silver 
nanoparticles (AgNPs) have been selected as antimicrobial agents due to their good 
antimicrobial efficacy against bacteria, viruses and other eukaryotic micro-organisms. The 
successful deposition of AgNPs on PTFE film surface, through the functional groups of 3,4-
dihydroxy-DL-phenylalanine (DOPA), has been demonstrated by physicochemical and 
morphological analyses. The nanoparticles exhibited a diameter around 68 nm and were 
homogeneously distributed on the surface, with only some agglomerates. In vitro cell tests with 
fibroblast NIH 3T3 cells showed an inhibition of cells proliferation on PTFE films 
functionalized with AgNPs after 3 days of culture, while good cells adhesion was observed with 
cells randomly distributed on sample surface and extensively spread. The antimicrobial 
efficiency has been demonstrated especially against Staphylococcus aureus (S. aureus) and Ag 
release was sustained for at least 14 days. 
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3.1 Introduction 
Periodontal diseases, specifically periodontitis, are multifactorial diseases, caused mainly by 
pathogenic bacterial species located in the subgingival niche. These bacterial species adhere to 
the tooth surfaces to form in a highly complex and organized structure called dental plaque [1, 
2], which displays properties that are typical of biofilms and microbial communities in general 
[3]. 
Approximately 500 bacterial species inhabit subgingival niche [4]. The abundance and diversity 
of microorganisms depend upon several factors, such as effectiveness of oral hygiene measures, 
degree of gingivitis, pocket depth, and the antimicrobial efficacy of the host immune response. 
Some microorganisms produce gingivitis and some types of chronic periodontitis, while others 
produce aggressive forms of periodontitis [5]. Important periodontal pathogens are 
Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis (P. gingivalis), Dialister 
pneumosintes, Bacteroides forsythus and Treponema denticola [5]. 
Regnerative approaches to treat periodontitis lesions offer exciting possibilities; however, they 
frequently fail to produce the desired clinical outcome due to infectious complications [6]. 
Long-term evaluation studies indicate that guided tissue regeneration (GTR) procedures, with 
currently available membranes, exhibit large variability in the surgical outcome due at least in 
part to bacterial infection following placement of the barrier membrane [7, 8]. In vitro data 
suggest that bacterial species vary in ability to attach to barrier membranes of different 
materials. For example, Wang et al. [9] demonstrated that Streptococcus mutans attached 
significantly more to the expanded polytetrafluoroethylene (ePTFE) and the collagen (COL) 
membranes than to the polyglactin 910. Ricci et al. [10] studied varying in vitro affinity for P. 
gingivalis to attach to 6 types of bioabsorbable and non-bioabsorbable barrier membranes. 
Polyglactin and COL membranes demonstrated high bacteria counts, polylactic acid (PLA) and 
synthetic glycolide and lactide copolymer barrier devices showed lowest bacteria counts, while 
ePTFE membranes revealed P. gingivalis cells mainly in the fibrillar areas of both the internal 
and external sides of the membrane. 
Microbial colonization of barrier membranes may already start at the time of membrane 
insertion [11]. Most likely, the membrane infecting pathogens are transferred via saliva from 
infected periodontal lesions or tongue dorsum to the regenerative-treated periodontal site. 
To prevent infectious failures with regenerative periodontal therapy, efforts should be directed 
towards the elimination or marked suppression of pathogens in the treated site as well as in the 
entire mouth prior to regenerative surgery and throughout the healing phase. Anti-infective 
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therapy in periodontal regeneration includes: (1) mechanical debridement; (2) local or systemic 
delivery of antimicrobial agents; (3) antimicrobial coating of barrier membranes; (4) proper oral 
hygiene measures by the patient [12]. 
In recent years, the focus of many laboratories has been the design of membranes that have 
some form of antibacterial properties. Bottino et al. [13] incorporated metronidazole benzoate 
(MET) to the layer interfacing with the epithelial tissue to reduce the amount of anaerobic 
Gram-negative bacteria (i.e. P. gingivalis) and anaerobic spore-forming Gram-positive bacilli. 
Chou et al. [14] reported on the antibacterial effects of two commercially available 
biodegradable membranes after mineralization with zinc phosphate that led to a significant 
decrease in Actinobacillus actinomycetemcomitans activity when compared to non-mineralized 
membranes. In a less recent work, Harvey et al. [15] have described the potential antibiotic 
bonding (tetracycline-HCl) to ePTFE by means of the cationic surfactant, 
tridodecylmethylammonium chloride. In vitro studies showed that the coated barrier 
membranes released biologically active tetracycline for 3-6 weeks, significantly decreasing 
cultivable pathogens. However, due to the emergence of antibiotic-resistant bacteria and 
limitations of the use of antibiotics, the researchers are searching for new antibacterial agents. 
In the present scenario, nanoscale materials have emerged up as novel antimicrobial agents 
owing to their high surface area to volume ratio and the unique chemical and physical 
properties [16, 17]. 
The use of nanoparticles is gaining impetus in the present century as they posses defined 
chemical, optical and mechanical properties. The metallic nanoparticles are most promising as 
they show good antibacterial properties due to their large surface area to volume ratio. Different 
types of nanoparticles (i.e. titanium, gold, silver [18, 19]) have come up but silver nanoparticles 
(AgNPs) have proved to be most effective as they have good antimicrobial efficacy against 
bacteria, viruses and other eukaryotic micro-organisms [20]. Due to their low toxicity to human 
cells, Ag ion or metallic Ag as well as AgNPs can be explored in burn treatment, dental 
materials, coating, etc. [21]. In recent years, various chemical and physical methods (i.e. plasma 
sprayed technology [22], sol-gel method [23]) have been employed to prepare AgNPs in 
different materials. However, poor metal/material adhesion, and incomplete control of the Ag
+
 
release in the liquid medium are the main drawbacks of these approaches. In addition, the 
complicated multistep procedures used by the aforementioned methods limited their practical 
applications. Thus, the development of simple and versatile strategies for surface modification 
reveal challenging. 
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Recently, 3,4-dihydroxyphenethylamine (Dopamine), a mussel-inspired catecholamine, has 
been demonstrated to spontaneously self-polymerize on various inorganic or organic materials 
surface and form uniformly films (polyDopamine) under mild conditions [24, 25]. The same 
behavior has been observed for 3,4-dihydroxy-DL-phenylalanine (DOPA), a precursor of 
Dopamine, leading to the formation of a polyDOPA layer [26]. Because of the self-
polymerizing and self-adhesive nature, the surface multifunctional groups on the polyDopamine 
and polyDOPA ad-layer (catechol and amine functional groups) were reported to be able to 
spontaneously reduce noble metal nanoparticles, without using a reducing agent, surfactant, or 
energy-consuming steps [27-
28
29]. In this chapter, the polyDOPA was applied to produce 
AgNPs on PTFE compact film surfaces for GTR applications in periodontal diseases. 
The functionalized films were characterized by X-Ray photoelectron spectroscopy, scanning 
electron microscopy, and atomic force microscopy. The coating stability was carried out in 
phosphate buffer saline (PBS) for 7 and 14 days. In terms of antibacterial efficacy, both Gram-
positive and -negative bacteria were tested using inhibition assay; while the toxicity of the 
functionalized films was evaluated by examining the Mouse embryonic fibroblast NIH 3T3 
cells proliferation and morphology. 
3.2 Materials and methods 
3.2.1  Materials 
The PTFE compact films (10 x 30 mm
2
) were kindly provided by BIOMICRON s.r.l. 
Laboratory (Torino, Italy). The films were pre-treated by immersion in ethanol/water (1/1 v/v) 
solution for 12 h at room temperature. Then, clean PTFE films were rinsed with large amount of 
demineralised water and dried at room temperature under a vented hood for 24 h. 
The monomer DOPA (Mw: 197.19 Da), the silver nitrate (Mw: 169.87 Da) and Tris 
((CH2OH)3CNH2; Mw: 121.14 Da) were purchased from Sigma-Aldrich (Milano, Italy) and 
used as received. 
3.2.2  Methods 
3.2.2.1 Surface functionalization 
Clean PTFE films were grafted with poly(DOPA) at room temperature for 48 h (PTFE-DOPA). 
The DOPA solution was prepared by dissolving DOPA at a concentration of 2 mg/ml in 10 mM 
Tris buffer. The pH was adjusted at 8.5 through HCl (1 M) dropwise addition into the solution 
to provide an alkaline medium for spontaneous DOPA polymerisation, as this pH is a typical 
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seawater pH. PTFE-DOPA films were then rinsed three times with large amount of 
demineralised water to remove free DOPA and dried at room temperature under a vented hood 
for 24 h. 
The grafted poly(DOPA) films were finally metallised with AgNPs in 50 mM aqueous AgNO3 
solution, in dark at room temperature (PTFE-DOPA-Ag). After 24 h, films were rinsed three 
times with large amount of demineralised water and dried at room temperature under a vented 
hood for 24 h. 
As control, pristine PTFE was subjected to the metallization process under the same conditions 
applied for PTFE-DOPA samples (PTFE-Ag). 
3.2.2.2 Water contact angle measurements 
The static contact angles of PTFE-based films were determined through a sessile drop method, 
using a 6 µl double distilled water droplet. Static contact angles of films were measured at room 
temperature in a VCA Optima (AST, Massachusetts, USA) instrument equipped with a VCA 
Optima XE software for data acquisition.  
3.2.2.3 Morphological and compositional analysis 
Surface morphology was observed using field emission-scanning electron microscopy (FEI 
Inspect F-50 FE-SEM, Oregon, USA) and compositional analysis (EDS). Samples were sputter 
coated with an ultrathin platinum (Pt) as a conductive layer for better quality image. 
3.2.2.4 Atomic force microscopy 
The examination of surface topography was imaged by atomic force microscopy (AFM) using 
the Nanoscope III (Digital Instruments, Veeco, California, USA) system in the tapping mode. 
Images were acquired in air at ambient temperature using a silicon probe with a nominal spring 
constant of 40 N/m and a nominal radius of curvature of 35 μm (model RTESP, Veeco). 10 x 10 
and 5 x 5 μm2 areas were scanned at a rate of 1 Hz while a 2 Hz frequency was use for 1 x 1 
μm2 areas, both using the minimum amount of force required to obtain steady images. Root 
mean square surface roughness (Rrms) was calculated using Nanoscope v5.12r5 software on a 10 
μm by 10 μm area. 
3.2.2.5 X-ray photoelectron spectroscopy 
Chemical composition of the functionalized films was investigated by X-ray photoelectron 
spectroscopy (XPS) (K-Alpha
TM+
 spectrometer, Thermal Scientific, Texas, USA) at a detection 
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angle of 45°. The characterizations were performed in survey and high resolution (HR) spectra 
using standard aluminium (1486.6 eV) and magnesium (1253.6 eV) X-Ray sources, 
respectively. A surface area of 0.005 cm
2
 was analyzed at 150 W without charge compensation. 
3.2.2.6 Stability test 
For stability studies, only PTFE-DOPA-Ag films were used. Stability test was carried out on 10 
x 10 mm
2 
film specimens incubated in 3 ml PBS at 37 °C and pH 7.4 for 7 and 14 days. The 
PBS medium was exchanged once every 2 days. 
Morphological and topographical evaluations of the exposed surfaces of film samples at each 
stability test time were analyzed by FE-SEM and AFM according to the procedures described, 
respectively, at par. 3.2.2.3 and 3.2.2.4. Surface chemical composition and wettability were 
evaluated through XPS analysis and water contact angle measurements, according to the 
previously described methods at par. 3.2.2.5 and 3.2.2.2 respectively. 
3.2.2.7 Antibacterial assay 
Antibacterial activity of PTFE-DOPA-Ag samples was preliminarily investigated against 
Escherichia coli ATCC 25922 (E. coli), a Gram-negative clinical isolate and Staphylococcus 
aureus ATCC 6538 (S. aureus), a Gram-positive strain isolated from human lesion. Both strains 
were supplied from Belgian Coordinated Collections of Microorganisms (BCCM) and play an 
important role in human infections and biofilm formation on medical devices [30]. E. coli and 
S. aureus strains were grown overnight in Luria–Bertani (LB) agar at 37 °C. Then, bacterial 
suspensions at the concentration of 1.5  108 Colony Forming Units per milliliter (CFU/mL) 
were prepared and dispersed uniformly onto the surface of Müller-Hinton agar plates. Disk-
shaped samples of PTFE and PTFE-DOPA-Ag (about 1.2 cm diameter) were UV sterilized for 
15 min and subsequently laid on the top of the inoculated plates. After 24 h of incubation at 37 
°C, the diameter of inhibition against the two bacterial strains was measured. 
3.2.2.8 Cell culture 
For all cell studies, only PTFE, PTFE-DOPA, and PTFE-DOPA-Ag films were analysed. 
Mouse embryonic fibroblast NIH 3T3 cells were supplied by American Type Culture Collection 
(ATCC, Virginia, USA). Dulbecco's modified Eagle's medium (DMEM; ATCC) supplemented 
with 10% Calf Bovine Serum (CBS; Gibco, Invitrogen) and 1% penicillin/streptomycin 
(Invitrogen) was used to culture the fibroblasts. Cells were first expanded, and a concentration 
of 5 × 10
4
 was seeded on the blend films and incubated at 37 °C in a humidified atmosphere of 
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5% CO2 for 1 and 3 days. Cell Crown
TM
 inserts (Scaffdex, Tampere, Finland) were used to fix 
the films at the bottom of the wells prior to cell seeding. 
Cell proliferation was assessed using the colorimetric indicator Alamar Blue assay (Life 
Technologies, Ontario, Canada). Media was removed and samples were rinsed once in PBS 
(Sigma-Aldrich). 300 µL of fresh medium containing a 10% solution of Alamar Blue was added 
to each well. The culture plates were wrapped in aluminum foil and incubated for 4 h at 37 °C 
in a humidified atmosphere of 5% CO2. Absorbance of the extracted dye, which is proportional 
to the number of cells attached to the film, was measured spectrophotometrically with a 
microplate reader (Molecular Devices, SpectraMax i3 multi-mode detection platform, 
California, USA) at wavelengths of 570 and 600 nm. A calibration curve, generated from a 
known number of fibroblast NIH 3T3 cells reacting with the Alamar Blue indicator, was used to 
quantify the number of cells attached on films. 
3.2.2.9 Cell adhesion 
Morphology and adhesion of the cells cultured on PTFE-based films were examined by FE-
SEM. Films were washed two times with PBS and fixed in Parafolmaldehyde for 30 min at 
room temperature. The films were then washed three times with PBS and dehydrated in 30%, 
50%, 70%, 80%, 90%, 95%, and 100% ethanol, respectively, for 10 minutes. After dehydration 
with ethanol, further substitution to amyl acetate was necessary. Thus, films were immersed in 
amyl acetate:ethanol solutions with composition 25:75; 50:50; 75:25; 100:0, respectively, for 15 
min and, then, placed in a Crtical Point Dryer room. The samples were finally dried under 
vacuum, coated with Pt, and examined with FE-SEM. 
3.2.3  Statistical analysis  
All data are expressed as means ± standard deviation. Differences between means were 
analyzed by one-way ANOVA followed by a Tukey’s post hoc test. For in vitro cell assay, 
statistical analysis was performed using two-way ANOVA with the Bonferroni’s post test. All 
statistical analyses were performed with Prism, Graph Pad Software. 
3.3 Results and discussion 
3.3.1  Chemical composition 
Table 3.1 reports on chemical composition of PTFE, PTFE-DOPA, PTFE-Ag, and PTFE-
DOPA-Ag samples calculated from XPS spectra (data not reported).  
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Table 3.1 XPS chemical composition of pure PTFE film, DOPA powder, PTFE film coated with DOPA (PTFE-
DOPA), and films immersed in AgNO3 solution (50 mM) for 24 hours (PTFE-Ag and PTFE-DOPA-Ag). 
Sample Atomic percentage (mol%) C/N 
C1s O1s F1s N1s Ag(3d) 
PTFE 30.8 0.7 68.5 - - - 
DOPA (theoretic value) 64.3 28.6 - 7.1 - 9.0 
PTFE-DOPA 51.4 15.2 28.7 4.5 - 11.4 
PTFE-Ag 34.3 1.1 64.5 - - - 
PTFE-DOPA-Ag 33.8 7.7 52.5 2.2 3.5 15.4 
 
As previously discussed (Chapter 2 – paragraph 2.3.1), polyDOPA coating induced changes in 
surface chemical composition (remarkably increased of carbon and oxygen contents and 
appearance of nitrogen element), indicating the successfully deposition of polyDOPA layer on 
PTFE film surfaces. 
After 24 h of metallization process, Ag element was observed on the surface of PTFE-DOPA-
Ag at 369 eV. It could be attributed to Ag(3d). The strong signal of Ag indicated that a layer of 
Ag has been deposited on the PTFE–DOPA surface. Because no Ag(3d) signal was discernible 
on the DOPA-modified PTFE film surface before the reaction in AgNO3, the peak in this 
spectrum was attributable to the silver uptake from the AgNO3 solution. The metallization 
process induced also changes in peak intensities and atomic compositions. Compared with 
PTFE-DOPA film, the contents of carbon, oxygen and nitrogen were reduced to 33.8 mol%, 7.7 
mol% and 2.2 mol%, respectively, while the fluorine percentage significantly increased 
reaching a value of 52.5 mol%. Thus, PTFE-DOPA-Ag showed atomic percentage similar to 
the pure PTFE composition, attributable to a partial release of DOPA in the AgNO3 solution or 
to the reaction of Ag
+
 with catechol and N-containing groups of polyDOPA. 
As control, pure PTFE was subjected to the metallization process. However, XPS spectra of 
PTFE-Ag film did not reveal the presence of silver and the atomic composition did not change 
compared to pristine PTFE. 
To further investigate the chemical structure and molecule interaction, high-resolution spectra 
of C1s and O1s were performed on PTFE, PTFE-DOPA, PTFE-Ag, and PTFE-DOPA-Ag 
samples as shown in Fig. 3.1. 
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Fig. 3.1 High resolution XPS spectra of C1s and O1s for PTFE, PTFE-DOPA, PTFE-Ag, and PTFE-DOPA-Ag 
samples. 
 
As observed in Chapter 2, the results of core-level C1s and O1s spectra of PTFE-DOPA 
samples proved that the hydrophilic groups, including –OH, -COOH, and –NH, were introduced 
onto model films. The relative percentage of O1s band was then influenced by the Ag 
metallization process. The atomic percentage of quinone (532.7 eV) has markedly reduced due 
to its involvement in Ag metal binding process (14.7% for PTFE-DOPA vs 4.5% for PTFE-
DOPA-Ag). The catechol and quinone groups in polyDOPA were recognized to chelate Ag
+
 
ions and further induced the reduction of Ag
+
 ions into metallic Ag, but no changes could be 
observed for the C-O band. The metallic Ag was then transformed into AgNPs through atom-
by-atom growth mode [28]. As observed before, no marked variations could be detected in the 
high resolution spectra of pristine PTFE films after 24 h of immersion in AgNO3 solution. 
High resolution spectra of Ag(3d) core level were also characterized to determine the chemical 
state of Ag on the surface of PTFE-DOPA-Ag films (Fig. 3.2). The Ag(3d5/2) and Ag(3d3/2) 
peaks were found at binding energies of 368 and 374 eV, respectively. The slitting of the 3d 
doublet of Ag was 6 eV which indicated the formation of metallic Ag on the surface of PTFE-
DOPA films [31]. 
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Fig. 3.2 XPS HR spectra of Ag(3d) for PTFE-DOPA-Ag samples. 
 
3.3.2  Morphological analysis  
Structure and morphology of PTFE samples before and after the coating process were 
visualized under SEM as shown in Fig. 3.3. 
As observed in Chapter 2 (par. 2.3.2), model PTFE film was not characterized by a smooth 
surface and some defects could be observed (Fig. 3.3a). The immersion in DOPA solution 
induced the formation of a polyDOPA thin layer on the surface of PTFE-DOPA samples (Fig. 
3.3b, black arrow). 
After 24 h of metallization, AgNPs were deposited dispersedly on the surface of DOPA-
modified PTFE films with the appearance of some agglomerates. The diameter of AgNPs was 
68.0 ± 9.5 nm, as shown in the SEM images. EDS spectra of PTFE-DOPA-Ag film surface 
confirmed the material that composed the nanoparticles. Moreover, on PTFE-DOPA-Ag film 
surface it was still visible the polyDOPA layer observed on PTFE-DOPA sample, as underlined 
by black arrows on Fig. 3.3d. 
No morphological changes could be observed on PTFE-Ag film (Fig. 3.3c) which further proof 
the absence of functionality for AgNPs metallization on the pristine PTFE surface. 
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Fig. 3.3 Morphology of (a) PTFE, (b) PTFE-DOPA, (c) PTFE-Ag, and (d) PTFE-DOPA-Ag films. EDS analyses of (e) 
PTFE-Ag and (f) PTFE-DOPA-Ag surfaces. 
 
3.3.3  Surface roughness and wettability properties  
Films topography was evaluated through AFM analysis. AFM images for PTFE, PTFE-DOPA, 
PTFE-Ag, and PTFE-DOPA-Ag samples along with their surface roughness values are shown 
in Fig. 3.4. 
 
Fig. 3.4 AFM height mode images and root mean square roughness values (Rrms) of (a) PTFE, (b) PTFE-DOPA, (c) 
PTFE-Ag, and (d) PTFE-DOPA-Ag samples. 
 
AFM analysis confirmed the SEM observations. As previously discussed (Chapter 2 – Par. 
2.3.3), the immersion in DOPA solution for 48 h markedly changed PTFE surface topography, 
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leading also to a statistically significant increase of PTFE-DOPA surface roughness compared 
to pristine PTFE (*** P < 0.01).  
The metallization process in AgNO3 solution did not change the surface topography of PTFE-
DOPA film. Moreover, no statistically significant changes could be detected in surface 
roughness values of PTFE-DOPA and PTFE-DOPA-Ag samples. However, as reported in Fig. 
3.5, uniform and monodispersed spherical particulates were evidently found by decreasing the 
scan area, indicating the role of polyDOPA as a reducing agent and template for the formation 
of AgNPs without requiring additional reducing agent. The particle analysis showed that the 
size of AgNPs on PTFE-DOPA-24Ag surface was 68.3 ± 10.2 nm, confirming the value 
obtained with SEM analysis. It is desirable to obtain nano-size nanoparticle instead of micro-
size, as it will produce higher antibacterial effect due to larger surface area [32, 33]. 
Finally, the immersion of pristine PTFE in AgNO3 solution resulted in a slightly decrease of 
Rrms value (* P < 0.01) but no marked variation in surface topography. 
 
Fig. 3.5 AFM height mode images of (a) PTFE-DOPA and (b) PTFE-DOPA-Ag samples at 1 μm x 1 μm scar areas. 
 
To further investigate the effects of functionalization processes on surface properties, water 
contact angle values have been collected from PTFE, PTFE-DOPA, PTFE-Ag, and PTFE-
DOPA-Ag films and reported in Fig. 3.6. 
The pristine PTFE showed hydrophobic property with a water contact angle of about 110°. The 
coating of polyDOPA resulted in a more hydrophilic surface, confirming the successful 
deposition of polyDOPA nano-layer onto PTFE surface containing hydrophilic groups (–OH 
and –NH-) [34]. 
The immersion of DOPA modified samples in AgNO3 solution led to slightly hydrophobic 
surfaces with a contact angle around 87° as a result of increased surface roughness due to the 
formation of AgNPs [35] and a partial release of DOPA in the AgNO3 solution. On the 
contrary, the surface wettability of pristine PTFE was not influenced by the immersion in 
AgNO3 solution; the water contact angle remained constant around 107°. These results 
corroborate with those obtained by XPS analyses. 
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Fig. 3.6 Water contact angle measurements of PTFE, PTFE-DOPA, PTFE-Ag, and PTFE-DOPA-Ag films. 
 
3.3.4  Cell proliferation and adhesion  
The toxicity of the prepared samples was evaluated by examining the viability of fibroblast NIH 
3T3 cells using Alamar Blue assay, after directly cultivating the cells on the samples for 1 and 3 
days. Cells grown on Petri dishes were used as control. Fig. 3.7 shows the number of cells 
proliferated on PTFE, PTFE-DOPA, and PTFE-DOPA-Ag films after 1 and 3 days of cell 
culture. 
 
Fig. 3.7 Cell proliferation on PTFE, PTFE-DOPA, and PTFE-DOPA-Ag films as a function of time. Cell grown on 
petri dish was used as control (Ctrl). 
 
For all time points, the cell proliferation was lower than Ctrl. However, difference in cell 
proliferation was observed for various samples. After 1 culture day, the number of cells on 
PTFE-DOPA samples was significantly higher than those on pristine PTFE, because of the 
improved surface wettability and the bioactive functional groups (i.e. OH-, NH2-) of polyDOPA 
[36]. Due to the partial release of polyDOPA during the metallization process and the 
consequent increase of surface hydrophobicity, PTFE-DOPA-Ag samples induced less cell 
proliferation as compared to PTFE-DOPA. The cell number on PTFE-DOPA-Ag films was 
106 
 
nearly identical to that on PTFE, indicating that no toxicity was involved because of the 
existence of AgNPs after 1 day of cells immobilization. After 3 days of culture, the number of 
cells on PTFE and PTFE-DOPA substrates increased reaching values around 2.5 x 10
5
 cells. 
The growth rate was more pronounced for pristine PTFE films. PTFE-DOPA-Ag films showed 
the same number of cells of day one, thus ,for longer culture times, the presence of AgNPs 
could inhibit proliferation of fibroblasts NIH 3T3 [37]. 
The cell morphology also assisted to understand cell behavior. Fig. 3.8 shows cells attaching on 
the surface of PTFE, PTFE-DOPA, and PTFE-DOPA-Ag films. 
 
Fig. 3.8 SEM morphology of fibroblast cells grown on PTFE (a1, a2), PTFE-DOPA (b1, b2) and PTFE-DOPA-Ag (c1, 
c2) films after seeding cells for 1 and 3 days, respectively denoted with numbers 1 and 2. Scale bar = 100 µm. 
 
Fibroblast NIH 3T3 exhibited circular shape on pristine PTFE films at one day of culture (Fig. 
3.8 a1), while a more flattened and elongated shape could be observed for cells seeded on 
PTFE-DOPA and PTFE-DOPA-Ag samples (Fig. 3.8, b1 and c1 respectively). After 3 days of 
culture, few cells rounded could be noticed on pristine PTFE surface (Fig. 3.8 a2). Contrarily, 
NIH 3T3 cells grown on PTFE-DOPA and PTFE-DOPA-Ag films (Fig. 3.8, b2 and c2 
respectively) were well spread with typical morphology of fibroblasts. Cells were randomly 
distributed on PTFE-DOPA and PTFE-DOP-Ag samples surfaces and only some of them 
remained round in shape and fail to express the typical morphology of spreading fibroblast. 
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The results from proliferation and adhesion tests proved that the polyDOPA coating allowed to 
improve cell response of PTFE substrates. The incorporation of AgNPs slightly inhibited 
fibroblasts proliferation, without compromising cell adhesion and maintaining a good 
biocompatibility of PTFE-DOPA-Ag films. 
3.3.5  Antibacterial efficiency  
AgNPs were reported as a nonspecific antimicrobial agent against wide range of 
microorganisms. The exact mechanism of action of silver (Ag) on the microbes is still not 
known. However, according to the morphological and structural changes found in the bacterial 
cells, it seems that AgNPs get attached to the cell membrane and also penetrate inside the 
bacteria. They interact with sulfur-containing proteins of bacterial membrane as well as with the 
phosphorus-containing compounds like DNA. When AgNPs enter the bacterial cell, it forms a 
low molecular weight region in the center of the bacteria to which the bacteria conglomerates 
thus, protecting the DNA from the Ag ions. The nanoparticles preferably attack the respiratory 
chain, cell division finally leading to cell death. The nanoparticles release also Ag ions in the 
bacterial cells, which enhance their bactericidal activity [16, 38]. 
In this chapter, both Gram-positive (S. aureus) and Gram-negative (E. coli) bacteria were used 
to evaluate the antibacterial efficacy on PTFE-DOP-Ag films by analysing the zone of 
inhibition. Fig. 3.9 shows the results of the test, which was conducted on untreated and coated 
samples. 
 
Fig. 3.9 Antibacterial efficacy on PTFE (C) and PTFE-DOPA-Ag (T) against S. aureus and E. coli evaluated by zone of 
inhibition assay. 
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Preliminary results of antibacterial tests suggested a potential activity of PTFE-DOPA-Ag 
against bacterial cells. In particular, the biocidal activity on PTFE-DOPA-Ag against S. aureus 
ATCC 6538 was higher when compared with that against E. coli ATCC 25922. This could be 
due to the more vulnerable nature of Gram-positive bacteria in comparison with Gram-negative 
towards AgNPs [39]. 
3.3.6  Dissolution feature of coating  
The dissolution process of DOPA-Ag coating was illustrated across the chemical composition, 
morphological, topographical and surface wettability changes. XPS results, Table 3.2, showed 
some changes in surface composition of PTFE-DOPA-Ag films after the immersion in PBS for 
7 and 14 days. A markedly decrease of the content of elements associated to the presence of 
polyDOPA and AgNPs (namely oxygen, nitrogen and silver) could be observed, while the 
content of the characteristics elements of PTFE substrate (carbon and fluorine) remained almost 
the same. After 14 days of incubation, nitrogen was no more detectable while the atomic 
percentage of O1s and Ag(3d) reached values of 0.8 mol% and 0.2 mol% respectively. 
Table 3.2 XPS chemical composition of PTFE film coated with DOPA and AgNPs (PTFE-DOPA-Ag) after incubation 
in PBS at 37 °C for 0, 7 and 14 days. 
Sample Time 
(days) 
Atomic percentage (mol%) 
C1s O1s F1s N1s Ag(3d) 
PTFE-DOPA-Ag 
0 33.8 7.7 52.5 2.2 3.5 
7 36.4 2.5 58.7 0.2 0.6 
14 37.9 0.8 62.5 - 0.2 
 
Fig. 3.9 shows the high-resolution spectra of C1s and O1s for PTFE-DOPA-Ag at each 
dissolution time. The polyDOPA release influenced the relative percentage of O1s and C1s 
bands. In fact, it could be observed that the atomic percentage reduction of species associated to 
the polyDOPA coating. 
As observed for polyDOPA and HAp coating (Chapter 2), the results obtained with XPS 
analysis suggested that dissolution reactions were occurring in two steps: an extremely fast 
release of Ag during the first week of immersion and a much more gradual release in the next 7 
days. 
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Fig. 3.10 XPS high-resolution spectra of O1s and C1s for PTFE-DOPA-Ag samples after incubation in PBS at 37 °C 
for 0, 7 and 14 days. Spectra are compared to those of pristine PTFE film. 
 
Morphological and topographical characterizations are shown in Fig. 3.10. After immersion in 
PBS for 7 days, AgNPs were still visible but in amounts lower than that of PTFE-DOPA-Ag 
films before incubation in PBS. The disappearance of AgNPs agglomerates was also observed 
and, increasing the immersion time at 14 days, no further changes have been detected. The 
increase in the distance between nanoparticles observed through SEM analysis could explain 
the XPS results that showed small Ag traces after incubation of PTFE-DOPA-Ag films in PBS.  
The incubation of samples in PBS for 7 and 14 days slightly reduced surface roughness, leading 
to values between 60 and 70 nm. However Rrms values remained higher than value of non-
functionalized PTFE and no statistical differences could be observed between films incubated 
for 7 and 14 days. Regarding the surface topography, the bright high peaks observed on PTFE-
DOPA-Ag films were still detectable but characterized by a smoother profile. 
The polyDOPA and AgNPs release changed also the wettability properties of PTFE-DOPA-Ag 
films. In fact, the immersion in PBS for 7 and 14 days led to contact angle values of (108.1 ± 
2.7)° and (101.9 ± 2.6)°, respectively, that showed a statistically significant difference with the 
contact angle value of PTFE-DOPA-Ag film before immersion ((86.6 ± 5.8)°). 
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Fig. 3.11 AFM height mode images, root mean square roughness values (Rrms) and SEM micrographs of PTFE-
DOPA-Ag samples as a function of the immersion time in PBS at 37 °C. Statistical analysis indicated the presence of 
statistically significant differences among PTFE-DOPA-Ag 0 days and 7, 14 days (* and ** P < 0.01 respectively). 
 
The coating dissolution test demonstrated that polyDOPA and AgNPs coating resulted in a 
greater early release, which can be of great value in avoiding bacterial infection [40]. Then the 
Ag release was sustained for at least 14 days, which could be key for inhibition of the bacteria 
and thereby to aid the regeneration of a new periodontium [41]. 
3.4 Conclusions 
Subgingival niche is crowded by pathogenic and opportunistic bacteria that caused periodontal 
diseases, specifically periodontitis. Without controlling the microbial activity, the regenerative 
approaches (namely GTR with barrier membranes) generally fail. In this chapter, an 
environmental-friendly technique has been adopted to anchor AgNPs on the surface of a model 
PTFE film. A mussel-inspired catecholamine (DOPA) was polymerized on PTFE surface, in 
mild conditions, to form a uniform film. The surface multifunctional groups on the polyDOPA 
ad-layer were subsequently used to reduce AgNPs. 
Physicochemical and morphological analysis demonstrated that the polyDOPA coating 
deposited on PTFE surface was an effective functional layer for metallization. The metal-
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binding ability of the catechol and N-containing groups presented in the polyDOPA coating 
could be used to deposit adherent and uniform metal coatings onto the PTFE films.  
The AgNPs produced in this work had a diameter around 68 nm and were homogeneously 
distributed on the surface, with only some agglomerates. The presence of nanoparticles slightly 
inhibited fibroblasts proliferation, without compromising cell adhesion and maintaining a good 
biocompatibility of PTFE-DOPA-Ag films. The antimicrobial efficiency has been proved 
against Gram-negative and Gram-positive bacteria. Moreover, as observed from the coating 
dissolution test, the AgNPs release and, thus, the antimicrobial effect, seemed to be sustained 
for at least 14 days. 
This work led to the effective development of PTFE substrates with improved antibacterial 
properties and good biocompatibility that can be used in GTR applications for the treatment of 
periodontal diseases. 
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SECTION III 
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4 
Investigation of PLCL/PLGA blends 
physical properties and biocompatibility 
for Tissue Engineering applications 
 
Abstract 
Binary blends of poly(DL-lactide-co-ε-caprolactone) (PLCL) (86 mol.% nominal DL,lactic acid 
content, Mw: 28000 Da) and poly(DL-lactide-co-glycolide) (PLGA) (LA:GA = 75:25 mol:mol; 
Mw: 66000-107000 Da) with various compositions (100/0, 75/25, 50/50, 25/75, 0/100 wt/wt) 
were prepared by dissolution in a common solvent, further stirring and final solvent casting. 
Morphological analysis of fractured sections of PLCL/PLGA blend films did not evidence 
phase separation between blend components. The behavior of blend glass transition 
temperatures as a function of composition suggested some degree of blend compatibility. On 
the other hand, the elastic modulus of PLCL/PLGA blends showed a negative deviation from 
the additive law of mixture. Mouse embryonic fibroblasts were used to evaluate the 
biocompatibility of the polymer blends in terms of cell proliferation and adhesion on the 
surfaces. PLCL/PLGA 25/75 blend promoted cell adhesion and growth. Due to its 
biocompatibility, its superior mechanical properties and compatibility between the components, 
PLCL/PLGA 25/75 blend was selected for further characterizations by in vitro degradation tests 
in physiological medium. Results showed PLCL rapid degradation within 4-8 weeks, leading to 
porous samples. 
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4.1 Introduction 
Tissue engineering (TE) is an emerging interdisciplinary and multidisciplinary field, involving 
biology, medicine, and engineering, aimed at the replacement of damaged, injured or missing 
body tissues with biologically compatible substitutes [1, 2]. TE research includes many areas, 
such as biomaterials, cells, biomolecules [3]. In terms of biomaterials, novel biomaterials have 
been designed to direct the organization, growth, and differentiation of cells in the process of 
forming functional tissues by providing both physical and chemical cues [4]. Biomaterials for 
TE should be biocompatible and biodegradable [5], they should promote cell attachment, 
spreading and proliferation [6], and have suitable mechanical strength and surface 
characteristics [7, 8]. Resorbable and degradable polymers, such as aliphatic polyesters, 
including poly(lactic acid) (PLA), poly(glycolic acid) (PGA), poly(caprolactone) (PCL) and 
their copolymers, have been studied in the last decades for applications such as scaffolds and 
drug delivery systems [9]. Tailored physicochemical and mechanical properties of polymers to 
the requirements of the final application can be achieved in a simple and cost-effective way by 
blending [10]. The final properties of polymer blends depend on the physicochemical properties 
of the single blend components, blend composition, compatibility between blend components, 
and the blending method [11]. 
Polymer industry and academia have developed a wide variety of polymer blends with novel 
and valuable properties, in order to enlarge the spectrum of available polymers. For example, 
McDonald et al. [10] tailored the physical properties, degradation rate and drug delivery 
characteristics of thin films for medical applications by blending PCL with poly(DL-lactic acid) 
(PDLLA) or with poly(L-lactide-co-glycolide) (PLGA) at a mixing ratio of 95:5; 90:10; 80:20 
(wt:wt), respectively. The thermal analysis of the blends indicated that the presence of PDLLA 
or PLGA increased the degradation rate of PCL amorphous regions. In vitro degradation tests 
showed that PCL/PDLLA blends had a higher weight loss compared to PCL/PLGA blends, as a 
function of incubation time in phosphate buffered saline (PBS). In the same experiment, the 
decrease in mechanical properties of both blends was similar. Drug (acetylsalicylic acid) release 
rate could be modulated by varying blend composition.  
Can and co-workers prepared and characterized blends of poly(L-lactide) (PLLA) and PCL with 
and without paclitaxel [12]. Physical and morphological analysis showed that PLLA/PCL 
blends (95/5; 90/10; 85/15; 80/20 wt/wt) were phase separated. The in vitro degradation rate 
was close to that of PCL possibly due to the prevention of water diffusion into PLLA as a result 
of the presence of hydrophobic PCL. However, by increasing PCL content of the blends, PCL 
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domains increased in size, contact surface between PCL and PLLA phases decreased and water 
access to PLLA matrix was facilitated resulting in a higher degradation rate of PLLA phase. 
Degradation-controlled followed by diffusion-controlled paclitaxel release mechanisms were 
observed. Drug release kinetics depended on blend composition and film thickness. 
Recently, poly(DL-lactide-co-ε-caprolactone) (PLCL) copolymer has attracted increasing 
attention. It is an amorphous biomaterial that combines the higher degradation rate of PLA with 
the mechanical toughness of PCL. In previous works, PLCL has been used to develop scaffolds 
for cartilage and nerve regeneration [13, 14] and membranes for periodontal regeneration [15]. 
However, the exceptional elastic properties of PLCL could be critical for some applications 
during in vivo placement, such as periodontal membranes [16]. 
One possible approach for enhancing the mechanical properties of PLCL is to blend it with the 
polymer PLGA in order to improve Young’s modulus and tensile strength. Amorphous PLGA 
copolymer has been extensively investigated and used for various medical applications due to 
its biodegradability, biocompatibility and good mechanical properties, especially tensile 
strength [17]. It has been used to prepare scaffolds for cartilage, bone, tendon, and vascular 
smooth muscle tissue regeneration [18-
1920
21].  
The aim of this chapter was the investigation of the physical (morphology, thermal and 
mechanical properties) and biological (cell adhesion and proliferation) properties of films made 
of blend between PLCL and PLGA (compositions 100/0, 75/25, 50/50, 25/75, 0/100 wt/wt) 
with the aim to select an optimal blend composition in terms of compatibility degree between 
the phases, mechanical properties and cell compatibility, for further testing. The selected 
composition was further analyzed for its in vitro degradation behavior.  
Although some compositions of PLCL/PLGA blends have already been developed in a previous 
work [9], reports on the effect of PLGA content on physicochemical and biological properties 
of PLCL/PLGA blends are missing. This work provides an extensive characterization of 
PLCL/PLGA blends which is fundamental for the selection of a suitable blend composition for 
specific applications in TE. 
4.2 Materials and methods 
4.2.1  Materials 
PLGA (LA:GA = 75:25 mol:mol; Mw: 66000-107000 Da) and PLCL (nominal 86 mol% of 
DL,lactic acid, Mw: 28000 Da) were supplied from Sigma-Aldrich (Milano, Italy). All solvents 
were of analytical grade and used without further purification (Sigma-Aldrich). 
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4.2.2.1  Poly(DL-lactide-co-glycolide) 
Poly(DL-lactide-co-glycolide) (Fig. 4.1) is synthesized by means of random ring-opening 
copolymerization of two different monomers, the cyclic dimers (1,4-dioxane-2,5-diones) of 
glycolic acid and lactic acid. During polymerization, successive monomeric units (of glycolic or 
lactic acid) are linked together in PLGA by ester linkages, thus yielding a linear, aliphatic 
polyester as a product. 
Depending on the ratio of lactide to glycolide used for the polymerization, different forms of 
PLGA can be obtained: these are usually identified in regard to the monomers' ratio used (e.g. 
PLGA 75:25 identifies a copolymer whose composition is 75% lactic acid and 25% glycolic 
acid). All PLGAs are amorphous rather than crystalline and show a glass transition temperature 
in the range of 40-60 °C. Unlike the homopolymers of lactic acid and glycolic acids, which 
show poor solubilities, PLGA can be dissolved by a wide range of common solvents, including 
chlorinated solvents, tetrahydrofuran, acetone or ethyl acetate. 
 
Fig. 4.1 Poly(DL-lactide-co-glycolide) (PLGA) chemical structure. x= number of units of lactic acid; y= number of 
units of glycolic. 
 
PLGA has been shown to undergo bulk erosion through hydrolysis of the ester bonds and the 
rate of degradation depends on a variety of parameters including the LA/GA ratio, molecular 
weight, and the shape and structure of the matrix. The intermediate co-polymers were found to 
be much more unstable compared to the homopolymers. Thus, 50/50 poly(DL-lactide-co-
glycolide) degrades in approximately 1–2 months, 75/25 in 4–5 months and 85/15 in 5–6 
months. 
The major popularity of these biocompatible co-polymers can be attributed in part to their 
approval by the Food and Drug Administration for use in humans, its good processibility which 
enables fabrication of a variety of structures and forms, controllable degradation rates and their 
success as biodegradable sutures compared to the earlier suture materials. As such, there has 
been extensive investigation into its use as an ideal biomaterial for temporary medical 
applications, such as controlled drug/protein delivery systems and as scaffolds for TE [22]. 
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4.2.2.2  Poly(DL-lactide-co-ε-caprolactone) 
Poly(DL-lactide-co-ε-caprolactone) is an amorphous copolymer of DL,lactic acid and ε-
caprolactone (Fig. 4.2) with a glass transition temperature of about 16 °C. 
By varying the copolymer composition, monomer sequencing and molecular weight, the 
copolymer properties can be tailored to meet the specific requirements of each particular 
application. The copolymers have been shown to be both biocompatible and biodegradable. 
Biodegradation proceeds via simple hydrolysis (random chain scission) leading to progressively 
lower molecular weight fragments [23]. 
 
Fig. 4.2 Poly(DL-lactide-co-ε-caprolactone) (PLCL) chemical structure. x= number of units of lactic acid; y= number 
of units of caprolactone. 
 
During the past 3 decades, research interest in random copolymers of DL-lactide and ε-
caprolactone has increased steadily as their potential in a wide range of biomedical applications 
has been realized. These applications have so far included biodegradable controlled-release 
drug delivery systems [24], monofilament surgical sutures [25] and absorbable nerve guides 
[26]. 
4.2.2  Methods 
4.2.2.1 Blend preparation 
PLCL/PLGA 100/0; 75/25; 50/50; 25/75; 0/100 (wt/wt) blends were prepared by solution 
mixing method. The polymers were separately dissolved in chloroform (Sigma-Aldrich) at 6% 
(wt/v) concentration and each polymer/solvent mixture was stirred using a magnetic stirrer for 4 
h, till complete dissolution of polymers. Proper volumes of the polymeric solutions were mixed 
to prepare blends and stirred for 2 h. Films were obtained by casting a volume of each solution 
(10 ml) on glass Petri dishes with 55 mm diameter. The solvent was removed via evaporation 
under a vented hood at room temperature for a period of 48 h. The blends were coded as 
follows: PLCL/PLGA 100/0; 75/25; 50/50; 25/75; 0/100. 
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4.2.2.2 Scanning electron microscopy 
Scanning electron microscopy (SEM LEO – 1430, Zeiss, Munich, Germany) was performed on 
cast film surfaces and sections (obtained by fracturing in liquid nitrogen). Samples were sputter 
coated with Au before SEM analysis. 
4.2.2.3 Differential scanning calorimetry 
The thermal behavior of cast films based on PLCL/PLGA blends was investigated by 
differential scanning calorimetry (DSC) using a TA INSTRUMENT DSC Q20. Film specimens 
(5-10 mg) were inserted into aluminum pans and non-isothermal scans were performed between 
−30 °C and 200 °C (first heating; cooling; second heating) at a heating rate of 10 °C/min under 
nitrogen atmosphere. The glass transition temperatures (Tgs) of PLCL and PLGA blend 
components were measured from the second DSC heating scan. 
4.2.2.4 Tensile testing 
Tensile mechanical properties of polymer blend films were analyzed to detect any variation 
respect to the constituent polymers. Tensile tests were performed on dry rectangular specimens 
(10 x 30 mm
2
) with 200 m thickness using MT®QTestTM/10 instrument. The traction force was 
applied along the length of the samples at a constant cross-head displacement rate of 2 mm/min. 
Young’s modulus (E), and maximum tensile strength and strain (max and εmax, respectively) 
were measured from the stress-strain curves. E was calculated from the slope of the initial linear 
portion of the stress-strain curve, and max and εmax were calculated as the maximum stress a 
material can withstand and the elongation at fracture, respectively [27]. 
4.2.2.5 In vitro testing 
Mouse embryonic fibroblast NIH 3T3 cells were supplied by American Type Culture Collection 
(ATCC, Virginia, USA). Dulbecco's modified Eagle's medium (DMEM; ATCC) supplemented 
with 10% Calf Bovine Serum (CBS; Gibco, Invitrogen) and 1% penicillin/streptomycin 
(Invitrogen) was used to culture the fibroblasts. Cells were first expanded, and a concentration 
of 5 × 10
4
 was seeded on the blend films and incubated at 37 °C in a humidified atmosphere of 
5% CO2 for 1 and 3 days. Cell Crown
TM
 inserts (Scaffdex, Tampere, Finland) were used to fix 
the films at the bottom of the wells prior to cell seeding. 
Cell proliferation was assessed using the colorimetric indicator Alamar Blue assay (Life 
Technologies, Ontario, Canada). Media was removed, samples were rinsed once in PBS, and 
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300 µL of fresh medium containing a 10% solution of Alamar Blue was added to each well. 
The culture plates were wrapped in aluminum foil and incubated for 4 h at 37 °C in a 
humidified atmosphere of 5% CO2. Absorbance of the extracted dye, which is proportional to 
the number of cells attached to the film, was measured spectrophotometrically with a microplate 
reader (Molecular Devices, SpectraMax i3 multi-mode detection platform, California, USA) at 
wavelengths of 570 and 600 nm. A calibration curve, generated from a known number of 
fibroblast NIH 3T3 cells reacting with the Alamar Blue indicator, was used to quantify the 
number of cells attached on films. 
Finally, the morphology of the cells cultured on blend films was examined by SEM (FEI Inspect 
F-50 FE-SEM). For SEM observation, films were washed two times with PBS and fixed in 
Paraformaldehyde for 30 min at room temperature. The films were then washed three times 
with PBS and dehydrated in 30%, 50%, 70%, 80%, 90%, 95%, and 100% ethanol, respectively, 
for 10 minutes. The samples were then dried under vacuum, coated with platinum, and 
examined with SEM. 
4.2.2.6 In vitro degradation 
For degradation studies, only PLCL/PLGA 100/0, 25/75, 0/100 blend films were used. In vitro 
degradation tests were carried out on 10 x 30 mm
2 
cast film specimens incubated in 6 ml PBS at 
37 °C and pH 7.4 for 1, 2, 4, 6 and 8 weeks. The PBS medium was exchanged once every 2 
weeks. 
Changes in sample weight during the in vitro degradation tests were monitored. Samples (n=5) 
were accurately weighed before in vitro degradation tests (Wo). Then, at each time, samples 
were collected, dried for 1 week under a vented hood at room temperature and then weighed 
again (Wf). The weight loss was calculated as a percentage according to Eq. 1: 
      
     
  
      (1) 
Morphological evaluation of the fractured and exposed surfaces of film samples at each 
degradation test time was analyzed by SEM according to the procedure described at par. 
4.2.2.2. Thermal and chemical properties were evaluated through DSC analysis, according to 
the previously described method at par. 4.2.2.3 and by infrared analysis in ATR modality 
(FTIR-ATR). FTIR-ATR analysis was carried out in a Perkin Elmer Frontier Optical 
Spectrometer fitted with an attenuated total reflection sampler. Spectra were obtained over the 
400-4000 cm
-1
 wavenumber range at room temperature.  
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Weight average molecular weights (Mw), number average molecular weight (Mn) and 
polydispersity indices (PI = Mw/Mn) of samples at each degradation test time were measured by 
gel permeation chromatography (GPC) using an Agilent system equipped with a Water 2414 RI 
detector. The measurements were performed using four Water columns (range 103–106 Å) at 
40 °C; tetrahydrofuran (THF, Sigma-Aldrich) as eluent (1.0 mL/min) and narrow polystyrene 
standards were used for calibration. 
4.2.3  Statistical analysis  
Results were expressed as mean ± standard deviation obtained from three different experiments. 
Statistical analysis was performed using analysis of variance (two-way ANOVA) by GraphPad 
Prism 5 software. Differences were considered statistically significant at p < 0.05. 
4.3 Results and discussion 
4.3.1  Morphological analysis  
Fractured surfaces of the PLCL/PLGA blends were investigated by SEM analysis. Fig. 4.3 
reports the photomicrographs of blend sections. 
 
Fig. 4.3 SEM images of the fractured sections of PLCL/PLGA (a) 100/0; (b) 75/25; (c) 50/50; (d) 25/75; (e) 0/100 
blend film samples. Scale bar = 20 µm. 
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Films showed a compact section. No evident phase separation between blend components could 
be detected for analyzed blend compositions, suggesting physical compatibility of PLCL/PLGA 
blends. 
4.3.2  Thermal analysis  
Fig. 4.4 collects DSC second heating thermograms for PLCL/PLGA samples (100/0, 75/25, 
50/50, 25/7, 0/100 wt/wt) prepared via solvent casting method. Both PLCL and PLGA are 
amorphous copolymers, therefore their glass transition temperature (Tg) is their unique 
characteristic thermal transition. Pure PLCL and PLGA exhibited a Tg of around 28 °C and 49 
°C, respectively. For each blend, DSC second heating traces showed the presence of two glass 
transition temperatures for each blend component, which values are collected in Table 4.1. 
 
Fig. 4.4 DSC second heating thermograms for PLCL/PLGA blends. 
 
Tg is a well-known indicator of blend miscibility. If the two components of a binary blend are 
miscible in the amorphous phase, only one Tg is expected (Fox equation). If they are 
immiscible, Tg values of both components are retained. If the two components are partially 
miscible, their Tg in blends shifts towards each other [28]. As shown in Table 4.1, Tg values of 
blend components were similar to those of pure polymers; however the difference between 
PLGA and PLCL Tgs calculated for each blend was lower compared to pure polymers, 
suggesting some compatibility degree for PLCL/PLGA 50/50 and PLCL/PLGA 25/75 blend 
compositions. This result appeared in contrast with SEM analysis, as immiscible (compatible 
and uncompatible) blends generally show a biphasic morphology. However, as reported in 
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literature [9], the lack of phase separation in SEM analysis may result from close physical 
properties between blend components, such as shrinkage ratio, absorbance, and refractive index. 
Table 4.1 Glass Transition temperatures measured by DSC analysis (second heating scan at 10 °C/min). 
Composition Tg
PLGA
 (°C) Tg
PLCL
 (°C) ΔTg (°C) 
PLCL/PLGA 100/0 - 27.2 ± 0.6 - 
PLCL/PLGA 75/25 49.0 ± 0.2 28.2 ± 0.3 20.7 ± 0.3 
PLCL/PLGA 50/50 47.7 ± 0.2 29.0 ± 0.5 19.0 ± 0.1 
PLCL/PLGA 25/75 47.7 ± 0.2 29.7 ± 0.1 17.9 ± 0.1 
PLCL/PLGA 0/100 48.6 ± 0.2 - - 
1       
       
     
Theoretical ∆Tg between PLGA and PLCL phase was 21.4 ± 0.5 °C 
4.3.3  Mechanical characterization  
Fig. 4.5 shows the stress-strain curves measured for PLCL/PLGA blend films by tensile tests. 
The PLCL/PLGA blend films stress/strain curves showed the typical trend of ductile polymers 
[27]. They were characterized by an initial linear elastic region, followed by a yielding zone, a 
subsequent drop in stress with neck formation due to chain orientation along the stress direction 
and a final increase of stress till final fracture. 
 
Fig. 4.5 Tensile stress-strain curves for PLCL/PLGA blend films (cross-head speed = 2 mm/min). 
 
In the elastic region, stress was proportional to strain and the deformation was completely 
reversible; the slope of this linear portion was calculated as the elastic modulus of the films (E). 
Yielding is due to plastic deformation leading to a decrease in polymer cross-sectional area. As 
the stress-strain curves showed, the nominal stress decreased after yielding, before setting at a 
constant value during necking. The final increase of the stress was due to strain hardening, 
occurring once the whole sample was necked. The stress increased till fracture which occurred 
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at maximum tensile stress (max) and strain (εmax). The values of E, max, and εmax calculated 
from the stress-strain curves of PLCL/PLGA blend films are collected in Table 4.2.  
Fig. 4.6 and 4.7 show E, max, and εmax as a function of blend composition compared to the 
additive law of mixtures. Mechanical behavior of blend samples can be predicted by the 
additive rule of mixture in case of miscible blends, while it shows a positive or a negative 
deviation from the additive rule of mixture in the case of compatible and uncompatible blends, 
respectively. 
PLCL/PLGA 100/0 and 0/100 exhibited different Young’s moduli of around 1.5 MPa and 24 
MPa, respectively. Blends showed intermediate values of the Young’s modulus respect to the 
blend components, which increased with increasing PLGA amount.  
Table 4.2 Young’s elastic modulus (E), maximum tensile strength (σmax) and strain (εmax) calculated from stress-strain 
curves. 
Composition E (MPa) σmax (MPa) εmax (%) 
PLCL/PLGA 100/0 1.5 ± 0.2 0.3 ± 0.1 894.1 ± 68.5 
PLCL/PLGA 75/25 1.6 ± 0.6 0.5 ± 0.0 682.7 ± 84.9 
PLCL/PLGA 50/50 4.2 ± 0.5 0.7 ± 0.1 481.6 ± 65.7 
PLCL/PLGA 25/75 10.2 ± 0.6 0.8 ± 0.0 548.8 ± 57.9 
PLCL/PLGA 0/100 23.6 ± 3.5 1.2 ± 0.1 461.4 ± 131.6 
 
Fig. 4.6 reports the behavior of E as a function of composition for PLCL/PLGA blends 
compared to the additive rule of mixture. E showed a negative deviation from the additive rule 
of mixture. Among the tested blend compositions, PLCL/PLGA 25/75 blend composition 
showed the highest Young’s modulus. 
 
Fig. 4.6 Elastic modulus of PLCL/PLGA blends against composition. Dotted line indicates prediction by the additive 
law of mixtures. 
 
The maximum tensile stress (Table 4.2) of PLGA (1.2 MPa) was higher than that of PLCL (0.3 
MPa), whereas εmax value was higher for PLCL (894% for PLCL vs. 461% for PLGA). Blend 
maximum tensile stress and strain were intermediate respect to blend components, respectively 
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increasing and decreasing with increasing PLGA amount (Fig. 4.7). Values of blend max and 
εmax more closely approached those predicted by the additive rule of mixtures (Fig. 4.7). 
 
Fig. 4.7 Maximum tensile strength (a) and strain (b) of PLCL/PLGA blends against composition. Dotted line indicates 
prediction by the linear additive law. 
 
Therefore, a comparison between tensile mechanical parameters and prediction by the additive 
rule of mixture suggested that PLCL/PLGA blends displayed limited compatibility. Superior 
mechanical properties were displayed by PLCL/PLGA 25/75 blend (E = 10.2 ± 0.6 MPa, max = 
0.8 ± 0.0 MPa, and εmax = 548.8 ± 57.9%). 
4.3.4  Cell proliferation and adhesion  
Cell adhesion and proliferation over time on a material are the indication of its cellular 
compatibility and suitability for TE applications. Different polymeric blends of PLCL/PLGA 
(100/0, 75/25, 50/50, 25/7, 0/100 wt/wt) prepared via solution casting were seeded with 
fibroblast NIH 3T3 and tested by Alamar Blue assay in order to determine the cell attachment 
and proliferation on the films. 
Fig. 4.8 shows the number of cells attached to the samples after 1 and 3 days of cell culture. No 
correlation between blend composition and cell growth could be observed. The number of cells 
increased on all samples after 1 culture day. The proliferation process was more pronounced for 
PLCL/PLGA 100/0 and 50/50 films whose cell number almost doubled in the first day, 
approaching the value of Ctrl (3.1 x 10
5
 cells ). At 3 days, a further increase in cells number 
could be observed for all material tested. The cell number on blends with composition 100/0, 
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50/50 and 25/75 (wt/wt) was significantly higher than those on PLCL/PLGA 75/25 and 0/100 
films after 3 days culture time. Thus, the results indicated that PLCL/PLGA 100/0, 50/50 and 
25/75 films were suitable for the support of cell adhesion and proliferation. 
 
Fig. 4.8 Cell proliferation on PLCL/PLGA blend films as a function of time. Petri dish was used as control (Ctrl). 
 
The morphologies of adherent cells and cell-polymer interaction were analyzed by SEM. Fig. 
4.9 shows the morphology of cells adhered to PLCL/PLGA films with different compositions 
after 1 and 3 days culture time. After 1 culture day, slightly differences in cell morphology on 
different samples could be observed. Fibroblasts appeared more elongated and adherent to the 
films with the increased of PLGA content (Fig. 4.9 c1, d1 and e1).  
At 3 days, cell morphology markedly changed on all materials tested except for PLCL/PLGA 
0/100 blend: cells appeared more elongated on films with lamellopodia expanded outside. On 
PLCL/PLGA 25/75 films, showing the highest cell density according to Alamar blue assay (Fig. 
4.8), cells spread uniformly and extensively; the development of lamellopodia demonstrated 
that cell adhesion was high (Fig. 4.9 d2). 
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Fig. 4.9 SEM morphology of fibroblast cells grown on blend PLCL/PLGA 100/0 (a1, a2), 75/25 (b1, b2), 50/50 (c1, 
c2), 25/75 (d1, d2) and 0/100 (e1, e2) after seeding cells for 1 and 3 days, respectively denoted with numbers 1 and 2. 
Scale bar = 100 µm. 
 
Based on mechanical characterization and cell proliferation and adhesion tests, the 
PLCL/PLGA 25/75 blend was found to be a suitable candidate for TE applications. 
4.3.5  In vitro  degradation test  
In vitro hydrolytic degradation tests were carried out on the selected PLCL/PLGA 25/75 blend 
films and their control pure components (PLCL, PLGA). 
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PLGA and PLCL copolymers are known to degrade through bulk hydrolysis of the ester 
linkages within the polymer backbone to form the constituent monomers (lactic and glycolic 
acids for PLGA, and lactic acid and caprolactone for PLCL) which can be naturally removed 
from the body [29, 30]. The hydrolysis reaction is autocatalytic, i.e. the bulk material degrades 
at a faster rate than the surface due to a build up of carboxylic acid end groups [31]. 
4.3.5.1 Weight loss and pH variations 
The weight percentage reduction of films over the duration of in vitro degradation tests was 
monitored (Fig. 4.10). 
 
Fig. 4.10 Weight loss percentage as a function of incubation time in PBS for PLCL/PLGA 100/0, 2575 and 0/100. 
 
PLCL/PLGA 100/0 showed higher weight loss at each time among the analyzed materials: it 
lost only 6.5 ± 1.7% of the initial weight after 2 weeks of incubation in PBS, and about 46% 
after 8 weeks. Weight loss for PLCL/PLGA 0/100 specimens remained constant at around 6-
6.5% until 6 weeks of incubation in PBS, after which it increased up to 26.9 ± 6.8% after 8 
weeks. PLCL/PLGA 25/75 blend weight loss progressively increased as a function of time, 
reaching 28.8 ± 3.4% after 8 weeks. Blend weight loss behavior was approximately 
intermediate between that of the pure polymers. 
The pH of the incubation medium was also monitored as a function of time (Fig. 4.11). In the 
case of PLCL/PLGA 0/100 and 25/75 blend, pH was approximately constant at 7.4 up to 6 and 
4 weeks incubation in PBS, respectively. Then, for both samples, pH decreased as a function of 
incubation time reaching the values of 5.1 ± 0.2 and 5.2 ± 0.5 after 8 weeks.  
On the other hand, PLCL/PLGA 100/0 degradation rate was faster than the other materials as 
suggested by the lower pH at each incubation time. Within the first 4 weeks, pH was 
approximately 6.9. After 4 weeks incubation in PBS, pH started to become slightly acidic and 
decreased progressively as a function of incubation time up to about 4 after 8 weeks. Changes 
in pH were attributed to the release of acidic degradation products. 
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Fig. 4.11 pH values of the PBS solution as a function of incubation time in PBS for PLCL/PLGA 100/0, 0/100 and 
25/75 blend. Data are average values and bars represent standard deviation. 
 
4.3.5.2 Molecular weight measurements 
Molecular weight was also monitored as a function of incubation time in PBS. In general, a 
bulk degradation process occurs for PGA, PLA, PCL, and their copolymers: polymer molecular 
weight decreases due to the hydrolysis of polymer ester bonds, forming shorter polymer chains 
[32]. When the size of the polymer fragments becomes small enough so that scaffold 
mechanical properties are significantly decreased, scaffold collapses and degradation products 
are released. 
Fig. 4.12 shows the Mw and PI variation of PLCL/PLGA 100/0, 0/100 and 25/75 blend at 
different incubation time in PBS. 
 
Fig. 4.12 Variation of (a) weight average molecular weight (Mw) and (b) polydispersity indices of PLCL/PLGA 100/0, 
25/75 and 0/100 blend films as a function of degradation time. 
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Mw of PLCL/PLGA 100/0 films decreased progressively as a function of time, from 28185 ± 
5020 Da to 3135 ± 312 Da after 8 weeks incubation in PBS. On the other hand, PLCL/PLGA 
0/100 and 25/75 blend molecular weights initially slightly increased (1 weeks incubation in 
PBS), suggesting the degradation and release of low molecular weight fractions. Then, 
molecular weight of PLCL/PLGA 0/100 and 25/75 blend progressively decreased as a function 
of time to about 2900 Da and 4300 Da, respectively (8 weeks). 
Mw values of PLCL/PLGA 25/75 blend films were intermediate between those of blend 
components up to 4 weeks, becoming similar to those of pure polymers at 6 and 8 weeks 
incubation in PBS.  
The polydispersity indexes of PLCL/PLGA 100/0 and 25/75 blend samples were approximately 
constant at 1.7 value up to 2 weeks, then they increased to a maximum of 1.9 ± 0.5 for PLCL 
and 2.2 ± 0.2 for blend films after 4 weeks. The PLCL/PLGA 100/0 and 25/75 PIs finally 
decreased to about 1.6 and 1.4 after 8 weeks, respectively. The initial increase in PI was a result 
of random chain scission during degradation, while the subsequent decrease was due to the 
decrease in molecular weight and the release of some of the degradation products [33]. 
No significant variation of PI was measured for PLCL/PLGA 0/100 during degradation tests 
(1.7 ± 0.3). 
4.3.5.3 Thermal properties 
Thermal behavior of samples was analyzed as a function of their incubation time in PBS. 
Polymer glass transition temperature is a function of different parameters among which the 
polymer molecular weight. It is a reversible step change in molecular mobility, from a rigid 
glassy state to a mobile rubbery state. This change is linked to the free volume associated to the 
polymer chain ends. When the molecular weight decreases, more chain ends are present and 
more free volume is generated. The polymer chains have, therefore, more space to move and the 
rubbery state is reached earlier, i.e. at a lower temperature [34]. 
Table 4.3 collects Tg values (measured from the second DSC heating scan) of PLCL/PLGA 
100/0, 0/100 and 25/75 blend as a function of degradation time. 
Table 4.3 Glass transition temperatures of PLCL and PLGA as a function of incubation time in PBS. 
Samples degradation time 
(weeks) 
Tg
PLGA
 (°C) Tg
PLCL
 (°C) 
PLCL/PLGA 100/0   
0 - 27.2 ± 0.6 
1 - 26.2 ± 0.7 
2 - 27.7 ± 0.4 
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4 - 21.0 ± 1.1 
6 - 20.8 ± 2.5 
8 - 12.3 ± 0.2 
PLCL/PLGA 25/75   
0 47.7 ± 0.2 29.7 ± 0.0 
1 44.3 ± 0.3 30.9 ± 0.2 
2 45.5 ± 0.6 30.7 ± 0.2 
4 35.6 ± 2.9 - 
6 36.7 ± 0.9 - 
8 32.7 ± 0.8 - 
PLCL/PLGA 0/100   
0 48.6 ± 0.2 - 
1 49.2 ± 0.2 - 
2 46.4 ± 1.1 - 
4 44.8 ± 0.9 - 
6 39.2 ± 3.5 - 
8 29.8 ± 1.4 - 
 
No significant changes for PLCL/PLGA 100/0 and 0/100 Tgs could be observed up to 2 and 4 
weeks of incubation in PBS, respectively. Then, glass transition temperatures progressively 
decreased reaching 12.3 °C for PLCL/PLGA 100/0 samples and 29.8 °C for PLCL/PLGA 0/100 
samples after 8 weeks. This behavior was in agreement with molecular weight data which 
showed that both PLCL/PLGA 100/0 and 0/100 molecular weights slightly decreased as a 
function of degradation time. Another factor that may lead to the decrease of material glass 
transition is the water diffused into the polymer, due to the plasticizing effect of the water 
molecules [35]. 
Similarly to the pure polymers, blend thermal properties did not change significantly in the first 
2 weeks of the degradation test, in agreement with molecular weight analysis. After 4 weeks, 
PLCL Tg was no longer detectable while PLGA Tg gradually decreased. These changes could be 
attributed to the molecular weights reduction. 
The PLCL Tg decrease below the physiological temperature (37 °C) was responsible for PLCL 
softening during incubation of films in PBS, causing PLCL leaching out from the blend 
membrane structure and progressive pore formation. On the contrary, the glass transition 
temperature of PLGA, both as blend component and as pure polymer, decreased below 37 °C 
after 4 and 6 weeks incubation in PBS, respectively. These changes caused film softening and 
loss of film shape. 
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4.3.5.4 FTIR-ATR analysis 
Changes in surface chemical composition of PLCL/PLGA 100/0, 0/100 and 25/75 blend 
samples as a function of degradation time were monitored by FTIR-ATR analysis. 
The FTIR-ATR spectra of films, as a function of incubation time in PBS, are shown in Fig. 
4.13. Spectra showed similar absorption bands: weak absorption bands at around 3000 cm
-1
 
were due to alkyl groups stretching vibration and strong absorption bands at about 1742 cm
-1
 
were attributed to the stretching vibration of C=O bond. The bands at 1452 cm
−1
 arose from the 
bending vibration of methyl group -CH3 while the absorption peaks of C=O bending vibration 
appeared at about 1267 cm
-1
. The ester bond was confirmed by the presence of absorption bands 
in the 1044-1184 cm
-1 
interval region, assigned to the C–O–C ether group stretching. Finally, 
the bands at about 865 cm
-1
 arose from the stretching vibration of C-C bond [36].  
PLCL/PLGA 25/75 blend spectra were more similar to PLCL/PLGA 0/100 than to 
PLCL/PLGA 100/0 spectra, due to the higher quantity of PLGA phase in blend. The main 
difference between PLCL/PLGA 100/0 and 0/100 was related to the absorption bands around 
1420 cm
-1
 observed for PLGA based films. This peak was attributed to the C-H stretching 
vibration of methyl groups of PLGA copolymer. 
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Fig. 4.13 FTIR-ATR spectra of PLCL/PLGA 100/0, 25/75 and 0/100 samples as a function of incubation time in PBS. 
 
For all analyzed materials, FTIR spectra of films immersed in PBS showed a measurable 
increase of the absorbance of the peak centered in the 1650-1550 cm
-1
 interval region with 
increasing the degradation time. This peak, not present in the spectra of initial samples, is 
characteristic of the stretching vibrations of carboxylate groups. Indeed, hydrolytic degradation 
process breaks ester bonds and produces alcohol and carboxylate groups. Moreover, after 8 
weeks for PLCL/PLGA 0/100 and 25/75 samples and after 4 weeks for PLCL/PLGA 100/0 
samples, a peak between 3400 cm
-1 
and 3600 cm
-1
 appeared attributed to the presence of 
terminal –OH groups and to increased amount of absorbed water. In the case of PLCL/PLGA 
100/0 samples, its intensity increased with increasing immersion time in PBS [37]. 
4.3.5.5 Morphological analysis 
A non-uniform degradation process, as it is typical in materials that degrade by in bulk 
autocatalytic hydrolysis, was suggested from visual inspection of the specimens (data not 
shown).  
All the films became softer after incubation in PBS, due to the temperature of the bath, which 
was close (PLGA) or superior (PLCL) to polymer Tg and PBS absorption leading to material 
plasticization. However, PLCL/PLGA 0/100 and 25/75 samples remained intact after 6 weeks 
while PLCL/PLGA 100/0 films lost their shape and fragmented starting from 4 weeks.  
The morphology of the external surface and fractured section of PLCL/PLGA 100/0, 0/100 and 
25/75 blend film samples after 0-8 weeks incubation in PBS at 37 °C was observed through 
SEM analysis. Morphology of both surface and fractured section of PLCL/PLGA 0/100 films 
did not change significantly as a function of incubation time in PBS while that of PLCL/PLGA 
100/0 films could not be monitored after 2 weeks of exposure due to their rapid break up and 
softening (data not shown). 
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Fig. 4.14 reports the morphological analysis of PLCL/PLGA 25/75 blend films as a function of 
incubation time in PBS. 
 
Fig. 4.14 Morphology of the surface (numbers 1) and fractured sections (numbers 2) of PLCL/PLGA 25/75 samples as 
a function of their incubation time in PBS: (a) 0 weeks; (b) 1 weeks; (c) 2 weeks; (d) 4 weeks; (e) 6 weeks; (f) 8 weeks. 
Scale bar = 100 µm (numbers 1) and 20 µm (numbers 2). 
 
PLCL/PLGA 25/75 blend films initially were non-porous, with smooth surfaces; however, 
extensive micropores developed during degradation. It was possible to observe the appearance 
of numerous pores on the surface of blend cast films after 1 week incubation in PBS. Moreover, 
the cross-section of PLCL/PLGA 25/75 blends showed pores with a few micron size after 4 
weeks of incubation in PBS, probably caused by PLCL dissolution and degradation. 
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4.4 Conclusions 
Blending PLGA and PLCL through a solvent casting process generated suitable materials for 
TE applications. PLCL/PLGA 25/75, 50/50 and 75/25 did not show evident phase separation, 
attributed to similar physical properties between blend components. The behavior of blend 
component Tgs suggested immiscibility for all the tested compositions; however, some degree 
of compatibility was found for PLCL/PLGA 25/75 and 50/50 blends. Mechanical properties of 
blend samples confirmed the limited compatibility for PLCL/PLGA 25/75 and 50/50 blends. 
Among these two compositions, PLCL/PLGA 25/75 blend showed superior mechanical 
properties (toughness). 
In vitro cell tests using mouse embryonic fibroblast NIH 3T3 cells indicated that PLCL/PLGA 
100/0, 50/50 and 25/75 films supported cellular attachment and proliferation, especially on 
PLCL/PLGA 25/75 blend surface, fibroblasts spread uniformly and extensively with the 
development of lamellopodia. This blend composition was further characterized for its stability 
in physiological medium, evidencing a degradation behavior intermediate between that of the 
pure polymers, in term of weight loss and molecular weight changes, becoming similar to those 
of pure PLGA after 6 weeks incubation in PBS. The cross-section of PLCL/PLGA 25/75 blends 
showed pores with a few micron size after 4 weeks of incubation in PBS, probably caused by 
PLCL dissolution and degradation. 
In summary, it can be concluded that PLCL/PLGA 25/75 blend polymer film combined the 
deformability of PLCL with the higher mechanical stiffness, the cell adhesion properties and the 
slowly degradation rate of PLGA, leading to a tough material with similar degradation rate to 
PLGA and superior cell adhesion and proliferation. 
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5 
Improving fibroblast response and 
antimicrobial efficiency via 
polyelectrolytes multilayer assembly for 
Tissue Engineering applications 
 
Abstract 
In this chapter, the layer-by-layer (LbL) technique was applied for the coating of PLCL/PLGA 
25/75 (wt/wt) films with the purpose to enhance fibroblast cell response and confer antibacterial 
efficacy. A surface priming treatment was applied and optimized before depositing LbL 
coating. PLCL/PLGA 25/75 (wt/wt) films were pre-functionalized through aminolysis by using 
1,6-hexamethylenediamine reagent. The effect of aminolysis treatment on physicochemical and 
morphological properties was evaluated, leading to the selection of the following parameters: C 
= 0.08 g/mL, t = 8 min and T = 37 °C. Then, multilayered chondroitin sulfate/chitosan 
(CHS/CH) coatings were deposited on the aminolysed films. The feasibility of multilayer 
coating was confirmed by QCM-D analysis. Further confirmations of LbL build up on blend 
films derived from: water contact angle measurements (the contact angle jumped alternatively 
between 45° and 65° relying on the outmost layer component), FTIR-ATR analysis (appearance 
of absorbance peaks characteristics of CHS and CH), and fluorescence microscopy (using 
FITC-labeled CH). In vitro cell tests demonstrated the ability of coated samples to improve 
fibroblast NIH 3T3 adhesion and proliferation. Biocompatibility properties increased with 
increasing the layer number and on CH-terminating layers. However, no antibacterial activity 
was observed for films coated with 16 layers. Finally, the immersion of 16-layers coated 
samples in physiological medium for 14 days led to almost complete dissolution of the coating. 
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5.1 Introduction 
Tissue Engineering (TE) has rapidly developed as a multidisciplinary field in the area of human 
health care [1]. It combines biology, medicine, materials science and engineering to generate 
products with suitable biochemical and physical–mechanical performance to repair or replace 
damaged, injured or missing body tissues [2]. Most of the current research in TE focuses on 
improving the scaffolds used for tissue culture. Optimal scaffolds are required to be 
biocompatible, biodegradable and mechanically stable. The scaffold should also provide a 
physical support for cells and an environment for their proliferation, growth and differentiation. 
In addition to these basic requirements, it is crucial that the scaffold surface elicits the desired 
response from cells in contact with it. It is the scaffold surface that determines the initial 
cellular response to the implant, and therefore its acceptance and durability in the body [3]. 
The biomaterial chosen to fabricate the scaffolds influences both surface and mechanical 
properties of the implants. Scaffold surface properties such as chemical composition, 
wettability, surface charge, and morphology determine the initial interaction of biomaterials 
with cells [4].  
Polyesters, such as poly(lactic acid) (PLA), poly(glycolic acid) (PGA), poly(ε-caprolactone) 
(PCL) and their copolymers, have been well documented for their excellent biodegradability, 
biocompatibility, non-toxicity and their biocompatible degradation products [5]. However, the 
surface properties of polyesters are not ideal for cell growth. They are relatively hydrophobic 
compared to the natural extracellular matrix, are unable to interact specifically with cells, and 
do not possess any functional groups for the attachment of biologically active molecules [6]. 
Surface treatments are thus necessary to optimize the properties of these polymers. 
Surface modifications are aimed at increasing biomaterial hydrophilicity through both physical 
(i.e. plasma treatment [7, 8]) and chemical methods (i.e. hydrolysis, aminolysis [9]), while 
maintaining their bulk properties. The functional groups introduced can be used as anchors to 
bind specific biomacromolecules, such as extracellular matrix (ECM) components. Several 
approaches can be adopted to modify the surface properties of biocompatible polymers with 
biomacromolecules, such as covalent attachment [10-1112], physical adsorption [13, 14], and 
affinity bonding [15]. In this chapter, the Layer-by-Layer (LbL) self-assembly technique was 
investigated to surface engineer polyester films based on poly(DL-lactide-co-ε-caprolactone) 
(PLCL) and poly(DL-lactide-co-glycolide) (PLGA) blend. 
The LbL deposition method consists of the alternate adsorption of oppositely charged 
polyanions and polycations that self-organize on the material surface, leading to the formation 
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of polyelectrolyte multilayer (PEM) films [16]. In comparison to conventional coating methods, 
PEMs are easy to prepare and the procedure is applicable regardless of the shape of solid 
materials. Varying the nature of the polyelectrolytes selected and the conditions used for the 
deposition, LbL films with a wide range of physicochemical properties can be produced, thus 
enabling a diverse array of biomedical applications, including drug delivery, tissue engineering, 
and bioactive implant coatings [17, 18]. The investigation of LbL multilayers composed of 
naturally derived polymers, such as proteins, polysaccharides or their fragments, has been of 
particular interest due to their excellent biocompatibility. In particular, ECM components can 
promote cell adhesion and proliferation [19]. 
In this study, chondroitin sulfate/chitosan (CHS/CH) PEM-functionalized PLCL/PLGA blend 
substrates were developed to enhance fibroblast NIH 3T3 cell adhesion, proliferation and 
function, and to confer antibacterial efficacy to the membranes. CHS and CH were chosen as 
PEM layers because they are natural polymers and they are resorbable in vivo. CHS is an 
important ECM polysaccharide of bone, cartilage, and connective tissues; it takes also an 
important role in maintaining cell functions. Its high negative polarity allows CHS to be used as 
polyanion in LbL assembly. CH, derived from chitin, has been exploited for wide biomedical 
applications such as wound dressing, drug delivery, and tissue engineering owing to its non-
toxicity, non-immunogenicity, biocompatibility and biodegradability. It is a cationic 
polysaccharide, which antibacterial activity has received considerable attention in recent years 
[20, 21]. 
We investigated the formation, physicochemical properties, cellular response, and antibacterial 
efficiency of PEMs composed of water-soluble CHS and CH. However, prior to the multilayer 
build-up, initial charges need to be introduced on the substrate. In this contest, a chemical 
method was selected: the aminolysis treatment. It was performed, setting different combinations 
of parameters, in order to find the optimal process conditions on the basis of modified substrate 
physicochemical properties. The optimal set of aminolysis parameters were then used for the 
modification of PLCL/PLGA blend films, subsequently coated through LbL technique. 
PE film deposition was monitored by dissipative quartz crystal microbalance and fluorescence 
microscopy, while film morphology, wettability and chemical composition were characterized 
via SEM, water contact angle measurement and FTIR-ATR, respectively. In vitro fibroblast 
adhesion and proliferation on films were then evaluated. 
Once selected the optimal number of layers of LbL coating for our application, the PEM film 
was further characterized via antibacterial tests, XPS analysis, quantification of surface amino 
groups, and coating stability in phosphate buffer saline (PBS). 
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5.2 Materials and methods 
5.2.1  Materials 
Poly(DL,lactide-co-glycolide) (PLGA; LA:GA = 75:25 mol:mol; Mw: 66000-107000 Da) and 
poly(DL,lactide-co-caprolactone) (PLCL; 86 mol.% nominal DL,lactic acid content; Mw: 28000 
Da) were used to produce the polymeric substrates. Aminolysis was performed by using 1,6-
hexamethylenediamine (Mw = 116.2 Da) that is an organic compound with the formula 
H2N(CH2)6NH2. The molecule is a diamine, consisting of a hexamethylene hydrocarbon chain 
terminated with amine functional groups. Chondroitin sulfate A sodium salt from bovine 
trachea (CHS) and chitosan highly viscous derived from crab shell with 75-85% deacetylation 
degree (CH; Mw: 190-310 kDa) were used as polyelectrolytes for LbL deposition coating. All 
chemicals and solvents were supplied by Sigma-Aldrich (Milano, Italy) and used as received. 
5.2.1.1  Chitosan 
Chitosan (Fig. 5.1) is the most important derivative of chitin, a natural polysaccharide first 
identified in 1884. Chitin is synthesized by an enormous number of living organisms, such as 
arthropods, fungi and yeast, organisms in the lower plant and animal kingdoms. 
CH is obtained by (partial) deacetylation of chitin in the solid state under alkaline conditions 
(concentrated NaOH) or by enzymatic hydrolysis in the presence of chitin deacetylase. Because 
of the semicrystalline morphology of chitin, chitosan obtained by solid-state reaction has a 
heterogeneous distribution of acetyl groups along the chains [22]. 
 
Fig. 5.1 Chitosan (CH) chemical structure. 
 
CH is biocompatible, biodegradable, non-toxic and non-immunogenic. It is a cationic 
antibacterial polysaccharide that has been shown to disrupt bacterial cell membrane integrity 
[22, 23]. These properties find several biomedical applications in TE [24], wound healing [25], 
drug and gene delivery [26, 27]. 
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5.2.1.2  Chondroitin sulfate  
Chondroitin sulfate (Fig. 5.2), a natural complex glycosaminoglycan (GAG), is composed of 
alternate disaccharide sequences of differently sulfated residues of D-glucuronic acid (GlcA) 
and of N-acetyl-D-galactosamine (GalNAc). Although all natural CHS have an identical 
carbohydrate backbone, different degrees and positions of sulfate groups give rise to a wide 
range of composition. 
 
Fig. 5.2 Chondroitin sulfate (CHS) chemical structure. 
 
Chondroitin sulfate is the most abundant GAG in the body. Although cartilage and 
intervertebral disc are tissues having the highest content of CHS, these molecules are largely 
distributed in tissues, and are the main GAG components in blood and urine. Used worldwide in 
many pharmaceutical and nutraceutical applications, CHS is obtained by extraction from tissues 
of several animals (i.e. bovine, porcine, avian, cartilagenous fishes). 
CHS is quite water soluble, which limits its use alone in the solid state for biomedical 
applications, being frequently combined with other polymers. In fact, its anionic nature enables 
efficient interaction with cationic molecules to form interesting structure. Due to its nature, 
chondroitin sulfate has been mostly used in the development of supports for cartilage tissue 
engineering applications [28]. 
5.2.2  Sample preparation 
5.2.2.1 Preparation of PLCL/PLGA 25/75 samples via solvent casting 
Substrates were based on PLCL/PLGA 25/75 (wt/wt) blend, prepared by solution mixing 
technique. The polymers were dissolved in chloroform (Sigma-Aldrich) at 6% (wt/v) 
concentration, till complete dissolution. Films were obtained by casting 10 ml of solution on 
glass Petri dishes with 55 mm diameter. The solvent was removed via evaporation under a 
vented hood at room temperature for a period of 48 h. 
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5.2.2.2 Surface activation through aminolysis treatment 
The surface activation of samples is a necessary step to allow the deposition of a multilayered 
coating by LbL process, as schematizing in Fig. 5.3. PLCL/PLGA 25/75 (wt/wt) blend films 
were aminolysed by incubation in 1,6-hexamethylenediamine/1-propanol solutions, with 
different concentrations and treatment times. After the aminolysis treatment, the samples were 
rinsed with a large quantity of demineralised water to remove free 1,6-hexamethylenediamine 
and dried at room temperature under a vented hood for 48 h. 
 
Fig. 5.3 Schematic representation of aminolysis process by dipping polymeric film in 1-6-hexamethylenediamine/1-
propanol solution. The surface exposes primary amino groups. 
 
Aminolysis was performed combining the different conditions listed in Table 5.1. After each 
aminolysis treatment, samples were subjected to physicochemical characterizations to find the 
optimal process parameters for the surface modification. 
Table 5.1 Processing parameters analyzed during the optimization of the aminolysis treatment. 
Concentration 
(g/ml) 
Time 
(min) 
Temperature 
(°C) 
0.06 
4, 8, 12, 16, 20 37 0.08 
0.1 
 
5.2.2.3 Preparation of multilayer coating 
Layer-by-Layer process allows the deposition of multilayered coatings on the surface of 
samples, made of alternately charged polyelectrolytes that electrostatically interact each other 
stabilizing the coating. 
LbL build up was achieved using the pipette approach, wherein 1 ml of each polyelectrolyte 
was deposited directly onto aminolysed films, beginning with the polyanion (CHS). 
Polyelectrolyte solutions were prepared at a concentration of 0.2% (wt/v) in 0.2M NaCl buffer 
(CH was previously dissolved in 1% (v/v) of acetic acid at a concentration of 2% (wt/v)) at pH 
4.5. After the polymer was allowed to adsorb for 15 min, substrates were rinsed with 0.2M 
NaCl buffer (pH 4.5) for 5 min. Then the polycation (CH) was added, allowed to absorb for 15 
min and rinsed for 5 min. These deposition steps were repeated 10 times. Finally, coated 
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substrates were rinsed with 0.2M NaCl buffer (pH 4.5) for 15 min and dried under vented hood 
for 48 h. 
A total number of 20 layers was deposited on PLCL/PLGA 25/75 (wt/wt) blend film surface 
through this technique. Pristine and aminolysed films were coded, respectively, as Blend and 
Blend-NH2, while the coated films were coded as Blend-nL, where n represented the number of 
deposited layers. 
The coating characterization was performed as a function of the deposited layer number. 
5.2.3  Sample characterization 
5.2.3.1 Water contact angle measurement 
The static water contact angles of film surfaces were determined through a sessile drop method, 
using a 6 µl double distilled water droplet. Static contact angles of films were measured in air at 
room temperature in a VCA Optima (AST, Massachusetts, USA) instrument equipped with a 
VCA Optima XE software for data acquisition. 
5.2.3.2 Infrared analysis in ATR modality 
The analysis was carried out in a Perkin Elmer Frontier Optical Spectrometer fitted with an 
attenuated total reflection sampler (FTIR-ATR, Massachusetts, USA). Spectra were obtained 
over the 400-4000 cm
-1
 range at room temperature, using diamond crystal. 
5.2.3.3 Colorimetric method to quantify amino groups 
The determination of the density of amino groups on modified (Blend-NH2 and LbL coated 
Blend) and control Blend film surfaces was performed by Kaiser Test (Sigma-Aldrich, Milano, 
Italy), that is based on Ninhydrin reaction with NH2 terminal groups, that leads to the formation 
of a purple compound (Fig. 5.4). 
 
Fig. 5.4 Reaction of Ninhydrin with amino groups, resulting in a purple compound. 
 
In detail, the Kaiser reagents were added to squared samples (0.5 cm
2
) in the following order 
and amounts: 75 μl of Phenol, 100 μl of KCN, 75 μl of Ninhydrin. The mixtures were heated at 
100 °C for 5 min and then diluted with ethanol/water 60/40 (v/v). The obtained solutions were 
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filtered by using GHP membrane filters (pores diameter 0.45 μm) in order to avoid light 
scattering phenomena, due to the presence of polymer particles inside the solution, that can 
cause a significant shift of the baseline during the UV test. The optical absorbance of the Kaiser 
product was recorded at a wavelength interval between 450 and 740 nm, with a 
spectrophotometer (Perkin Elmer Lambda25 UV/VIS Spectrometer). It is known that the 
amount of free amino groups in the test sample, after heating with ninhydrin, is proportional to 
the maximum optical absorbance (A) of the solution at 570 nm [29]. 
The measurements were taken over three replicate samples and then averaged. Starting from the 
averaged absorbance value (A), the molar extinction coefficient ε (15000 M-1 cm-1) and the path 
length b (1 cm), the molar concentration of the diluted solution (C) was obtained through 
Lambert-Beer law: 
        
From this molar concentration and the final volume (after dilution), the number of NH2 moles 
on surface samples was calculated. 
5.2.3.4 Morphological analysis 
The surface morphologies were visualized using scanning electron microscopy (FEI Inspect F-
50 FE-SEM, Oregon, USA). Each sample was coated with an ultrathin platinum (Pt) as a 
conductive layer for better quality image. 
5.2.3.5 Quartz crystal microbalance analyses 
LbL film build up for (CHS/CH)10 films was monitored in situ by dissipative quartz crystal 
microbalance (QCM-D), using a Q-Sense E4 unit (Q-sense, Sweden). Changes in frequency 
(Δf) and energy dissipation (ΔD) were measured at the fundamental frequency of the crystal (f 
= 5 MHz) as well as at the third, fifth, and seventh overtones (15, 25, and 35 MHz, 
respectively). The gold coated crystals used in the experiments were used as received, just 
rinsed several times with demineralised water and ethanol and then dried prior to the 
experiments. Analysis started with the system primed with a 0.2M NaCl solution (buffer 
baseline). Then, polyelectrolyte (PE) films were formed by injecting 400 μL of the PE solution 
(CHS or CH) into the measuring cell, allowing 15 min for adsorption, followed by rinsing with 
2000 μL of 0.2M NaCl solution. This procedure continued until 10 bilayers were deposited. The 
film thickness was calculated from the frequency and energy dissipation data using QTools 
software and the Voigt-based viscoelastic model proposed by Voinova et al. [30, 31]. For these 
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calculations, the polyion film density was assumed to be 1200 kg/m
3
 and the 0.2M NaCl buffer 
fluid density and viscosity were assumed to be 1000 kg/m
3
 and 1 mPa·s, respectively [32]. 
5.2.3.6 Fluorescence microscopy 
To further evaluate the build up of LbL nanocoating, CH was conjugated with fluorescein 
isothiocyanate (FITC-CH) as decribed by Huang et al. [33]. Samples coated with CHS and 
FITC-CH were analyzed under a fluorescence microscope (Nikon ECLIPSE TE2000-U). 
Photomicrographs were taken using a 100 W mercury arc light source with a standard 
fluorescein (490 nm excitation/520 nm emission) filter set. Blend, Blend-NH2 and Blend-nL 
(where n = 1, 2, 6, 10, 16, 20 layers) films were analysed. To quantify and compare the 
differences in fluorescence signal, the images were evaluated with Matlab 2012a. The green 
channel was extracted and the intensity was calculated as the mean value of the resultant matrix. 
5.2.3.7 Cell proliferation and adhesion 
Mouse embryonic fibroblast NIH 3T3 cells were supplied by American Type Culture Collection 
(ATCC, Virginia, USA) and grown in Dulbecco's modified Eagle's medium (DMEM; ATCC) 
supplemented with 10% Calf Bovine Serum (CBS; Gibco, Invitrogen) and 1% 
penicillin/streptomycin (Invitrogen). A cells concentration of 5 × 10
4
 was seeded on the films 
and incubated at 37 °C in a humidified atmosphere of 5% CO2. Cell Crown
TM
 inserts (Scaffdex, 
Tampere, Finland) were used to fix the films at the bottom of the wells prior to cell seeding. 
Cell proliferation was assessed using the colorimetric indicator Alamar Blue assay (Life 
Technologies, Ontario, Canada). Media was removed, samples were rinsed once in PBS, and 
300 µL of fresh medium containing a 10% solution of Alamar Blue was added to each well. 
The culture plates were wrapped in aluminum foil and incubated for 4 h at 37 °C in a 
humidified atmosphere of 5% CO2. Absorbance of the extracted dye, which is proportional to 
the number of cells attached to the film, was measured spectrophotometrically with a microplate 
reader (Molecular Devices, SpectraMax i3 multi-mode detection platform, California, USA) at 
wavelengths of 570 and 600 nm. A calibration curve, generated from a known number of 
fibroblast NIH 3T3 cells reacting with the Alamar Blue indicator, was used to quantify the 
number of cells attached on films. 
The morphology of the cells cultured on Blend-based films was examined by SEM (FEI Inspect 
F-50 FE-SEM). Films were washed two times with PBS and fixed in Parafolmaldehyde for 30 
min at room temperature. The films were then washed three times with PBS and dehydrated in 
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increasing ethanol concentrations for 10 minutes. The samples were then dried under vacuum, 
coated with Pt, and examined with SEM. 
5.2.3.8 X-ray photoelectron spectroscopy 
Chemical composition of the modified and control Blend films were investigated by X-ray 
photoelectron spectroscopy (XPS) (PHI 5000 Versaprobe instrument) at a detection angle of 
45°. The characterizations were performed in survey and high resolution (HR) spectra. A 
surface area of 0.005 cm
2
 was analyzed at 25.6 W without charge compensation. 
5.2.3.9 Stability test 
For stability studies, only LbL coated Blend films with optimized number of layers were used. 
Stability test was carried out on 10 x 10 mm
2 
film specimens incubated in 3 ml PBS at 37 °C 
and pH 7.4 for 7 and 14 days. The PBS medium was exchanged once every 2 days. 
Morphological evaluation of the exposed surfaces of film samples at each stability test time was 
performed by FE-SEM according to the procedures described at paragraph 5.2.3.4. Surface 
chemical composition was evaluated through FTIR-ATR and XPS analysis, according to the 
previously described method at paragraphs 5.2.3.2 and 5.2.3.8, respectively. Finally, surface 
wettability properties and the density of amino groups were evaluated through the procedures 
reported on paragraphs 5.2.3.1 and 5.2.3.3, respectively. 
5.2.3.10 Antibacterial assay 
Antibacterial activities of Blend-16L samples were preliminarily investigated against 
Escherichia coli (E. coli) ATCC 25922, a Gram-negative clinical isolate, and Staphylococcus 
aureus (S. aureus) ATCC 6538, a Gram-positive strain isolated from human lesion. Both strains 
were supplied from Belgian Coordinated Collections of Microorganisms (BCCM) and play an 
important role in human infections and biofilm formation on medical devices [34]. 
E. coli and S. aureus strains were grown overnight in Luria–Bertani (LB) agar at 37 °C. Then, 
bacterial suspensions at the concentration of 1.5  108 Colony Forming Units per milliliter 
(CFU/mL) were prepared and dispersed uniformly onto the surface of Müller-Hinton agar 
plates. Disk-shaped samples of Blend-16L (about 1.2 cm diameter) were UV sterilized for 15 
min and subsequently laid on the top of the inoculated plates. After 24 h of incubation at 37 °C, 
the diameter of inhibition against the two bacterial strains was measured and compared with 
that of Blend control samples. 
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5.2.4  Statistical analysis 
All data are expressed as means ± standard deviation. Differences between means were 
analyzed by one-way ANOVA followed by a Tukey’s post hoc test. For in vitro cell test, 
statistical analysis was performed using two-way ANOVA with the Bonferroni’s post test. All 
statistical analysis were performed with Prism, Graph Pad Software. 
5.3 Results and discussion 
5.3.1  Characterization of aminolysis treatment  
Aminolysis represented the first coating step, activating sample surface for subsequent covering 
by LbL method. Blend films were incubated in 1,6-hexamethylenediamine/1-propanol solutions 
in order to form surface NH2 amino moieties that, after protonation into NH3
+
 positively 
charged groups, allowed the deposition of the first polyanion layer by LbL technique. 
The process parameters to be accurately selected in order to optimize the aminolysis procedure 
were the concentration (C) of aminolysing solution and the time (t) of the treatment, while the 
temperature of the solution was maintained constant at 37 °C. Different experimental conditions 
were tested to find the optimal values of aminolysis parameters. Samples aminolysed at each 
experimental condition were analyzed through contact angle measurement, SEM and FTIR-
ATR analyses, and amount of free amino groups introduced on the surface. 
The aminolysis treatment has been reported to cause an increase of surface hydrophilicity and, 
consequently, a decrease of water contact angle values. Moreover, this phenomenon appeared 
more pronounced with increasing the treatment time and the concentration of aminolysing 
solution [9]. Fig. 5.5 shows the influence of the different process parameters on Blend-NH2 
surface wettability. 
 
Fig. 5.5 Average contact angle values measured on untreated Blend samples (Ctrl) and on Blend-NH2 films aminolysed 
at 37 °C. using different process conditions. 
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A statistically significant increase of surface wettability was observed after the aminolysis 
process, compared to unmodified Blend film (*** P < 0.01), confirming the successful 
introduction of amino groups. At the same aminolysis reagent concentration, the water contact 
angle value did not decrease proportionally with increasing the treatment time. In fact, 
aminolysis may cause polymer degradation with the formation of cracks and surface roughness, 
affecting the water contact angle values. At each concentration, the effect of treatment time on 
surface morphology was thus analysed. The SEM images reported in Fig. 5.6 show the 
influence of aminolysis time on polymer surface morphology. 
 
Fig. 5.6 SEM images of untreated Blend and aminolysed Blend-NH2 films at 37 °C as a function of solution 
concentration (where C1 = 0.06 g/ml, C2 = 0.08 g/ml, C3 = 0.1 g/ml) and treatment time (namely 4, 8, 12, 16, 20 min). 
Scale bar = 100 μm. 
 
Blend films showed pronounced superficial degradation at longer incubation time: after 16 and 
20 min of treatment, formation of surface cracks and pores could be observed, independently 
from solution concentration. These results could explain the lack of a trend in the water contact 
angle values as a function of treatment time. 
By comparing both the surface morphology and the static contact angle, it was possible to select 
these optimal treatment parameters: 
 C = 0.06 g/ml  t = 12 min 
 C = 0.08 g/ml  t = 8 min 
 C = 0.1 g/ml  t = 8 min. 
SEM analysis showed that surface morphology was not significantly different among the 3 
selected samples, as compared to control untreated Blend samples. With increasing reagent 
concentration, the optimal aminolysis time decreased (at fixed temperature). These results 
showed that it is necessary to adjust aminolysis solution concentration and treatment time to 
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obtain a significant increase of surface wettability via aminolysis treatment and avoid polymer 
degradation. In details, using a solution with a lower concentration, a longer exposition time is 
requested; on the contrary, if the solution concentration is higher, a shorter treatment time is 
necessary. 
Further characterizations have been performed on samples aminolysed with the parameters 
reported above. A colorimetric assay, based on Ninhydrin reaction with NH2 terminal groups, 
was applied to quantify the amino groups density on aminolysed Blend-NH2 samples. Fig. 5.7 
shows the results obtained from the analysis. 
 
Fig. 5.7 Amino groups density on not treated Blend samples and aminolyzed films using the optimal treatment 
parameters. 
 
Blend samples physically adsorbed Ninhydrin molecules. After the three aminolysis treatments, 
the quantity of adsorbed molecules significantly increased as a consequence of the introduction 
of surface amino groups on Blend film surface. However, no differences could be observed 
between the three processes, leading to amino groups densities of around 0.07 μmol/cm2. 
Finally, aminolysed Blend films were characterized by FTIR-ATR analysis to verify the 
effectiveness of the treatment through the chemical analysis of the surface. Fig. 5.8 compares 
FTIR-ATR spectra of untreated and aminolysed films. 
 
Fig. 5.8 FTIR-ATR spectra of the surface of untreated Blend film and samples aminolysed with the optimal treatment 
parameters. 
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Characteristic peaks of polyesters could be observed in all the analyzed samples, namely, the 
strong absorption band at about 1750 cm
-1
 attributed to the stretching vibration of C=O bond 
and the absorption bands in the 1000-1184 cm
-1 
interval region related to the ester bond (C–O–
C ether group stretching) [35]. FTIR-ATR spectra of aminolysed films evidenced three 
additional peaks, suggesting the success of the aminolysis process: the broad peak between 
3600 cm
-1
 and 3200 cm
-1
 attributed to the stretching vibrations of the N-H/O-H; the wide band 
in the 1650-1600 cm
-1
 region associated to amide I stretching vibration; the peak at around 1550 
cm
-1
 arised from amide II bending vibration [36]. The intensity of these new peaks increased 
with increasing the aminolysis solution concentration. 
Based on the performed characterizations, no significant differences in the surface 
functionalization with NH2 was observed for the three samples. Therefore, the following 
aminolysis parameters were selected: 
C = 0.08 g/ml 
t = 8 min. 
as they caused a more significant reduction of static contact angle value (as a consequence of 
the formation of surface hydrophilic amino groups), without affecting surface morphology of 
Blend-NH2 samples. 
5.3.2  Characterization of multilayer coating  
5.3.2.1 CHS/CH film build up 
Frequency shifts (ΔF/v) and changes in energy dissipation (ΔD) overtime for the build up of 
(CHS-CH)10 multilayers film, as monitored via QCM-D, are presented in Fig. 5.9. 
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Fig. 5.9 Plots of change in dissipation (ΔD, right axis) and QCM frequency shifts (ΔF/v, left axis) over time during the 
deposition of a (CHS/CH)10 film. Frequency was monitored at the third (●), fifth (▲), and seventh (■) overtones of the 
fundamental frequency, corresponding to 15, 25, and 35 MHz, respectively. 
 
Qualitatively identical evolutions could be observed with increasing number of absorption steps 
for the distinct harmonics. As each polyelectrolyte (PE) was injected into the system, a decrease 
in frequency was observed corresponding to an increase in film mass, thus indicating LbL 
deposition. The frequency decay for each CHS/CH deposition step was more pronounced for 
lower frequencies. Regarding ΔD, an increase was detected after each CHS and CH injection 
due to the non-rigid adsorbed layer structure of the film that was forming onto the crystal 
surface. When rinsing with NaCl after CHS and CH adsorption, a small upturns in the 
frequency curve and downturns in the dissipation curve could be identified, suggesting small 
amounts of polymer desorption. 
The normalized frequency shift (-ΔF/v) for each bilayer number (Fig. 5.10 a) showed a non-
linear growth regime [37], with higher bilayer numbers (above 5
th
) exhibiting an increased 
growth rate. Equally, larger dissipation changes were observed at higher bilayer numbers, 
indicating that CHS/CH films became more viscoelastic as they grew. 
The viscoelastic nature of (CHS/CH)10 films, as indicated by the large dissipation changes, and 
the differences in the frequency curve decrease for the three overtones revealed that the 
adsorbed layer did not obey the Sauerbrey equation [38], which directly relates frequency shift 
data to mass absorbed for rigid films. Indeed, the Voigt-based viscoelastic model [24, 39] was 
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applied to the frequency and dissipation data measured at the third, fifth, and seventh overtones. 
Thus, it was possible to estimate the thickness during the building of the film (Fig. 5.10 b). 
 
Fig. 5.10 (a) Normalized frequency shift (-ΔF/v) data for each bilayer number. Frequency was monitored at the third 
overtone of the fundamental frequency (□), its fifth (▲) and seventh (○) overtone. (b) Increase in PE multilayer 
thickness over time, during the successive polymer layer deposition, calculated with the Voigt model. 
 
It was found that the film thickness increased linearly for the first 5 bi-layers, at a rate of ca. 40 
nm per layer. After the deposition of the 5
th
 bi-layer, the growth regime changed and an 
exponential trend was observed, yielding (CHS/CH)10 multilayers at 760.7 ± 21.5 nm thick 
(data is the average of three representative experiments). 
5.3.2.2 Contact angle measurement 
Multilayer construction offers many possibilities to change the wettability of substrates since 
there are a variety of components that can be chosen as polyanion or polycation. The gradual 
build up of multilayers was expected to modify the wettability of LBL-modified Blend-NH2 
films. This was confirmed by measuring the contact angles with distilled water (Fig. 5.11). 
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Fig. 5.11 Water contact angle as a function of the number of coating layers. The even layer numbers correspond to 
chitosan (CH) as the outermost layer; the odd layer numbers correspond to chondroitin sulfate (CHS) as the outermost 
layer. The number 0 corresponds to Blend-NH2 film. 
 
The contact angle initially did not change significantly with increasing layer numbers for the 
first 4 layers. This phenomenon could be interpreted considering that the substrate surface was 
not fully covered by the outermost layer component during the initial 4 layer coating steps. 
Thus, the surface of the first layers is composed of CHS/CH and some uncoated Blend-NH2 
film. These results were consistent with those found in other studies [40]. From the five-layers 
coating, the contact angle began to jump alternatively between 45° and 65° relying on the 
outmost layer component. The typical alternate trend of static contact angle suggested the 
correct deposition of the LbL coatings and at least five layers were necessary to deposit uniform 
interfaces. This alternate change in contact angle was also reported in other work in the 
literature [33, 41]; therefore, the wettability of coated Blend-NH2 films was controlled by the 
outmost coating component. However, after the deposition of the 16
th
 layer, CH outmost layers 
decreased their contact angle. Liu et al. [42] explained this phenomenon as a layer 
interpenetration between neighboring CH and CHS layers, where the segments of the 
underlying layer are able to influence the surface hydrophilicity. 
5.3.2.3 Fluorescence microscopy 
The analysis has been conducted on coated films to further evaluate the build up of LbL 
nanocoating. FITC-CH was substituted to the normal one during the deposition steps and its 
distribution on sample surfaces was monitored. Pristine Blend sample was selected as control. 
Fig. 5.12 shows the images of films intrinsic fluorescence and changes in fluorescence signal 
with the increase in layer numbers. 
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Fig. 5.12 Images of fluorescence microscopy and changes in fluorescence signal intensity for Blend, Blend-NH2 and 
Blend-XL films (where X = 1, 2, 6, 16, and 20 alternate CHS/FITC-CH layers). 
 
Blend and Blend-1L substrates were dark when observed under a fluorescence microscope. 
After the deposition of the first FITC-CH layer (Blend-2L), a fluorescence phenomenon could 
be observed, corresponding to a statistically significant increase of fluorescence signal intensity 
compared to previous values (*** P < 0.01). No changes in signal intensity values were 
detected between Blend-2L and Blend-6L. After the deposition of the 6
th
 FITC-CH layer, the 
fluorescent intensity was found to linearly increase with increasing the FITC-CH layer 
numbers, demonstrating that the multilayer was built up in a LbL manner. Statistical analysis 
found significant difference between uncoated and LbL coated samples and between films 
coated with different number of layers (*** P < 0.01). In addition, fluorescence of CHS/FITC-
CH-coated substrates was uniformly distributed over the entire film surface with only some 
bright dots. This suggested a continuous coating of sample surface at the micrometer scale, 
while the bright areas could be attributed to a higher local concentration of FITC-CH. 
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5.3.2.4 Morphological analysis 
SEM images were used to verify if the acid pH (4.5) employed for the deposition of the layers 
could cause any change of the sample surface, such as increased roughness and formation of 
cracks. Fig. 5.13 shows the surface morphology of Blend, Blend-NH2, and Blend-nL films 
(where n = 5, 6, 9, 10, 15, 16, 19, and 20 layers). 
 
Fig. 5.13 SEM images of Blend, Blend-NH2, and Blend-NH2 samples coated with 5, 6, 9, 10, 15, 16, 19 and 20 alternate 
CHS/CH layers. Scale bar = 50 μm. 
 
Blend was characterized by a relatively smooth surface. After aminolysis and deposition of LbL 
nanocoating, surface roughness increased. 
Surface integrity was preserved up to the deposition of the 16
th
 layer while sample treatment in 
polyelectrolyte and washing solutions at pH 4.5 caused surface degradation phenomena and the 
formation of pores. Shown by water contact angle analysis, the same outmost layer did not 
present the same contact angle when increase the layer number. This result could be due both to 
layer interpenetration and to the presence of pores on sample surface. 
Based on morphological results, the maximum number of layers deposited on Blend-NH2 films 
was 16, to avoid sample surface morphological alteration. 
5.3.2.5 FTIR-ATR analysis 
Chemical composition of Blend films coated with alternate layers of CHS and CH through LbL 
technique, was investigated by FTIR-ATR analysis. Fig. 5.14 compares FTIR-ATR spectra of 
untreated, aminolyzed and n-layers coated Blend films, where n = 5, 6, 9, 10, 15, 16. 
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Fig. 5.14 FTIR-ATR spectra of Blend, Blend-NH2 and Blend-nL films (where n = 5, 6, 9, 10, 15, 16 layers). 
 
Characteristic peaks of polyesters, already described in paragraph 5.3.1, could be observed in 
all the analyzed samples. FTIR-ATR spectra of LbL coated and Blend-NH2 films evidenced 
three additional bands, attributed to aminolysis modification and the presence of CHS and CH: 
the broad peak between 3600 cm
-1
 and 3200 cm
-1
 attributed to the stretching vibrations of the 
N-H/O-H; the wide band in the 1650-1600 cm
-1
 region associated to amide I stretching 
vibration; the peak at around 1550 cm
-1
 arised from amide II bending vibration. The intensity of 
these new peaks increased with increasing the number of deposited layer. However, the typical 
absorption band of CHS sulfonate groups (S=O stretching at around 1230 cm
-1
) was not 
detected in FTIR-ATR spectra of LbL coated Blend samples, as it was masked by the intense 
C=O bending and C-O-C stretching bands of polymers, in the 1300-1000 cm
-1 
wavenumber 
region [43, 44]. FTIR-ATR results suggested that multilayer deposition of CHS and CH 
polyelectrolytes on aminolyzed samples was successful. 
5.3.2.6 Cell proliferation and adhesion 
Fibroblast proliferation at 1 and 3 days was evaluated with Alamar Blue assay and results are 
shown in Fig. 5.15. Cells grown on Petri dishes were used as control. 
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Fig. 5.15 Cell proliferation on Blend, Blend-NH2, and Blend-nL films (where n = 5, 6, 9, 10, 15, 16 layers) as a function 
of time. Cells grown on petri dish were used as control (Ctrl). 
 
The number of cells increased on all samples after 1 culture day compared to the initial seeded 
amount. Moreover, all samples displayed an increase in cell number from 1 to 3 days of culture 
and no marked differences could be observed on anionic- and cationic-terminating layers. 
In detail, a significantly lower cell number was observed on aminolysed Blend films at day 1 
compared to unmodified Blend samples, while no marked differences in the number of cells 
adhered to Blend and Blend-NH2 films could be detected after 3 days in culture. A similar cell 
response was found also by Zhu et al. [45] with aminolysed PCL films. Compared to Blend-
NH2, the deposition of 5 layers did not affect cell response at day 1, which could be due to 
incomplete coverage of the substrate as already suggested by water contact angle analysis. On 
the contrary, a slight increase in cell number after 1 day could be observed for a higher layer 
number than 6, reaching values comparable to Blend and Ctrl for Blend-15L and Blend-16L 
films. After 3 days of culture, the number of cells proliferated on coated samples with 5-10L 
was comparable to that on unmodified Blend substrates and lower than for the Ctrl. The number 
of cells was higher after the deposition of 15 and 16 layers, showing comparable results to Ctrl. 
The morphology of the fibroblasts seeded on Blend-based substrates after 3 days of culture was 
compared (Fig. 5.16). 
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Fig. 5.16 SEM morphology of fibroblast cells grown on Blend, Blend-NH2 and Blend-nL films (n = 5, 6, 9, 10, 15, 16) 
after seeding cells for 3 days. Scale bar = 100 µm. 
 
Cells randomly adhered on both control Blend and modified Blend films, without preferred 
directions. However, fibroblasts attached on Blend and Blend-NH2 films, and on samples with 
cationic-terminating layers were more stretched and showed the typical star-like morphology of 
spreading fibroblast. Cells developed numerous cellular processes (lamellipodia and filopodia) 
to facilitate cell–substrate and cell–cell interactions. On the contrary, cell morphology on 
substrates coated with 5, 9 and 15 layers showed that NIH 3T3 cells did not spread but 
remained rounded. 
Considering cell proliferation as the basis of forming tissue, the results suggested that CHS/CH 
coating was helpful for improving cell growth and in turn tissue formation. In particular, the 
CH-terminating polyelectrolyte layer markedly improved fibroblast adhesion. Generally, the 
factors that affect the cell adhesion are considered to be the hydrophobic/hydrophilic property, 
electric charge, surface morphology, and the surface functional groups of a biomaterial. Cell 
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adhesion may be mediated by interactions of the positively charged materials with cell 
membranes or by cellular uptake and subsequent activation of intracellular signal transduction 
pathways [46]. Thus, the improved cell adhesion for samples coated with CH-terminating layers 
was due to the electrostatic interactions with the negatively charged surface of the cell 
membrane. On the contrary, the negative charge on the CHS-terminating layer slightly inhibited 
the formation of initial cell contact due to the electrostatic repulsion interactions. 
Due to the results obtained from the proliferation and the adhesion tests, 16 layers were selected 
as optimal number of layers for our application. 
5.3.2.7 XPS analysis and CH quantification 
Once Blend samples were aminolysed under the selected optimal process parameters (C = 0.08 
g/ml; t = 8 min; T = 37 °C) and subsequently coated via LbL technique with the optimized 
number of layers (namely, 16 layers), they were characterized by XPS analysis to verify the 
effectiveness of the aminolysis treatment and the presence of the two deposed polyelectrolytes 
(CHS and CH) in the LbL coating. Fig. 5.17 compares XPS spectra of untreated, aminolysed 
and LbL functionalized Blend films. 
 
Fig. 5.17 XPS spectra of Blend, Blend-NH2, and Blend-16L films. 
 
In the reported spectra, peaks due to surface activation and functionalization were present. The 
characteristic compositional peaks of Blend-based films were detected at around 530 eV, 
associated with the presence of oxygen (O1s), and at around 285 eV, due to the presence of 
carbon (C1s). The presence of primary amino groups (-NH2) on the surface of aminolysed 
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sample was confirmed by the appearance of N1s peak at around 400 eV. The deposition of 16 
alternate layers of CHS and CH caused the appearance of the S2p peak, confirming the 
successful deposition of CHS layers, and a marked increase of N1s peak intensity compared to 
aminolysed sample, suggesting the successful deposition of CH layers. Moreover, peaks 
associated to the buffer employed for the preparation of polyelectrolyte solutions could be 
observed on Blend-16L spectra, namely Na1s at about 1100 eV and Cl2p around 200 eV. In 
addition, a double N1s peak was observed after the deposition of 16 layers as compared to 
Blend-NH2 film (Fig. 5.18) indicating the presence of both un-protonated amino groups (-NH2) 
and protonated amino groups (NH3
+
), at about 398 and 400 eV respectively. 
 
Fig. 5.18 High resolution XPS spectra of N1s for Blend-NH2 and Blend-16L films. 
 
Table 5.1 shows the chemical composition of Blend, Blend-NH2 and Blend-16L films. 
Aminolysis was effective, in fact the percentage of N on Blend film surface increased from 0 
mol% to 0.7 mol% after the treatment. LbL method was effective and the amount of CHS and 
CH increased. In fact, the percentage of S, which was zero after aminolysis, became 0.1 mol% 
while the percentage of N increased from 0.7 mol% to 7.7 mol%. 
Table 5.1 XPS chemical composition of untreated, aminolysed and 16-layers coated Blend films. 
Sample Atomic percentage (mol%) 
C1s O1s N1s S2p Na1s Cl2p 
Blend 65.9 29.7 - - - - 
Blend-NH2 63.0 35.4 0.7 - - - 
Blend-16L 55.8 29.7 7.7 0.1 2.9 2.0 
 
A colorimetric assay (Kaiser test) was applied to quantify NH2 density on Blend-16L films. The 
density on untreated, aminolysed and coated samples is shown in Fig. 5.19. The deposition of 
CH layers caused a marked increase of amino groups concentration that was less than 0.08 
µmol/cm
2
 for Blend-NH2 films whereas it was around 0.2 µmol/cm
2
 after the LbL deposition. 
These results further demonstrated the successful deposition of the multilayer nanocoating. 
165 
 
 
Fig. 5.19 Amino groups concentration on untreated and aminolysed Blend samples, and coated Blend films with 16 
layers. 
 
5.3.2.8 Antibacterial efficiency 
CH, a naturally occurring, biocompatible, cationic antibacterial polysaccharide has been shown 
to disrupt bacterial cell membrane integrity [23, 47]. Although many mechanisms of action 
have been proposed, CH and its derivatives have been shown to bind to the negatively charged 
bacterial cell membrane and cause leakage, both when used in solution and when immobilized 
on surfaces [48]. When suitably assembled in a PEM, CH cationic charges are able to interact 
with bacteria that attempt to adhere to the surface [49]. 
In this work, both Gram-positive (S. aureus) and Gram-negative (E. coli) bacteria were used to 
evaluate the antibacterial efficacy on Blend-16L films by visualizing the zone of inhibition. Fig. 
5.20 shows the results of the test, which was conducted on untreated and coated samples. 
 
Fig. 5.20 Antibacterial efficacy on Blend (C) and Blend-16L (T) against S. aureus and E. coli evaluated by zone of 
inhibition assay. 
 
No antibacterial activity was observed on all the analysed samples. Two hypothesis could 
explain the results. First, the amount of CH introduced on Blend surface through the LbL 
technique was not enough to observe an antibacterial effect. In fact, as reported in literature, 
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antimicrobial activity of CH was influenced by several factors, including a dose-dependent 
growth-inhibitory effect [50]. Secondly, the test performed was not enough sensitive for this 
material. Thus, more extensive tests will be performed (i.e. antimicrobial activity assay in liquid 
through viable cell counting method) and improvements to the antibacterial activity of the 
nanocoating will be carried out (i.e. introduction of silver nanoparticles or antimicrobial drugs 
onto the LbL coating). 
5.3.2.9 Dissolution feature of coating 
The dissolution process of the optimised LbL nanocoating was studied by physicochemical and 
morphological analyses. Table 5.2 collects data from water contact angle measurements, NH2 
quantification and XPS analysis for Blend-16L films, before and after 7 and 14 days of 
incubation in PBS at 37 °C. 
Table 5.2 Contact angle values, amount of amino groups and XPS chemical composition of Blend-16L films before and 
after incubation in PBS at 37 °C for 7 and 14 days. 
Sample Time 
(days) 
Contact 
angle (°) 
NH2 
concentration 
(µmol/cm
2
) 
Atomic percentage (mol%) 
C1s O1s N1s S2p 
Na1s Cl2p 
Blend-
16L 
0 57.9 ± 6.4 0.20 ± 0.02 55.8 29.7 7.7 0.1 2.9 2.0 
7 52.9 ± 2.7 0.24 ± 0.02 60.5 34.6 4.3 0.1 - - 
14 62.8 ± 2.7 0.22 ± 0.01 62.7 36.4 < 0.1 0.1 - - 
 
A marked decrease in the content of nitrogen could be observed: after 14 days of incubation, 
nitrogen was no more detectable (< 0.1 mol%). On the contrary, the atomic percentage of S2p 
remained constant. 
The incubation of samples in PBS for 7 days did not change the surface wettability properties of 
Blend-16L. Increasing the immersion time at 14 days, slight variation of surface hydrophilicity 
could be observed, leading to a contact angle value of about 63° (* P < 0.01 comparing with 
Blend-16L incubated for 7 days). Regarding the quantification of amino groups, no significant 
changes could be observed after the incubation in PBS. 
The coating dissolution test demonstrated that the optimised CHS/CH multilayer coating was 
probably released/degraded in 14 days. The release of CH cationic antibacterial polymer was 
considered of great value to avoid bacterial infection [51]. Then, the coating dissolution was 
sustained for at least 14 days, which could be the key for inhibition of the bacteria and thereby 
to aid tissue regeneration. 
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5.4 Conclusions 
LbL self-assembly is a simple and versatile method for the modification of biomaterial surfaces. 
In this work, CHS and CH were employed to surface engineer polyester blend films by LbL 
with the aim to improve fibroblast NIH 3T3 cell response and, at the same time, to confer 
antibacterial efficacy. 
Blend sample surface was pre-modified to introduce positively charged groups which are 
necessary for the stable deposition of the first LbL layer. Aminolysis treatment was performed 
on Blend films, varying concentration of aminolysing solution and reaction time, in order to 
find out the optimal aminolysis treatment parameters through a physicochemical analysis. 
The film surface characterization allowed to select the optimal parameters of the priming 
treatment: C = 0.08 g/mL, t = 8 min and T = 37 °C. These processing conditions allowed a 
significant reduction of static contact angle without affecting surface morphology of Blend film, 
as demonstrated by SEM analysis. The formation of amino groups was verified by XPS and 
FTIR-ATR analysis. 
After aminolysis treatment, LbL coating was performed on activated Blend films. The success 
of the coating and the change in surface properties were confirmed by combined techniques. 
The successful deposition of the multilayer coating based on CHS and CH and its nanometric 
thickness was confirmed by QCM-D analysis. Contact angle analysis suggested an even coating 
after the deposition of five layers: for that samples, the surface wettability was dominated by the 
outmost coating layer. Fluorescence microscopy and FTIR-ATR analysis verified the growth of 
CHS and CH layers on Blend-NH2 films. Finally, SEM images did not show degradation 
phenomena for films coated with less than 16 layers. 
In vitro investigations were also performed. Coated Blend films exhibited stronger ability for 
fibroblast cells attachment expecially for samples coated with 15 and 16 layers and with 
cationic-terminating polyelectrolyte layers. The optimal number of layers for our application 
was selected to be 16 and further characterization was performed.  
XPS analysis confirmed the presence of the polyelectrolytes on the coated sample and the 
amount of amino groups significantly increased after the deposition of the coating. The 
polyelectrolytes release was sustained for at least 14 days but no antibacterial activity was 
observed on all the analysed samples. 
In summary, it can be concluded that both the aminolysis treatment and the LbL coating were 
carried out with success and optimized. The introduction of CHS and CH onto Blend surface 
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improved Blend biocompatibility properties but further improvements are needed in terms of 
antibacterial activity. 
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6 
Composite porous membranes 
for bone tissue regeneration 
 
Abstract 
Guided tissue regeneration (GTR) represents a promising approach for periodontal tissues 
regeneration in periodontal loss, because it isolates the healing tissue from migration of 
epithelial and gingival connective tissue cells and allows bone tissue cells to repopulate the 
bony defect. The aim of the work described in the current chapter was the preparation and 
characterization of three dimensional sponge-like composite membranes for GTR applications 
fabricated by freeze-drying, with a similar composition to that of natural bone, and based on β-
tricalcium phosphate (TCP) dispersed in a chitosan/gelatin (CH/G) network cross-linked with 
genipin (GP) and disodium phosphate salt (DSP). Three kind of membranes were developed: 
CH/G, CH/G+GP-DSP and CH/G/TCP+GP-DSP. They were characterized in terms of their 
cross-linking degree (Kaiser test), morphology (SEM analysis), chemical structure (EDS and 
FTIR-ATR analyses), thermal stability (TGA analysis), tensile mechanical behavior, stability in 
water (water absorption and dissolution tests), and biological response by in vitro cell tests 
using MG-63 human osteoblast-like cells. Successful double cross-linking of CH/G network 
was confirmed by the performed characterizations. All membranes showed a typical foam-like 
morphology with interconnected pores having an average diameter of 100-200 μm. Cross-
linking and the addition of TCP did not change thermal stability of the membrane. On the 
contrary, both cross-linking and TCP presence caused a marked increase of membrane stability 
in water solution, as well as of tensile modulus and maximum tensile strength. In addition, 
compared to uncross-linked samples, CH/G+GP-DSP and CH/G/TCP+GP-DSP membranes 
showed improved cell response, in terms of cell viability and morphology. 
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6.1 Introduction 
Alveolar bone loss is a common finding associated with periodontal degeneration [1]. Various 
treatment modalities have been used to regenerate or fill bony defects using a wide variety of 
surgical approaches, such as barrier membranes, a series of bone grafts and other 
osteoconductive/inductive materials or protein mixtures, and cell-based technologies. However, 
guided tissue regeneration (GTR) represents the most well-documented regenerative procedure 
for obtaining periodontal tissues regeneration in periodontal loss [2]. GTR is effective in halting 
tissue and bone destruction and promoting new tissue and bone formation [3]. A physical 
barrier (membrane) is placed to cover the area in which the regenerative process takes place. 
The membrane prevents migration of unwanted epithelial and gingival connective tissue cells 
into the healing area and allows bone tissue cells to repopulate the bony defect [4]. 
Although a number of barrier membranes (non-absorbable and bioabsorbable) are already being 
used in clinical practice, novel membranes have been developed in an effort to overcome the 
limitations of the currently used devices, namely the weak mechanical and 
osteoconductive/osteoinductive properties. The researchers are developing different approaches 
to meet the demands of degradable GTR membranes in terms of mechanical properties and 
biocompatibility, like the incorporation of bioactive inorganic fillers. 
Devices for bone regeneration should mimic bone morphology, structure and function. Bone is 
composed of an organic phase (17-20 wt%) made of type I and type III collagen (COL) and 
glycosaminoglycans (GAGs), and an inorganic phase (69-80 wt%) made up of hydroxyapatite 
(HAp) [5]. For this reason, composites based on apatite crystals and natural polymers have 
received increasing attention in bone tissue regeneration due to their ability to preserve the 
structural and biological functions of the damaged hard tissues in a biomimetic way. Moreover, 
bone regeneration usually employs three-dimensional (3D) porous materials. The membrane 3D 
porous structure provides the necessary support for the cells to proliferate and maintain their 
differential function, and its architecture defines the ultimate shape of new bone [6]. 
Based on a biomimetic approach, in this chapter, three dimensional sponge-like composite 
membranes based on β-tricalcium phosphate (TCP) and a double cross-linked network of 
chitosan/gelatin were obtained and investigated for GTR applications, having a similar 
composition to that of natural bone. 
Calcium phosphate ceramics are excellent candidates for bone repair and regeneration because 
their chemical compositions are similar to the inorganic component of bone. They were found 
to bond to bone through a layer of bone-like apatite formed on their surface in vivo. In 
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particular, TCP has been shown to be bioactive and biodegradable. The degradation rate of TCP 
is 10 times higher than that of HAp [7]. 
Chitosan (CH) is a partially deacetylated product made from chitin and is structurally similar to 
GAGs [8]. Chitosan is biocompatible, can be degraded by enzymes in the human body and the 
degradation products are non-toxic. CH device with various geometries, pore sizes, and pore 
orientation can be obtained by freezing at a controlled-rate and further lyophilization. CH is 
widely used in biomedical fields due to its many advantages like hemostasis, accelerating tissue 
regeneration and antibacterial property [9-
10
11]. However, for improving its mechanical or 
biological properties, blending with other polymers (i.e. COL or gelatin) has been widely 
investigated [12]. 
Gelatin (G) is a partially degraded product of COL, which has been known to possess 
antigenicity due to its animal origin. In contrast, G has relatively low antigenicity compared to 
its precursor, yet it still retains some of the information signals which may promote cell 
adhesion, differentiation and proliferation, such as the Arg–Gly-Asp (RGD) sequence of COL 
[13]. For this reason, G has been blended with CH to improve its biological activity. 
Chitosan-gelatin devices in both cross-linked and uncross-liked form have been developed and 
tested for the regeneration of various tissues including skin [14], cartilage [15], nerves [16], and 
bone [17]. Chemical and physical cross-linking methods have been used to increase CH/G 
blend stability in aqueous media and mechanical properties. Physical cross-linking methods 
include microwave energy [18], and UV-irradiation [19]. Their main advantage is that they do 
not cause potential harm but it is difficult to obtain the desired cross-linking degree. Commonly 
used chemical cross-linkers include aldehydes (formaldehyde, glutaraldehyde) [20], polyepoxy 
compounds [21] and carbodiimides [22]. The main limitation in the use of chemical cross-
linkers arises from the presence of some unreacted cross-linker inside the CH/G network and 
from the risk of formation of toxic products by reaction between the substrate and the cross-
linking agent during in vivo biodegradation. For this reason, much interest has been addressed 
toward naturally derived cross-linking agents, with a low toxicity. 
Genipin (GP) is a natural cross-linking reagent, used for its ability to cross-link CH and proteins 
containing residues with primary amine groups, particularly G and soy protein isolates [23], 
producing blue-colored hydrogels. It has been used as a cross-linking agent to prepare cartilage 
substitutes, drug carriers, or conduits for peripheral nerve regeneration [24-
25
26]. However, the 
covalent cross-linking reaction between CH/G blend and GP depends on the pH; values 
between neutral and weakly basic conditions (pH 7–9) are favorable for the cross-linking 
reaction [27]. Therefore, in this chapter, CH/G-based solutions were pre-neutralized and 
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ionically cross-linked by dibasic sodium phosphate (DSP) and subsequently covalently cross-
linked by GP to fabricate 3D porous membranes. 
The membranes were prepared by freeze-drying process, that is a conventional technique for the 
fabrication of porous materials which pore structure is controlled by the ice crystal growth. 
Optimal pore diameters for 3D porous structures for bone repair are in the 100-400 μm range 
[28]. Pore size may be controlled by the temperature set in the freeze-drying process: pore 
diameters increase with increasing the temperature due to a higher ice crystal growth rate. Then, 
the physicochemical, morphological and mechanical properties of double cross-linked porous 
membranes were investigated. 
6.2 Materials and methods 
6.2.1  Materials 
Type A gelatin from porcine skin (Mw: 50-100 kDa), chitosan highly viscous derived from crab 
shell with 75-85% deacetylation degree (Mw: 190-310 kDa), β-tri-calcium phosphate (Mw = 
310.18 Da), and dibasic sodium phosphate (Mw = 141.96 Da) were supplied from Sigma-
Aldrich (Milano, Italy). Genipin was purchased from Challenge Bioproducts (Taiwan). All 
solvents used were of analytical grade and used without further purification. 
6.2.1.1  Gelatin 
Gelatin (Fig. 6.1) is a non expensive and commercially available biomaterial that has gained 
interest in biomedical engineering, mainly because of its biodegradability. It is a protein 
produced by partial hydrolysis of COL, the most widespread protein in the body occurring in 
most connective tissues as skin, tendon and bone, that is usually derived from pig-skin with an 
acidic process (type A) or from bovine origin with a basic (lime cured) process (type B) [29]. G 
contains: 84-90% proteins, 1-2% mineral salts, and 8-15% water. It is a heterogeneous mixture 
of single or multi-stranded polypeptides, each with extended left-handed proline helix 
conformations and containing between 50-1000 amino acids. G does not express antigenicity in 
physiological conditions, it is completely resorbable in vivo and its physicochemical properties 
can be suitably modulated [30]. Since biodegradable polymers may be rapidly in vivo 
reabsorbed, cross-linking strategies have been applied to prolong G resistance in vivo and to 
improve its mechanical properties [31]. 
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Fig. 6.1 Gelatin (G) chemical structure. 
 
6.2.1.2  β-tricalcium phosphate  
β-tricalcium phosphate (Fig. 6.2) is the beta crystal form of tricalcium phosphate, a calcium salt 
of phosphoric acid with the chemical formula Ca3(PO4)2, with a Ca/P ratio of 1.5. It is widely 
used in orthopedic and alveolar reconstruction surgery due to its high bioactivity properties and 
its biodegradability. TCP and, generally, all calcium phosphate ceramics are absorbed by 
phagocytosis. 
 
Fig. 6.2 β-tricalcium phosphate (TCP) chemical structure. 
 
TCP has also the potential to function as a source of calcium and phosphate ions for the local 
tissue during the degradation process, which possibly results in stimulation of osteoblastic 
function and promotion of bone formation.  
6.2.1.3  Genipin 
Genipin (Fig. 6.3) is a hydrolytic product of geniposide, an iridoid glucoside isolated from the 
fruits of Genipa Americana and Gardenia jasminoides Ellis. Because it is a naturally occurring, 
biodegradable molecule with low cytotoxicity, GP has found applications in herbal medicine 
[32], whereas the dark blue pigments obtained by the reaction of GP with primary amines have 
been used in the fabrication of heat, pH and light resistant food dyes [33]. It has also been 
investigated as a cross-linking material in many biological applications. 
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Fig. 6.3 Genipin (GP) chemical structure. 
 
GP possess cross-linking activity towards amino containing materials [11]. The cross-linking 
reaction mechanisms between biopolymers containing primary amine groups and GP are 
different at different pH values as reported in Fig. 6.4. Under acidic and neutral conditions, a 
nucleophilic attack by the amino groups of biopolymer on the olefinic carbon atom at C-3 
occurs, followed by opening of the dihydropyran ring and attack by the secondary amino group 
on the newly formed aldehyde group. In other words, GP acts as a dialdehyde but its 
condensation products are much more stable compared to glutaraldehyde [28]. In the product, 
short chains of condensed GP act as cross-linking bridges. Under basic conditions, the ring-
opening reaction of GP occurs via a nucleophilic attack by hydroxyl ions in aqueous solution to 
form intermediate aldehyde groups, which subsequently undergo aldol condensation. The 
terminal aldehyde groups on the polymerized GP undergoes a Schiff reaction with the amino 
groups on biopolymer to form cross-linked networks. Therefore, the pH condition plays an 
important role in influencing the cross-linking reactions. 
 
Fig. 6.4 Cross-linking reactions involving GP, (a) first stage of the reaction (nucleophylic attack) and (b) second stage 
of reaction (nucleophylic substitution). 
 
Butler et al. [34] found that the fastest reaction is a nucleophilic attack of an amino group of CH 
to carbon 3 of GP which results in the opening of the dihydropyran ring and the formation of a 
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tertiary amine, i.e. a GP derivative linked to a glucosamine unit. The subsequent slower reaction 
is a nucleophilic substitution of the ester group of GP to form an amide. Simultaneously, 
polymerization can take place between GP molecules already linked to amino groups of CH 
which could lead to the cross-linking of amino groups by short GP olygomers. The dark-blue 
coloration of samples is associated with the oxygen radical-induced polymerization of GP as 
well as its reaction with amino groups. 
6.2.1.4  Dibasic sodium phosphate  
Dibasic sodium phosphate (Fig. 6.5a) is an inorganic compound with the formula Na2HPO4. It 
is one of several sodium phosphates, it is highly hygroscopic and water soluble. Recently, it has 
been investigated as a cross-linking material for biomedical applications [35]. 
 
Fig. 6.5 (a) Dibasic sodium phosphate (DSP) chemical structure, (b) structure of polymer network formed by ionic 
cross-linking. 
 
DSP possesses cross-linking activity towards positively charged materials. Ionic cross-linking is 
a simple and mild procedure; no auxiliary molecules such as catalysts are required [36], which 
is of great interest for medical or pharmaceutical applications. Indeed, ionic cross-linking can 
be ensured by the classical method of preparing cross-linked network, namely by the addition of 
the cross-linker, either solubilised [37] or dispersed [38] to the polymeric solution. As reported 
in Fig. 6.5b, a network is formed in the presence of negatively charged entities, which form 
bridges between the positively charged polymeric chains. 
6.2.2  Sample preparation 
Porous CH/G, CH/G+GP-DSP and CH/G/TCP+GP-DSP membranes were prepared by freeze-
drying technique. CH was dissolved in 0.5M acetic acid (Sigma-Aldrich, Italy) at a 
concentration of 2.5% (wt/v). G was dissolved in demineralised water for 1 h at 50 °C, then CH 
was added under moderate stirring reaching a solution concentration of 3% (wt/v). CH and G 
were mixed at 1:2 weight ratio and stirred for about 2 h at 50 °C. 
For cross-linked samples, DSP was dissolved in demineralised water at a concentration of 1M 
and added dropwise to CH/G solution at defined volume percentage (7.5% (v/v) respect to the 
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volume of CH/G solution). Then GP was introduced at 1.5% (wt/wt) with the respect to CH/G 
amount. 
Finally, to obtain the composite membranes, TCP was added to the polymeric solution to obtain 
a composite with weight ratio between the polymeric and organic components equal to 50/50 
(wt/wt). The inorganic filler was introduced when a gel started to form as suggested by visual 
inspection and by the viscosity increase of the mixture. 
Each mixture was kept at 50 °C under stirring until the gelification process was almost 
completed. Then, volumes of 10 ml of gel were spread on Petri dishes with 60 mm diameter and 
freeze-dried (Scanvac, CoolSafe) at –55 °C for 48 h to obtain porous polymeric matrices. After 
freeze-drying, CH/G samples were neutralised with a 0.1M NaOH solution, rinsed several times 
in demineralised water until pH was neutral and then freeze-dried at -55 °C for 24 h. 
6.2.3  Sample characterization 
6.2.3.1  Cross-linking degree determination  
The determination of cross-linking degree on CH/G, CH/G+GP-DSP and CH/G/TCP+GP-DSP 
membranes was performed by Kaiser Test (Sigma-Aldrich, Milano, Italy), that is based on 
Ninhydrin reaction with NH2 terminal groups, that leads to the formation of a purple compound 
(Fig. 6.6). The cross-linking degree was defined as the percentage of free amino groups in the 
test membranes reacted with GP subsequent to cross-linking [39]. 
 
Fig. 6.6 Reaction of Ninhydrin with amino groups, resulting in a purple compound. 
 
In detail, the Kaiser reagents were added to squared samples (0.5 cm
2
) in the following order 
and amounts: 75 μl of Phenol, 100 μl of KCN, 75 μl of Ninhydrin. The mixtures were heated at 
100 °C for 5 min and then diluted with ethanol/water 60/40 (v/v). The optical absorbance of the 
Kaiser product was recorded at a wavelength interval between 450 and 740 nm, with a 
spectrophotometer (Perkin Elmer Lambda25 UV/VIS Spectrometer). It is known that the 
amount of free amino groups in the test sample, after heating with ninhydrin, is proportional to 
the maximum optical absorbance (A) of the solution at 570 nm [36]. 
The measurements were taken over three replicate samples and then averaged. Starting from the 
averaged absorbance value, the molar extinction coefficient ε (15000 M-1 cm-1) and the path 
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length b (1 cm), the molar concentration of the diluted solution (C) was obtained through 
Lambert-Beer law: 
        
From this molar concentration and the final volume (after dilution), the number of NH2 moles in 
samples was calculated. Then, the cross-linking degree was calculated by the following 
equation, using uncross-linked CH/G blend as a control: 
                         
                  
         
     
where NHcontrol and NHsample were the mole fractions of free NH2 remaining in uncross-linked 
(control group) and cross-linked (samples) groups, respectively. 
6.2.3.2  Morphological analysis 
Scanning electron microscopy (SEM LEO – 1430, Zeiss, Munich, Germany) and compositional 
analysis (EDS) were performed on membrane surfaces and liquid nitrogen fractured sections. 
Samples were sputter coated with Au before SEM-EDS analysis. 
Both images (sample surface and section) were analysed with ImageJ software (National 
Institute of Health, USA) to evaluate the average pore size and the pore size distribution. Three 
images for each samples were analysed at a magnification of 150x. 
6.2.3.3  Infrared analysis in ATR modality  
The analysis was carried out in a Perkin Elmer Frontier Optical Spectrometer fitted with an 
attenuated total reflection sampler (FTIR-ATR). Spectra were obtained over the 400-4000 cm
-1
 
wavenumber range at room temperature, using diamond crystal. 
6.2.3.4  Thermogravimetric analysis  
The thermal stability and degradation profile of porous membranes was evaluated through 
thermogravimetric (TGA) analysis using a TA INSTRUMENT Q500 system under a nitrogen 
atmosphere. The experiments were performed with a 10-15 mg sample in aluminum pans at 10 
°C/min heating rate in the 50-800 °C temperature range. 
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6.2.3.5  Tensile test  
Porous samples were obtained for tensile test in the form of rectangular samples (10 x 30 mm
2
). 
Tensile tests were performed on dry and wet specimens using MT
®
QTestTM/10 instrument and 
a load cell of 500 N was applied. The samples were tested at room temperature. Prior to testing 
in wet conditions, all samples were immersed in phosphate buffer solution (PBS) at pH 7.4 for 5 
min (Sigma-Aldrich, Italy). Then, samples were dried at the surface by gentle contact with a 
filter paper and immediately tested. The traction force was applied along the length of the 
samples at a constant cross-head displacement rate of 2 mm/min. Young’s modulus (E), 
maximum tensile strength and strain (max and εmax, respectively) were measured from the 
stress-strain curves. E was determined as the slope of the linear elastic region, and max and εmax 
were calculated as the maximum stress a material can withstand before failing and the total 
elongation just before fracture, respectively [40]. 
6.2.3.6  Water absorption and dissolution tests  
The membranes for the water absorption tests were weighed and then put in 6 ml of  PBS (pH 
7.4) at 37 °C. These membranes had a rectangular shape of 10 x 30 mm
2
. The swollen 
membranes were drawn at various time points (1, 3, 6, 9, 24 h) dried superficially by gentle 
contact with a filter paper and weighed again. The water absorption (WA) percentage was 
calculated using the following equation: 
      
     
  
     
where Wi and WA were the sample weight before and after water absorption, respectively. 
The membranes for the dissolution tests were weighed and then put in PBS (pH 7.4) at 37 °C. 
The membranes were drawn at various time points (1, 3, 7, 14, 28, 42, 56 d). After each time 
point, samples were freeze-dried at -55 °C for 24 h, then they were weighed again and the 
dissolution percentage (ΔW) was calculated as: 
      
     
  
     
where Wo and Wf were the sample weight before and after the degradation test. 
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6.2.3.7  Cell viability and adhesion 
MG-63 human osteoblast-like cells (ATCC, Rockville, MD) were grown in a controlled 
atmosphere (5% CO2; T = 37 °C) in Dulbecco’s Modified Eagle’s Medium (DMEM, Sigma-
Aldrich, Italy) supplemented with 10% fetal bovine serum (FBS), 1% non-essential aminoacids, 
2.0 mM L-glutamine, and 1% penicillin-streptomycin (all from GIBCO, Invitrogen, Italy). After 
thawing, cells were routinely split 1:10 every 3-4 days and used between the 3
rd
 and 4
th
 
passages. 
Before seeding, membranes were sterilized in 70% ethyl alcohol solution (Sigma-Aldrich, Italy) 
for 2 h and washed two times in PBS (GIBCO) for 1 h. In order to improve cell adhesion, 
samples were then conditioned overnight in 10% serum added DMEM at 5% CO2, 37 °C. The 
media was then discarded and membranes considered ready for seeding. Cells were detached 
using 0.25% trypsin in 1 mM ethylenediaminetetraacetic acid (EDTA, Sigma-Aldrich, Italy) 
and seeded at a density of 1 x 10
4
 cell/cm
3
 by applying 50 l of cell suspension on the samples 
placed in multi-well plates with 24 wells and on control wells at 37 °C for 30 min in a 
humidified chamber, in order to avoid the slip down of cells. Then 1.5 ml of DMEM was added 
to cover the samples placed in Corning
®
 ultra-low attachment multi-well plates. Cells were 
cultured for 1 and 3 days. 
MG-63 cell viability was evaluated through 3-dimethylthiazol-2,5-diphenyltetrazolium bromide 
(MTT) colorimetric assay. After incubation (1 and 3 days), the medium was removed and 200 
µl of MTT (Sigma, Italy) solution (5 mg/ml in DMEM without phenol red) and 1.8 ml of 
DMEM were added to the cell monolayer. The multi-well plates were incubated at 37 °C for 
further 4 h. After discarding the supernatants, the dark blue Formazan crystals were dissolved 
by adding 2 ml of solvent (10% HCl 1N in isopropanol; Sigma, Italy) and quantified 
spectrophotometrically (Secomam, Anthelie light, version 3.8, Contardi, Italy) at 570 nm. 
Results are reported as a percentage viability of polystyrene culture plates (TCP), where the 
cells were placed directly into adherent TCP at the same culture density as placed onto the 
samples. 
SEM analysis was finally performed to evaluate cell adhesion. Samples from cell culture tests 
were fixed in 2% glutaraldehyde (Sigma-Aldrich) in 0.1M cacodylate buffer (pH 7.4; Sigma-
Aldrich) and post-fixed in 1% osmium tetroxide (Sigma, Milan, Italy). Specimens were then 
dehydrated in increasing ethanol concentrations, CPD-dried (Crytical Point Drying), mounted 
on aluminium stubs, gold-sputtered by the Edwards Sputter Coater B150S equipment and 
observed with a Philips XL 20 SEM (FEI Italia SRL, Milan, Italy) microscope. 
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6.2.4  Statistical analysis  
All data are expressed as means ± standard deviation. Differences between means were 
analyzed by two-way ANOVA with the Bonferroni’s post test. For mechanical characterization, 
statistical analysis was performed using one-way ANOVA followed by a Tukey’s post hoc test. 
All statistical analyses were performed by Prism, Graph Pad Software. 
6.3 Results and discussion 
The theoretical double cross-linked structure of CH/G blend is represented in the following 
diagram (Fig. 6.7). 
 
Fig. 6.7 Proposed structure of cross-linked CS/G blend. 
 
6.3.1  Cross-linking degree 
The cross-linking degree of GP-cross-linked membranes was determined by the ninhydrin 
assay, and was defined as the percentage of free amino groups in the test membranes reacted 
with GP subsequent to cross-linking [40]. Table 6.1 collects the results obtained from the UV 
spectra analysis for CH/G, CH/G+GP-DSP, and CH/G/TCP+GP-DSP porous membranes. 
Table 6.1 Absorbance values at 570 nm and cross-linking degree obtained for CH/G, CH/G+GP-DSP, and 
CH/G/TCP+GP-DSP porous membranes. 
Sample Absorbance at 570 nm Cross-linking degree (%) 
CH/G 0.84 ± 0.17 - 
CH/G+GP-DSP 0.53 ± 0.09 35.3 ± 9.3 
CH/G/TCP+GP-DSP 0.54 ± 0.11 40.6 ± 4.4 
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Uncross-linked CH/G samples showed the highest absorbance value at 570 nm (0.84 ± 0.17) 
due to the high quantity of free amino groups. On the contrary, absorbance values of GP cross-
linked membranes significantly decreased, meaning that samples were highly cross-linked. 
Moreover, the addition of DSP and TCP in CH/G blends did not seem to interfere with the 
cross-linking process as the ninhydrin assay did not detect the ionically cross-linked amino 
groups 
The cross-linking degree was expressed as a percentage of free amino groups involved in GP-
cross-linking mechanism. Cross-linking degree of CH/G/TCP+GP-DSP membranes was similar 
to that of CH/G+GP-DSP membranes. This result suggested that TCP did not interfere with the 
GP cross-linking process of the CH/G blend. 
6.3.2  Porosity and morphological analysis 
The physical characteristics of a scaffold can be described by the average pore size, pore size 
distribution, pore volume, pore interconnectivity and pore shape. Pores are necessary for bone 
tissue formation because they allow migration and proliferation of osteoblasts and 
mesenchymal stem cells, as well as the proper vascularization of the implant [41]. In addition, a 
porous surface improves the mechanical interlocking between the implant biomaterial and the 
surrounding natural bone, providing greater mechanical stability at this critical interface [42]. 
Optimal pore diameters for porous structures for bone repair are in the 100-400 µm range [29] 
which are suitable for human osteoblast cell penetration and a minimum pore size is required 
for tissue in-growth [43]. Pore interconnectivity is required for access to nutrients and transport 
of waste products while pore shape and roughness are necessary for better cell spreading [44]. 
SEM analysis was performed on surfaces and sections of CH/G, CH/G+GP-DSP and 
CH/G/TCP+GP-DSP porous membranes to evaluate the effect of composition and cross-linking 
on sample morphology. SEM photomicrographs and EDS spectra are shown in Fig. 6.8. 
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Fig. 6.8 SEM micrographs of (1) Surface and (2) fractured section, and (3) EDS spectra of (a) CH/G, (b) CH/G+GP-
DSP, and (c) CH/G/TCP+GP-DSP porous membranes. Scale bar = 200 µm. 
 
A lower surface pore density was observed for CH/G and CH/G+GP-DSP samples (Fig. 6.9 a1 
and b1, respectively) compared to CH/G/TCP+GP-DSP (Fig. 6.9c1). The introduction of TCP 
increased surface pore density and produced pores with rougher walls (Fig. 6.9c1). 
The sections of porous membranes showed a typical foam-like morphology with interconnected 
pores, characterised by a wide distribution of pore sizes. Pore density was high for all samples 
and pores showed thin walls. The cross-linking process and the presence of TCP did not cause 
marked morphological changes. 
EDS spectra of fractured sections of CH/G membranes (Fig. 6.9a3) showed the characteristic 
elements of gelatin and chitosan: carbon (C) and oxygen (O). DSP characteristic elements could 
be detected for CH/G+GP-DSP and CH/G/TCP+GP-DSP porous membranes (Fig. 6.9 b3 and 
c3, respectively), namely sodium (Na) and phosphorus (P). Finally, EDS spectra of the 
composites membrane also showed the characteristic elements of TCP: calcium (Ca) and 
phosphorus (P). 
Pore analysis within membrane surface and section was determined by SEM photomicrographs 
analysis using ImageJ software. Pore distribution are shown in Fig. 6.8 and Table 6.2.  
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Fig. 6.9 (a) Surface and (b) section pore distribution of CH/G, CH/G+GP-DSP, and CH/G/TCP+GP-DSP membranes. 
 
Table 6.2 Mean pore size of CH/G, CH/G+GP-DSP, and CH/G/TCP+GP-DSP samples. 
Sample Section (µm) Surface (µm) 
CH/G 66.8 ± 4.6 129.6 ± 45.2 
CH/G+GP-DSP 130.2 ± 60.9 121.5 ± 4.3 
CH/G/TCP+GP-DSP 151.7 ± 11.5 123.8 ± 18.1 
 
Results from morphological analysis of surfaces (Fig. 6.9a) demonstrated that a high percentage 
of pores on CH/G membranes showed sizes in the 25-100 µm range: probably, the additional 
freeze-drying step induced the formation of small-sized pores. The cross-linking process caused 
the formation of pores with wider size range (1-300 μm) compared to uncross-linked 
membranes, which are crucial for protein adsorption and cell adhesion. Finally, the addition of 
TCP increased the percentage of pores with 75-300 μm size. The mean pore size was found to 
vary from 66.8 ± 4.6 μm for CH/G membranes to about 130 μm and 150 μm for CH/G+GP-
DSP and CH/G/TCP+GP-DSP samples, respectively. 
SEM analysis of the fractured sections (Fig. 6.9b) showed a porous morphology with a different 
pore size distribution compared to sample surface. In detail, SEM analysis indicated that 75-
80% of pores within the membranes had a size in the 75–300 μm range. A mean pore size of 
around 125 μm was found for all the analysed membranes. 
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6.3.3  FTIR-ATR analysis  
Chemical composition of membranes has been evaluated through FTIR-ATR analysis. Fig. 6.10 
compares FTIR-ATR spectra of CH/G, CH/G+GP-DSP and CH/G/TCP+GP-DSP samples. All 
spectra showed the typical adsorption bands of gelatin and chitosan. Bands due to N-H and O-H 
stretching vibrations overlapped in the absorption peak at 3288 cm
-1
 while the peak at 2879 cm
-1
 
represented the symmetric stretching vibration of aliphatic group (–CH3). The characteristic 
bands of amide I (C=O) axial stretching vibration and amide II (N-H) bending vibration 
appeared, respectively, at 1639 cm
-1 
and 1544 cm
-1
, and that of amide III at 1236 cm
-1
, caused 
by C-N stretching vibrations, amide N-H in-plane bending vibrations and CH2 wagging 
vibrations [45]. Finally, bands at 1414 cm
-1
, 1150 cm
-1 
and 1070 cm
-1 
represented, respectively, 
the O-H bending vibration, the C-O-C asymmetric stretching and the C-O stretching vibrations. 
The first peak originated from CH deacetylation, while the last two bands were typical of CH 
saccharide structure [46]. 
 
Fig. 6.10 FTIR-ATR spectra of CH/G, CH/G+GP-DSP, and CH/G/TCP+GP-DSP porous membranes. 
 
As reported in literature [47], FTIR-ATR spectra of GP-cross-linked samples should display a 
slight increase of the ratio between the intensities of amide I (1630-1640 cm−
1
) and amide II 
(1540-1550 cm−
1
) bands, attributed to the formation of amide and tertiary amine linkages 
between CH and G macromolecules through the reaction of primary amine moieties with the 
cross-linker. In this chapter, CH/G+GP-DSP and CH/G/TCP+GP-DSP samples only showed 
slight variations respect to those of uncross-linked sample due to (1) the absorption band of GP-
cross-linked amide groups at around 1600 cm−
1
 which merged with the strong absorption band 
of amide I in CH and G, and (2) the formation of a reduced number of cross-links between CH 
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macromolecules in the form of GP oligomers [48, 49]. On the contrary, it was possible to 
observe the characteristic peaks of DSP cross-linker. Bands at 943 cm−
1
,
 
853 cm−
1
 and 517 cm−
1
 
were attributed to PO3 in-phase-stretching, P-OH stretching and PO3 out-of-plane-bending, 
respectively  [50]. Moreover, characteristic bands of the inorganic phase were detected in the 
composite membrane: peak at 1025 cm−
1 
was due to δ3 of phosphate mode, peak at 940 cm
−1 
corresponded to δ1 of phosphate and band at 853 cm
−1 was attributed to P-OH stretching 
vibration [51]. These peaks were partially overlapped with DSP typical absorption bands. 
6.3.4  TGA analysis  
The thermal stability and degradation profile of CH/G, CH/G+GP-DSP, and CH/G/TCP+GP-
DSP porous membranes were evaluated through thermogravimetric (TGA) analysis. The 
derivative of TGA (DTG) curves is shown in Fig. 6.11. 
 
Fig. 6.11 Derivative of TGA curves for CH/G, CH/G+GP-DSP, and CH/G/TCP+GP-DSP porous membranes. 
 
DTG curves revealed three weight loss steps [9]: the first was related to water evaporation 
while the other two were due to CH and G pyrolisis, that occurred separately. As reported in 
literature, during heating, the initially ordered structure of G was gradually destroyed. This may 
be possible after the break-up of inter- and intra-molecular hydrogen bonds which were 
responsible for maintenance of G chains in the form of a triple helix. After that, breaking up of 
C-C, C-H, C-NH, C-C=O, and C-COOH bonds increased the state of disorder in the G structure 
[52]. According to the literature [53], pyrolisis of polysaccharides. such as CH, started by a 
random split of the glycosidic bonds, followed by a further decomposition forming acetic and 
butyric acids and a series of lower fatty acids, where C2, C3 and C6 were predominant. 
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Table 6.3 collects values of degradation temperature (Td) and weight loss calculated from the 
DTG curves. Values of Td did not change significantly upon cross-linking and addition of TCP. 
On the contrary, it could be possible to observe a slight decrease in weight loss for 
CH/G/TCP+GP-DSP composite membranes. 
Table 6.3 Maximum degradation rate temperatures (Td) and weight loss for CH/G, CH/G+GP-DSP, and 
CH/G/TCP+GP-DSP porous membranes. 
 I STEP II STEP III STEP 
Sample Td (°C) Weight 
loss (%) 
Td (°C) Weight 
loss (%) 
Td (°C) Weight 
loss (%) 
CH/G 70.4 5.7 194.9 12.9 308.3 40.9 
CH/G+GP-DSP 78.2 8.8 181.1 14.2 318.1 37.6 
CH/G/TCP+GP-DSP 74.6 3 182.7 6.4 310.3 17.6 
 
6.3.5  Mechanical characterizations  
Tensile tests were performed on dry and wet samples. Fig 6.12 shows the behavior of the elastic 
modulus (E), maximum tensile strength and strain (max and εmax, respectively) of CH/G, 
CH/G+GP-DSP, and CH/G/TCP+GP-DSP porous samples.  
 
 
189 
 
 
Fig. 6.12 -DSP, and 
CH/G/TCP+GP-DSP porous membranes in dry (on the left) and wet (on the right) conditions. 
 
Both in dry and wet conditions, GP-DSP cross-linking slightly improved the mechanical 
properties of CH/G membrane in terms of Young’s modulus and maximum tensile strength. For 
dry samples, Young’s modulus and maximum tensile strength were, respectively, 14.9 ± 5.1 
MPa and 0.6 ± 0.0 MPa for CH/G, and 23.6 ± 3.0 MPa and 0.7 ± 0.0 MPa for CH/G+GP-DSP. 
For wet samples, they reached values of 0.08 ± 0.01 MPa and 0.04 ± 0.01 MPa for CH/G, and 
0.13 ± 0.01 MPa and 0.05 ± 0.01 MPa for CH/G+GP-DSP. In dry condition, a statistically 
significant increase of E and max was obtained by adding inorganic phase into CH/G matrix, 
due to the superior mechanical behavior of TCP compared to the polymeric phase. In detail, the 
tensile Young’s modulus increased to about 30 MPa, while the maximum tensile strength 
reached a value around 0.9 MPa. On the other hand, no significant differences could be 
observed between CH/G+GP-DSP and CH/G/TCP+GP-DSP samples. The elastic modulus of 
wet composite membranes markedly increased compared to uncross-linked and GP-DSP cross-
linked polymeric samples, reaching a value of 0.2 MPa, while no statistically significant 
difference could be detected for max. However, all tested materials displayed a marked 
decrease of E and max after immersion in PBS for 5 min, due to their plasticization. 
On the other hand, the cross-linking mechanism and the addition of TCP caused a decrease in 
the deformability of CH/G membranes both in dry and wet conditions. Significant changes 
could be observed between CH/G and CH/G/TCP+GP-DSP dry membranes, with maximum 
tensile strain values of 5.5 ± 1.1% and 2.6 ± 1.0%, respectively. In wet condition, cross-linked 
samples displayed identical εmax values of about 20%, which were statistically lower than for 
CH/G membranes (54.5 ± 16.6%). 
It is widely accepted that tensile strength for inorganic–organic hybrid materials can be viewed 
as an indication of the interfacial bonding strength between the mineral and organic components 
[54]. In addition, the proper stress transfer occurring between the mineral phase and the organic 
matrix has a major effect on the mechanical properties of the composite materials [55]. 
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Regarding the present contest, the chemical interaction and the intimate adhesion between 
inorganic powders and the organic matrix, as well as the superior stiffness of the organic phase 
were the reasons for the enhanced tensile strength of composites as compared to CH/G samples. 
As suggested by Bigi et al. [56], the presence of inorganic phase in the composite films induced 
an increase of its stiffness.  
6.3.6  Water absorption and dissolution tests  
One of the main factors affecting biocompatibility of biomaterials is their water content: a 
polymer matrix imbibing an adequate amount of water shows similar properties to living tissue 
in terms of physiological stability, low interfacial tension, and permeability [57]. Water 
absorption increases the pore size and total porosity, maximizing the surface area/volume ratio 
and allowing the porous matrices to have probability of cell inclusion as well as cell growth into 
the scaffold. The increase in water uptake influences also nutrients/waste exchange from culture 
media. However, while the water absorption behavior promotes cell adhesion, it could lower 
scaffold mechanical properties [58]. 
The water uptake of any polymer network depends on the nature of the polymer, polymer-
solvent compatibility and degree of cross-linking [59]. The influence of chemical composition 
of CH/G, CH/G+GP-DSP, and CH/G/TCP+GP-DSP porous membranes on their water 
absorption has been investigated; Fig. 6.13 reports the water absorption (WA) degree as a 
function of time for porous matrices. 
 
Fig. 6.13 Water absorption (WA) behavior of CH/G, CH/G+GP-DSP, and CH/G/TCP+GP-DSP porous membranes as a 
function of immersion time in PBS. 
 
Uncross-linked samples showed a higher water absorption behavior. Their WA degree 
increased in the first 6 h, reaching a plateau of about 1300%; then, a slightly decrease was 
observed, probably due to the beginning of dissolution process. The stability of CH/G samples 
in aqueous media increased with the addition of cross-linking agents and inorganic phase. 
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CH/G+GP-DSP and CH/G/TCP+GP-DSP porous membranes showed the same behavior: the 
WA degree slowly increased in a linear way, reaching values of around 850% after 24 h of 
immersion in PBS. 
CH and G contain primary amine and hydroxyl groups that increased their affinity to water and 
could form hydrogen bonds with water [60]. In cross-linked form, the ability of CH/G 
membranes to form hydrogen bonds with water molecules decreased [61]. Moreover, the higher 
the cross-linking density, the lower the swelling ability of CH/G samples due to the slower 
relaxation time of the polymeric chains [62]. 
The presence of TCP slightly decreased the water absorption as compared to cross-linked 
membranes. This was attributed to the lower hydrophilicity of the inorganic phase as compared 
to the polymer matrix. Moreover, TCP formed cross-links between the chains and decreased 
gelatin hydrophilicity by binding Ca and P to –COOH or NH2 groups. Since some of the NH2 
were bound to Ca groups, the -OH groups could not form hydrogen bonds, hence the decrease 
in water absorption behavior [58]. 
The weight loss of CH/G, CH/G+GP-DSP, and CH/G/TCP+GP-DSP membranes after 
predetermined times of immersion in PBS is represented in Fig. 6.14. Previous literature 
indicated that the degradability of CH/G porous scaffold proceeds through chitosan degradation 
and gelatin dissolution [63]. 
 
Fig. 6.14 Weight loss percentage as a function of incubation time in PBS for CH/G, CH/G+GP-DSP, and 
CH/G/TCP+GP-DSP porous membranes. 
 
All the different kinds of samples were not completely dissolved at the end of the dissolution 
test. In detail, at each observation time, uncross-linked membranes showed the highest weight 
loss with statistically significant different values compared to cross-linked samples. CH/G 
weight loss increased with time: at 14 days it was (66.0 ± 2.5)%, while, after 56 incubation days 
in PBS, it reached a value of (81.8 ± 5.8)%. 
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The two types of GP-DSP cross-linked membranes showed the same dissolution rate during the 
first 28 days of immersion in PBS: their weight loss increased with time, reaching values of 
about 50%. In the literature, the addition of TCP has been found to significantly decrease the 
dissolution rate of the composite membranes, as reported by Peter et al. [64]. After 28 
incubation days in PBS, CH/G+GP-DSP weight loss rapidly increased with time reaching a 
value of (72.2 ± 3.3)% after 56 days. On the contrary, CH/G/TCP+GP-DSP weight loss 
remained approximately constant up to the end of the dissolution test.  
6.3.7  In vitro  cell tests 
MTT assay involves a reduction reaction which reduces MTT reagent to a blue formazan 
product when incubated with viable cells. Thus, the absorbance of formazan indirectly reflected 
the level of cell metabolism and this process is taken as a measure of the viability of cells in 
culture. Fig. 6.15 shows cell viability at 1 and 3 days evaluated by MTT test. 
 
Fig. 6.15 MTT Test in MG63 cells on CH/G, CH/G+GP-DSP, and CH/G/TCP+GP-DSP porous membranes. 
 
Both after 1 and 3 days of culture, CH/G membranes were the less performing materials as 
compared to CH/G+GP-DSP and CH/G/TCP+GP-DSP samples, showing MTT values around 
50%. Probably, the high solubility of these membranes impaired the test. 
After 1 day of culture, MTT values detected in cells seeded onto the CH/G/TCP+GP-DSP 
membranes were slightly lower than those observed for CH/G+GP-DSP samples ((81 ± 1)% 
and (83 ± 3)%, respectively), while they slightly increased after 3 days of culture (about 72% 
for CH/G/TCP+GP-DSP and 69% for CH/G+GP-DSP). However, viability of MG-63 human 
osteoblast-like cells was no significantly different between the two cross-linked membranes. 
Figure 6.16 depicts the morphology of MG-63 cells adhering to CH/G, CH/G+GP-DSP and 
CH/G/TCP+GP-DSP membranes. 
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Fig. 6.16 SEM micrographs of MG-63 human osteoblast-like cells seeded onto (a) CH/G, (b) CH/G+GP-DSP, and (c) 
CH/G/TCP+GP-DSP porous membranes, for (1) 1 day and (2) 3 days. Scale bar = 20 μm. 
 
SEM observations confirmed the MTT results. Cells seeded onto CH/G membranes were 
characterized by a round shape both at 1 and 3 days of culture. In detail, after 1 day (Fig. 6.16 
a1), cells were poorly adherent to the substrate with apoptosis signs (as underlined by the 
arrow) while, after 3 days (Fig. 6.16 a2), no increase in the number of cells could be observed 
and the few cells formed clusters. 
No differences in cells morphology could be observed between 1 and 3 days for CH/G+GP-
DSP membranes (Fig. 6.16 b1 and b2, respectively). Some cells had a round shape while others 
have spread out and possessed long filopodia attachment. 
The addition of TCP did not change cells adhesion at 1 day of culture compared to CH/G+GP-
DSP samples. On the contrary, SEM micrographs after 3 days showed that MG-63 cells had a 
high affinity for CH/G/TCP+GP-DSP samples, displaying the typical spindle-like shape, with a 
stretched elongated shape and a spread morphology. 
6.4 Conclusions 
This chapter was focused on the development and characterization of porous membranes by 
freeze-drying method, having a similar composition to that of natural bone. A double cross-
linking method was studied, based on a covalent and ionic cross-linker (GP and DSP, 
respectively), and three different type of membranes were prepared. GP-cross-linking 
mechanism was confirmed by the ninhydrin assay, while the introduction of DSP was proved 
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by FTIR-ATR analysis. The double cross-linking process did not significantly influence sample 
morphology and thermal stability. An optimal interconnected porous networks for bone repair, 
with pores size within 100–200 μm range, were obtained for all membranes, as shown by SEM 
analysis. Lower sized pores were also present able to favor protein adsorption and thus cells 
attachment on the membrane, and to allow the flow of nutrients to cells within the substrate. 
Regarding the thermal stability, it did not change significantly upon cross-linking and addition 
of TCP. On the contrary, the cross-linking process and the addition of TCP increased the 
mechanical properties (both in dry and wet conditions), the membrane stability in contact with 
water media, and the cell response of CH/G network. In fact, Young’s modulus and maximum 
tensile strength increased, while deformability of CH/G membranes decreased by cross-linking, 
as a consequence of a stiffening effect by the cross-linkers and TCP. The water absorption 
degree and the dissolution rate were markedly reduced in cross-linked samples. Finally, 
viability of MG-63 human osteoblast-like cells seeded onto CH/G+GP-DSP and 
CH/G/TCP+GP-DSP membranes (measured by MTT assay) was significantly higher than for 
CH/G samples. SEM micrographs after 3 days showed that MG-63 cells had a high affinity for 
CH/G/TCP+GP-DSP samples, displaying the typical spindle-like shape, with a stretched 
elongated shape and a spread morphology. 
As a conclusion, CH/G/TCP+GP-DSP membranes were demonstrated to be suitable candidate 
as osteoconductive layer of GTR membranes. 
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7 
Bi-layered absorbable membrane for 
Guided Tissue Regeneration 
 
Abstract 
Periodontitis is an infectious disease that causes destruction of the tooth-attachment apparatus. 
When left untreated, periodontitis can result in progressive attachment loss that may eventually 
lead to tooth loss. Periodontal treatment can arrest further disease progression and promote the 
periodontal tissue to be reconstructed in some extent. Guided tissue/bone regeneration strategies 
(GTR/GBR) represent the most well-documented regenerative procedures for obtaining 
periodontal regeneration in periodontal loss. GTR/GBR membranes can be considered an 
interface-implant between gingival connective tissue/epithelium and alveolar bone tissue. Thus, 
developing a membrane with differentiated-structure, i.e. with compositional and structural 
properties that meet the functional requirements of the local tissue interface, could represent a 
challenge. In this chapter, a novel multicomponent membrane has been developed by the 
assembly of a compact layer, based on poly(DL-lactide-co-ε-caprolactone)/poly(lactic-co-
glycolic acid) (PLCL/PLGA) 25/75 (wt/wt) blend, and a porous layer, based on 
chitosan/gelatin/β-tricalcium phosphate network cross-linked with genipin and dibasic sodium 
phosphate. The assembly process was based on the insertion of an intermediate adhesive layer 
composed by a polyvinylpyrrolidone/polyethylene glycol (PVP/PEG) 70/30 (wt/wt) blend, 
which was selected based on different analysis (namely, water contact angle measurements, 
thermogravimetric analysis, differential scanning calorimetry, and lap shear strength test). 
Preliminary characterizations were then carried out on the bi-layered membrane. Morphological 
analysis did not show changes in compact and porous layer structure due to PVP/PEG 70/30 
insertion. The final device was characterized by an elastic modulus of about 61 MPa in dry 
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condition that markedly decrease in wet state (about 5 MPa). Finally, qualitative analysis of 
membrane manageability revealed its ability to adapt to mandible conformation after immersion 
in physiological solution. Despite the need for additional tests, it was possible to state the 
usability of the membrane in GTR/GBR applications. 
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7.1 Introduction 
Periodontal apparatus is the complex multi-tissue system, anchoring the teeth in the 
maxillar/mandibular bone. It includes dental root cementum, periodontal ligament (PDL), 
dento-gingival junction and alveolar bone. Periodontitis is the inflammatory disease of this 
system that can lead to its destruction, which may eventually result in tooth loss. Periodontitis is 
a very aggressive pathology and represents one of the major global health problem [1]. 
During the past few decades, several therapeutic approaches have been developed. Among 
them, two surgical regenerative approaches, namely guided tissue/bone regeneration 
(GTR/GBR), have been increasingly used for the repair and regeneration of both the structure 
and function of damaged periodontal tissues. In both techniques, a membrane is used as a 
physical barrier to create an excluded space around the defect by preventing the invasion of the 
fibrous connective and epithelial tissues into the defect space, thus allowing the missing 
periodontal tissues to regenerate [2-34]. Thus, GTR/GBR membranes for periodontal 
regeneration can be considered an interface-implant, having interfaces with gingival connective 
tissue/epithelium and PDL/alveolar bone tissue. An interface-implant should possess 
biomimetic composition and structure respect to the different interfaces. In the specific case, 
membranes should promote the regeneration of periodontium by enhancing bone growth while 
preventing the gingival tissue down-growth [5]. 
In this chapter, a novel functionally bi-layered membrane with a spatially designed structure 
was fabricated via assembly of the previously developed compact and porous layers. The 
rationale of a periodontal membrane with a bi-layered structure relies on the idea that the 
properties of the different layers should be optimized to design a membrane with compositional 
and structural properties as well as suitable dimensional properties and time-dependent 
mechanical integrity to allow periodontal regeneration. 
The bi-layered absorbable membrane developed in this chapter was composed by a compact 
synthetic film, based on poly(DL-lactide-co-ε-caprolactone)/poly(lactic-co-glycolic acid) 
(PLCL/PLGA) 25/75 (wt/wt) blend, and a porous membrane, based on chitosan/gelatin network 
enriched with β-tricalcium phosphate and cross-linked with genipin and dibasic sodium 
phosphate (CH/G/TCP+GP-DSP).  
For the assembly of the two layers, different techniques could be used. One approach could be 
based on a thermal treatment applied to the compact membrane at a temperature higher than the 
glass transition temperatures of PLCL/PLGA 25/75 blend films (Tgs in the range 30-50 °C). 
CH/G/TCP+GP-DSP membrane could be placed (and pressed) on the compact film, previously 
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softened by the thermal treatment, in order to link the layers after cooling. In alternative, the bi-
layered membrane could be fabricated by freeze-drying the porous layer directly on the 
compact film. As described by Franco et al. [6], PLCL/PLGA 25/75 film could be prepared in a 
petri dish; then, a suitable amount of CH/G/TCP+GP-DSP solution, at a temperature of 50 °C, 
could be poured on the Petri dish (coating the compact film base). The resulting samples could 
be then freezed and lyophilised to obtain the final device. However, both temperature and 
pressure employed in these process may change the structural-mechanical and morphological 
properties of the layers. Therefore, the use of an intermediate adhesive layer could represent an 
alternative, preserving the properties of the membrane layers. 
Different adhesive biomaterials could be employed, such as fibrin glues, cyanoacrylate or 
gelatin. For example, Shi et al. [7] developed a bi-layered dermal equivalent by combining a 
collagen/chitosan porous scaffold with a silicone membrane through a gelatin intermediate 
layer. In detail, at 50 °C, the 10% (wt/v) gelatin solution was smoothly spread on the silicone 
membrane (10 µl/cm
2
). After cooling to room temperature, at which the gelatin adhesive was 
transferred to a semi-gelation state, the scaffold was put onto the silicone membrane surface 
slightly to obtain the bi-layered device. However, the use of gelatin involves again the use of 
temperatures above compact film Tg, whereas cyanoacrylate degradation products may be 
cytotoxic and fibrin glue may results in infection transmission. 
In this chapter, blends between polyvinylpyrrolidone (PVP) and polyethylene glycol (PEG) 
(compositions 100/0, 80/20, 70/30, 60/40 wt/wt) were investigated with the aim to select an 
optimal blend composition in terms of compatibility degree between the phases and adhesive 
properties. PVP/PEG blends are examples of pressure-sensitive adhesives (PSAs), which are 
commonly used in a variety of applications because of their ease of application, low toxicity, 
and versatility [8]. In particular, a resorbable adhesive based on PVP/PEG blend is currently 
employed in a self-adhering hernia mesh (Cousin Biotech® Adhesix™). 
To function properly, PSAs must combine a liquid-like character to form good molecular 
contact under a light applied pressure and a solid-like character to resist an applied stress once 
the bond has been formed. This combination of properties usually requires a high molecular 
weight polymer, forming the backbone of the adhesive, and a low molecular weight fraction, 
favoring flow and deformation. The miscibility between the two components in PVP/PEG 
blends is provided by hydrogen bonding between PEG terminal hydroxyl groups and carbonyl 
groups of PVP monomeric units [9, 10], and it has been studied in detail in a series of articles 
[11-12 3]. PVP and PEG are fully miscible over the entire composition range [14], but they 
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display interesting PSA properties only in a fairly narrow window of compositions (between 30 
and 40 wt% PEG) [15]. 
We characterized PVP/PEG blends physicochemical and adhesive properties using water 
contact angle measurements, infrared spectroscopy, thermogravimetric analysis (TGA), 
differential scanning calorimetry (DSC) and lap shear strength test. The selected composition 
was then employed for the development of a bi-layered absorbable membrane, which was 
preliminarily characterized via scanning electron microscopy (SEM) and tensile test. 
7.2 Materials and methods 
7.2.1  Materials 
PLGA (LA:GA = 75:25 mol:mol; Mw: 66000-107000 Da), PLCL (nominal 86 mol% of 
DL,lactic acid, Mw: 28000 Da), Type A gelatin from porcine skin (Mw: 50-100 kDa), chitosan 
highly viscous derived from crab shell with 75-85% deacetylation degree (Mw: 190-310 kDa), 
β-tri-calcium phosphate (Mw = 310.18 Da), and dibasic sodium phosphate (Mw = 141.96 Da) 
were supplied from Sigma-Aldrich (Milano, Italy). Genipin was purchased from Challenge 
Bioproducts (Taiwan). Polyvinylpyrrolidone (PVP; Mw: 10
6
 Da) and polyethylene glycol (PEG; 
Mw: 400 Da) were supplied by BASF (Italy). All solvents were of analytical grade and used 
without further purification. 
7.2.1.1  Polyvinylpyrrolidone  
Polyvinylpyrrolidone (Fig. 7.1), also called polyvidone, is a white, hygroscopic powder with a 
weak characteristic odor. In contrast to most polymers, it is readily soluble in water and a large 
number of organic solvents, such as alcohols, amines, acids, chlorinated hydrocarbons, amides 
and lactams. On the other hand, the polymer is insoluble in the common esters, ethers, 
hydrocarbons and ketones. 
PVP is synthesized by free-radical polymerization of N-vinylpyrrolidone in water or alcohols 
with a suitable initiator. By selecting suitable polymerization conditions, a wide range of 
molecular weights can be obtained, extending from low values of a few thousand Daltons to 
approximately 2.2 million Daltons [16]. 
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Fig. 7.1 Polyvinylpyrrolidone (PVP) chemical structure. 
 
PVP is markedly hygroscopic and able to absorbs up to 40% of its weight in atmospheric water. 
This property combined with outstanding film formation, initial tack and adhesion to different 
materials, high capacity for complex formation, good stabilizing and solubilizing capacity, 
insensitivity to pH changes, ready radiation-induced cross-linkability as well as good biological 
compatibility have made PVP one of the most frequently used specialty polymers [1]. 
The U.S. Food and Drug Administration has approved this chemical for many uses and it is 
generally considered safe. In biomedical field, PVP is used as a binder in many pharmaceutical 
tablets;
 
it simply passes through the body when taken orally [17]. PVP added to iodine forms a 
complex, called povidone-iodine, that possesses disinfectant properties.
 
This complex is used in 
various products like solutions, liquid soaps and surgical scrubs. It is known under the trade 
names Betadine and Pyodine among a plethora of others. 
7.2.1.2  Polyethylene glycol  
Polyethylene glycol (Fig. 7.2) is a polyether compound with many applications from industrial 
manufacturing to medicine. PEG is also known as polyethylene oxide (PEO) or 
polyoxyethylene (POE), depending on its molecular weight. PEG, PEO, or POE refers to an 
oligomer or polymer of ethylene oxide. PEG and PEO are liquids or low-melting solids, 
depending on their molecular weights. PEG is prepared by polymerization of ethylene oxide 
and is commercially available over a wide range of molecular weights, from 300 g/mol to 
10000000 g/mol [18]. 
 
Fig. 7.2 Polyethylene glycol (PEG) chemical structure. 
 
PEG has several chemical properties that make it especially useful in various biological, 
chemical and pharmaceutical settings. It is non-toxic and non-immunogenic, thus it can be 
added to media and attached to surfaces and conjugated to molecules without interfering with 
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cellular functions or target immunogenicities. It is hydrophilic (aqueous-soluble) and its 
attachment to proteins and other biomolecules decreases aggregation and increases solubility. 
Finally, it has high flexibility, thus it provides for surface treatment or bioconjugation without 
steric hindrance [3]. 
7.2.2  Sample preparation 
7.2.2.1  Preparation of blend PVP/PEG 
PVP/PEG 100/0; 80/20; 70/30; 60/40 (wt/wt) blends were prepared by solution mixing method. 
The polymers were separately dissolved in MilliQ water at 4% (wt/v) concentration and each 
polymer/solvent mixture was stirred using a magnetic stirrer for 1 h, till complete dissolution of 
polymers. Proper volumes of the polymeric solutions were mixed to prepare blends and stirred 
for 2 h. Films were obtained by casting a volume of each solution (15 ml) on Teflon Petri dishes 
with 50 mm diameter. The solvent was removed via evaporation under a vented hood at room 
temperature for a period of 7 days and in vacuum oven at 65 °C for other 6 h. The blends were 
coded as follows: PVP/PEG 100/0; 80/20; 70/30; 60/40. PEG films could not be prepared as the 
polymer was in molten state at room temperature. 
7.2.2.2  Preparation of bi-layered absorbable membrane  
Compact (PLCL/PLGA 25/75) and porous (CH/G/TCP+GP-DSP) layers were combined with 
optimized PVP/PEG blend composition, namely 70/30 (wt/wt), as schematically reported in 
Fig. 7.3. Each layer was produced as reported in Chapter 4, 5 and 6. Then, a 20% (wt/v) 
PVP/PEG 70/30 blend solution was smoothly spread on the PLCL/PLGA 25/75 film (20 
μl/cm2). After 30 min, CH/G/TCP+GP-DSP membrane was put onto the compact film to obtain 
the bi-layered absorbable device and left under a vented hood at room temperature for 1 day. 
 
Fig. 7.3 Schematic rapresentation of the assembly process for the bi-layered absorbable membrane. 
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7.2.3  Sample characterization 
7.2.3.1  Water contact angle measurements  
The static contact angles of PVP/PEG blend films were determined through a sessile drop 
method, using a 5 µl double distilled water droplet. Static contact angles of films were 
measured in air at room temperature in a CAM 200 KSV Instrument equipped with an Attention 
Theta software for data acquisition. 
7.2.3.2  Infrared analysis in ATR modality  
The analysis was carried out in a Perkin Elmer Frontier Optical Spectrometer fitted with an 
attenuated total reflection sampler (FTIR-ATR). Spectra of PVP/PEG blend films were obtained 
over the 400-4000 cm
-1
 range at room temperature, using diamond crystal. 
7.2.3.3  Thermogravimetric analysis  
The thermal stability and degradation profile of PVP/PEG blend films was evaluated through 
thermogravimetric (TGA) analysis using a TA INSTRUMENT Q500 system under a nitrogen 
atmosphere. The experiments were performed with a 10-15 mg sample in aluminum pans at 10 
°C/min heating rate in the 35-700 °C temperature range. Results were then analysed through a 
TA Universal Analysis 2000 software. 
7.2.3.4  Differential scanning calorimetry  
The thermal behavior of cast films based on PVP/PEG blends was investigated by differential 
scanning calorimetry (DSC) using a TA INSTRUMENT DSC Q20. Each film specimens (5-10 
mg) were precisely weighed in aluminum pans and non-isothermal scans were performed 
between −65 °C and 100 °C for pristine PEG and between −65 °C and 220 °C for the other 
materials (first heating; cooling; second heating) at a heating rate of 10 °C/min under nitrogen 
atmosphere. The characteristic temperatures of PVP and PEG blend components were measured 
from the DSC heating scan through a TA Universal Analysis 2000 software. 
7.2.3.5  Lap shear strength test  
The test was performed according to ASTM D3163 which is commonly performed to measure 
the shear strength of adhesives that bond plastic substrates. It uses a single lap joint (lap shear) 
specimen to determine the shear strength of adhesives. 
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Two plates were bonded together with adhesive as shown in Fig. 7.4. The test specimens were 
placed in the grips of MT
®
QTestTM/10 instrument and pulled at 1.3 mm/min until rupture 
occurs. The grips used to secure the ends of the assembly must align so that the applied force is 
applied through the centerline of the specimen. 
Two different adhesion conditions have been investigated: 
1. the plates were bonded as soon as the adhesive was spread on the surface, with or without 
the application of a pressure for 1 day; 
2. the plates were bonded one day after the spreading of the adhesive, with or without the 
application of a pressure for 1 day. 
Pressure was applied by pouring a becker with 25 ml of water on the superimposed plates. 
The maximum force and maximum shear stress (divide the maximum force by the shear area 
and report in units of kilogram/square centimeter) were measured. The type of failure was also 
determined; it can be either adhesive (the adhesive separates from one of the substrates) or 
cohesive (the adhesive ruptures within itself). 
 
Fig. 7.4 Adhesive lap joint shear strength test specimen. 
 
7.2.3.6  Morphological analysis  
Scanning electron microscopy (SEM LEO – 1430, Zeiss, Munich, Germany) was performed on 
bi-layered membrane sections (obtained by fracturing in liquid nitrogen). Samples were sputter 
coated with Au before SEM analysis. 
7.2.3.7  Tensile test  
Tensile mechanical properties of bi-layered membranes were analyzed in dry and wet 
conditions. Tensile tests were performed on rectangular specimens (10 x 30 mm
2
) using 
MT
®
QTestTM/10 instrument. The traction force was applied along the length of the samples at 
a constant cross-head displacement rate of 2 mm/min. Young’s modulus (E) and maximum 
tensile strength and strain (σmax and εmax, respectively) were measured from the stress-strain 
206 
 
curves. E was calculated from the slope of the initial linear portion of the stress-strain curve, 
and σmax and εmax were calculated as the maximum stress a material can withstand before failing 
and the total elongation just before fracture, respectively [19]. 
7.2.3.8  Bi-layered membrane manageability  
Mandible anatomical model with periodontal defects were employed to evaluate membrane 
manageability. The device was immersed in PBS for 5 min, then it was properly cut to fit the 
defect site and finally inserted. Digital pictures were taken. 
7.2.4  Statistical analysis  
All data are expressed as means ± standard deviation. Differences between means were 
analyzed by one-way ANOVA followed by a Tukey’s post hoc test. For lap shear strength test, 
statistical analysis was performed using two-way ANOVA with the Bonferroni’s post test. All 
statistical analysis were performed with Prism, Graph Pad Software. 
7.3 Results and discussion 
7.3.1  Characterization of PVP/PEG blend  
The surface wettability of PVP/PEG films (Fig. 7.5) changed based on blend composition. The 
static contact angle significantly decreased with the addition of PEG content, reaching a value 
of (44.4 ± 0.9)° for PVP/PEG 60/40. 
 
Fig. 7.5 Static contact angle measurements of PVP/PEG cast blend films as a function of PEG content. 
 
Changes in chemical composition of PVP/PEG blends were evaluated through FTIR-ATR 
analysis. In fact, the results obtained from FTIR-ATR spectroscopy gave a unique identification 
of the functional interacting groups [20]. Fig. 7.6 compares the FTIR-ATR spectra of cast blend 
films and pure polymers. 
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Fig. 7.6 FTIR-ATR spectra of PVP/PEG 100/0, 80/20, 70/30, 60/40 and PEG. 
 
PVP/PEG 100/0 spectra showed characteristic bands at 1652 cm
-1
 and 1281 cm
-1
 related, 
respectively, to the stretching vibrations of C=O and C-N bonds. The peak at 1421 cm
-1
 arose 
from the stretching vibration of -CH2 group while the peak at 2951 cm
-1
 was attributed to the 
stretching vibration of C-H bond. Finally, the wide band at 3445 cm
-1
 could be due to the 
presence of water into the polymer [21, 22]. The characteristic adsorption bands of PEG were 
associated to the stretching vibration of the –OH functional group (3449 cm-1) and to the 
symmetric stretching vibration of C-O bond (1095 cm
-1
). Other peaks related to the stretching 
and bending vibrations of –CH2 group at 2866 cm
-1
 and 844.7 cm
-1
, respectively. Finally, the 
adsorption bands in the region 1249-1295 cm
-1
 arose from the asymmetric stretching vibration 
of C-O-C group [23]. 
The adsorption bands of PVP and PEG described above could be observed also in the spectra of 
blend samples; the intensity of these bands changed based on blend composition. 
At room temperature, PVP is easily soluble in liquid PEGs with a low molecular weight (100-
600 g/mol). PVP solubility is related to the formation of hydrogen bonds between hydroxyl 
terminal groups of PEG short chains (proton donators) and the complementary carbonyl groups 
of long PVP macromolecules (electron donators). The simultaneous formation of two hydrogen 
bonds through the two –OH terminal groups of PEG makes this polymer a reversible cross-
linker for PVP [5]. 
The hydrogen bond formation is generally associated to a shift of wavenumbers in FTIR-ATR 
spectra. As it is possible to observe in Table 7.1, the wavenumbers of –OH and C=O groups 
slightly changed in blend spectra compared to the values observed for the pure polymers. This 
was probably caused by the formation of hydrogen bonds between PVP and PEG. 
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Table 7.1 Wavenumbers of -OH and C=O groups obtained from the FTIR-ATR spectra of PVP/PEG 100/0, 80/20, 
70/30, 60/40 and PEG. 
Composition -OH (cm
-1
) C=O (cm
-1
) 
PVP/PEG 100/0 - 1652.0 
PVP/PEG 80/20 3428.2 1655.2 
PVP/PEG 70/30 3419.9 1657.8 
PVP/PEG 60/40 3421.8 1658.7 
PEG 3445.4 - 
 
Thermal properties of PVP/PEG blend films were evaluated through TGA and DSC analyses. 
Fig. 7.7 compares the mass loss derivative curves (DGA) of cast blend films. PVP/PEG blends 
were characterized by a two step thermal degradation, one for each blend component. The first 
degradation step could be attributed to PEG pyrolysis while the second one could be associated 
to PVP degradation. The mass loss during the two steps changed based on blend composition 
(Table 7.2): PVP/PEG 60/40 samples showed the maximum mass loss value in the first step 
(about 33%) while in the second step, the maximum value was reached by PVP/PEG 80/20 
sample (around 68%). 
 
Fig. 7.7 DGA curves of PVP/PEG blend films and PEG. 
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Table 7.2 Characteristic temperatures obtained from DGA curves analysis for PVP/PEG blend films and PEG. Ti and Tf 
represent, respectively, the temperature of beginning and end of the thermal degradation process while Tdegr represents 
the degradation temperature. 
Composition 1
st
 STEP 2
nd
 STEP 
Ti (°C) Tf (°C) 
Weight 
loss (%) 
Tdegr (°C) Ti (°C) Tf (°C) 
Weight 
loss (%) 
Tdegr (°C) 
PVP/PEG 100/0 - - - - 376.2 481.1 81.4 439.6 
PVP/PEG 80/20 221.6 372.1 15.8 345.7 378.1 479.3 67.7 438.7 
PVP/PEG 70/30 223.9 387.7 26.7 331.8 393.3 479.9 55.6 438.3 
PVP/PEG 60/40 220.1 378.9 32.9 375.2 385.7 474.6 49.5 440.7 
PEG 187.6 390.6 88.6 356.3 - - - - 
 
Fig. 7.8 collects DSC first heating thermograms for PVP/PEG samples. The heating 
thermogram of PVP/PEG 100/0 revealed a broad symmetric endotherm of water 
thermodesorption at (100.2 ± 8.4) °C related to water evaporation. In fact, PVP is a highly 
hygroscopic polymer able to absorb high quantity of water from the surrounding environment, 
absorbed in vapour state or residual from material processing [13]. Thermograms of PVP/PEG 
blends showed the same endothermic peak of PVP/PEG 100/0 sample, with similar temperature 
and with progressively decreasing intensity as a function of PEG content. 
 
Fig. 7.8 DSC first heating thermograms for PVP/PEG blend films and PEG. 
 
As reported in literature, the DSC technique provides an alternative tool to determine the 
amount of water absorbed by hydrophilic polymers [24]. To this purpose, the heat of water 
thermodesorption must match that of bulk water evaporation. Polymer hydration may then be 
measured through the enthalpy change associated with water desorption, dividing the obtained 
dehydration enthalpy (ΔHd) by the reference value of water vaporization (ΔH = 2255 J/g) [25]. 
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Table 7.3 collects the hydration values for PVP/PEG blend samples and PEG, obtained from 
DSC first heating thermograms. The amount of water absorbed by PVP/PEG 100/0 films was 
about 10 times higher than the quantity absorbed by PEG (10.2 ± 1.2 % and 0.6 ± 0.1 %, 
respectively). PVP–PEG hydrogen bonding resulted in the formation of a hydrogel containing 
2–5% of water at room temperature. 
Table 7.3 Dehydration enthalpies (ΔHd) and hydration values measured by DSC analysis (first heating scan at 10 
°C/min). 
Composition ΔHd (J/g) Polymer hydration (%)
1
 
PVP/PEG 100/0 230.5 ± 28.2 10.2 ± 1.2 
PVP/PEG 80/20 112.1 ± 27.3 4.9 ± 1.2 
PVP/PEG 70/30 64.9 ± 1.3 2.9 ± 0.6 
PVP/PEG 60/40 46.9 ± 15.3 2.0 ± 0.7 
PEG 12.9 ± 2.0 0.6 ± 0.1 
1                       
   
  
     
 
Results obtained from the analysis of the first heating thermograms showed that (i) PVP is an 
amorphous polymer with a high affinity for water while PEG is a comparatively less 
hygroscopic polymer, (ii) both polymers are easily soluble in water but short-chain liquid PEG 
can be also a good solvent for PVP. Consequently, the PVP–PEG hydrogels may be treated 
either as ternary compatible blends or PVP solutions in the PEG–water cosolvent [26]. 
DSC second heating traces for PVP/PEG blend and PEG are shown in Fig. 7.9. The heating 
DSC trace of PVP/PEG 100/0 showed a heat capacity jump at the glass transition temperature 
(Tg = (177.5 ± 1.6) °C) while it was not possible to measure PEG Tg because it was localized 
near the low temperature limit detected by the instrument (-65 °C). Thus, the value reported in 
literature was considered (-70 °C) [27]. The DSC heating trace of unblended PEG displayed a 
melting endotherm at (7.7 ± 0.1) °C. 
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Fig. 7.9 DSC second heating thermograms for PVP/PEG blend films and PEG. 
 
Adding PEG to the glassy PVP resulted in the appearance of two Tgs. Their values were close 
each other and they were called Tg
UPPER
 and Tg
LOWER
. As reported in Chapter 4 – Paragraph 4.2, 
experimental evidence of polymer miscibility is associated with a single glass transition 
temperature, which is intermediate between the two Tgs of the blend components [28]. On the 
contrary, blends of immiscible polymers that segregate into distinct phases exhibit two separate 
glass transitions with a similar value to that of the unblended components. In the intermediate 
case of partial blend miscibility, the Tgs of individual components are closer as compared to the 
values of pure polymers [29].  
The PVP and PEG glass transition temperatures differed by a value of (247.5 ± 1.6) °C. The 
temperature difference between the two Tgs in blend samples markedly decreased with 
increasing PEG content, reaching a value of about 50 °C for blends containing 40 %wt of PEG 
(Table 7.4). This result was a consequence of a decrease of both Tgs with increasing PEG 
content. 
Table 7.4 Glass Transition temperatures measured by DSC analysis (second heating scan at 10 °C/min). 
Composition Tg
UPPER
 (°C) Tg
UPPER
 (°C) ΔTg (°C)
1
 
PVP/PEG 100/0 177.5 ± 1.6 - - 
PVP/PEG 80/20 62.1 ± 3.4 -39.8 ± 1.2 132.1 ± 3.4 
PVP/PEG 70/30 15.2 ± 3.4 -50.9 ± 1.3 85.2 ± 3.5 
PVP/PEG 60/40 -19.3 ± 3.2 -53.9 ± 2.8 50.6 ± 3.2 
PEG - -70 - 
1       
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The two Tgs in PVP/PEG blend thermograms are due to: 
1. PVP–PEG hydrogen bonds, leading to the appearance of Tg
LOWER
; 
2. the presence of a non-balanced phase composed by plasticised PVP with small quantities 
of PEG and water, which caused the appearance of Tg
UPPER
 [10]. 
Both Tgs were composition dependent. The plasticizing effect of PEG affected the Tg
UPPER
 value 
which strongly decreased with the addition of PEG. The composition dependence of the Tg
UPPER
 
was fitted through a simple weight-average rule of mixing, the Fox equation, which describes 
the theoretic behavior of Tg in polymeric blends with specific interactions. The equation applied 
is reported below: 
 
  
 
    
     
 
    
  
   
 
   
    
 
where Tg refers to the glass transition temperatures of blend and Tg
x
 and wx refers, respectively, 
to the Tg and the weight fractions of PVP, water and plasticizing agent (PL = PEG). 
Fig. 7.10 plots both Tgs evaluated by the DSC technique and theoretic Tgs evaluated by Fox 
equation, against the composition of PVP/PEG blends. The theoretical curves were obtained 
setting      equal to 0 for the upper curve and           for the lower one (selected from 
the PVP/PEG hydration results described before). When PEG concentration was around 20-40 
%wt, the Tg
UPPER
 dropped below the temperature of water evaporation and obeyed to some 
extent to the Fox rule for the blends of 5% hydration. On the contrary, as reported in literature 
[27], at low PEG content in blends (0–10 wt%), the Tg was preceded by a water evaporation 
endotherm and the composition dependence of the Tg
UPPER
 followed the pattern predicted by the 
Fox rule of mixing for dry PVP/PEG blends. 
The success of the Fox equation in describing the composition dependence of the Tg
UPPER
-phase 
suggested the miscibility of PVP with PEG. Moreover, the negative deviation from Fox 
equation, observed for plasticizing agents with more than one hydroxyl group, underlined the 
formation of specific interactions between PVP and PEG. 
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Fig. 7.10 Glass transition temperatures of PVP/PEG blends against composition and predictions by Fox equation. 
 
The value of Tg
LOWER
 in PVP/PEG blends matched closely that found in literature for unblended 
PEG. Nevertheless, the Tg
LOWER
 could not be attributed to the occurrence of unblended PEG 
phase within the blends due to following reasons. 
1. If the Tg
LOWER
 belonged to the unblended PEG phase, the composition dependence of the 
upper Tg would display positive deviations from the values predicted by the Fox equation. 
2. PEG is a crystalline polymer, however its blends with amorphous PVP developed no 
crystallinity. Apparently PEG was strongly involved into formation of specific interactions 
(hydrogen bonding) with PVP and did not form a separate crystalline phase. 
In conclusion, the Tg
LOWER
 related unambiguously to some amorphous PVP-PEG interaction 
product that nucleated and grew within the upper Tg-phase. The Tg
UPPER
 corresponded to a 
homogeneous PVP/PEG mixture, or PVP solution in PEG, where in average each PEG 
molecule formed only a single H-bond with the PVP carbonyl, leaving the second OH group, at 
the opposite chain end, free. The phase with Tg
LOWER
 was due to the PVP-PEG complex 
formation, where the PVP units were cross-linked by H-bonding through both terminal groups 
of PEG short chains. The phase with lower Tg component was not spatially separated from the 
phase with higher Tg value, representing a homogeneous mixture on a molecular scale. 
It is well known from the literature that polymer cross-linking usually causes an increase in Tg 
[30]. Nevertheless, in PVP/PEG systems the PVP cross-linking through PEG chains resulted in 
appreciable Tg reduction compared with uncross-linked PVP in the upper Tg-phase at equivalent 
PEG concentrations. Apparent anomalous behavior of the PVP/PEG blends was due to the 
appreciable length and the flexibility of PEG chains, which represented both a H-bonded cross-
linker and spacer. Creating a space between longer PVP macromolecules, the PEG chains 
increased the free volume and, eventually, the molecular mobility of PVP chain segments 
between close H-bond network junctions [31]. Cross-linking PVP units by H-bonding to PEG 
terminal hydroxyls, the PEG chains behaved also as a cohesive toughness enhancer [32]. As 
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PEG short chains were responsible for cohesive strength among PVP molecules and also 
enhanced the free volume, a pressure sensitive adhesive formed. 
The results discussed above led to the selection of blends with PVP/PEG 70/30 and PVP/PEG 
60/40 composition as suitable adhesives for the bi-layered device. Both blends were further 
characterized through Lap shear strength test in order to evaluate their adhesive strength and 
results are reported in Fig. 7.11. The maximum shear stress (max) was calculated from the 
stress-strain curves, dividing the maximum force by the shear area. 
 
Fig. 7.11 Maximum shear stress (σmax) for PVP/PEG 70/30 and PVP/PEG 60/40 adhesives (a) immediately bonded and 
(b) bonded after 1 day. 
 
Statistically significant differences could be observed between PVP/PEG 70/30 and PVP/PEG 
60/40 adhesives when the plates were immediately bonded (Fig. 7.11a). In detail, max 
decreased with increasing PEG content. For both blends, no appreciable changes in adhesive 
ability derived from the application of a pressure.  
Fig. 7.11b reports results adhesive effectiveness for samples bonded one day after the spreading 
of the adhesive on the sample surface. No differences were detected between PVP/PEG blends 
with different composition, bonded by the same method (no pression, pression for 1 day). On 
the contrary, a marked decrease in maximum shear stress appeared when pressure was applied. 
The adhesive selected for the assembly of the bi-layered membrane was PVP/PEG 70/30 due to 
its superior maximum shear stress. Moreover, we decided to link the two layers as soon as the 
adhesive was spread over the compact layer and without the application of a pression. 
7.3.2  Preliminary characterization of absorbable bi -layered membrane 
The macroscopic shape and the SEM photomicrographs of bi-layered device are displayed in 
Fig. 7.12. The device can be obtained after CH/G/TCP+GP-DSP porous membrane was 
combined with a PLCL/PLGA 25/75 compact film. The bi-layer structure was clearly identified 
by the SEM cross-section image (Fig. 7.12b). Moreover, photomicrographs showed that the 
assembly process did not alter the morphology of compact and porous layers. In particular, the 
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use of PVP/PEG 70/30 glue did not change CH/G/TCP+GP-DSP membrane porosity, 
preserving the initial porous and interconnected structure. 
 
Fig. 7.12 (a) Macroscopic view of the section and (b) SEM images of the fractured section of bi-layered membrane. 
 
Fig. 7.13 shows the stress-strain curves measured for the bi-layered membrane by tensile tests 
in dry and wet conditions. The curves could be divided in two distinct regions: 
1. initial linear elastic region characterized by the mechanical behavior of both compact and 
porous layer; 
2. region characterized by the mechanical properties of compact layer. 
 
Fig. 7.13 Tensile stress-strain curves for bi-layered membrane in dry and wet conditions (cross-head speed = 2 
mm/min). 
 
The values of E, max, and εmax calculated from the stress-strain curves of bi-layered 
membranes, both in wet and dry conditions, are collected in Table 7.5. Statistically significant 
differences could be observed between the elastic modulus, which decreased from about 61 
MPa in dry condition to about 5 MPa in wet state. Similarly, σmax decreased from 1.7 MPa in 
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dry conditions to 0.2 MPa in wet conditions. On the contrary, no marked differences were 
detected for the maximum tensile strain. 
Table 7.5 Young’s elastic modulus (E), maximum tensile strength (σmax) and strain (εmax) calculated from stress-
strain curves. 
Composition DRY WET 
E (MPa) 61.2 ± 11.1 5.1 ± 0.8 
σmax (MPa) 1.7 ± 0.6 0.2 ± 0.0 
εmax (%) 73.9 ± 27.3 81.4 ± 5.3 
 
Finally, membrane manageability was qualitatively evaluated on a mandible anatomical model 
with simulated periodontal defect in alveolar bone (Fig. 7.14b). Before the insertion, membrane 
was immersed in PBS for 5 min in order to improve its flexibility (Fig. 7.14a) and properly cut 
to fit the defect site. Then, the bi-layered device was placed between gingival tissue and bone 
defect (Fig. 7.14 c and d). Through this experiment, it was possible to verify the ability of the 
membrane to adapt to the anatomical conformation of mandible. Finally, the device was 
covered with gum flaps that were fixed with sutures (Fig. 7.14 e and f). Due to the presence of 
an antimicrobial coating on the membrane side in contact with gingival tissue, it was not 
necessary to close with first intention gum flaps. 
 
Fig. 7.14 Manageability of the bi-layered absorbable membrane evaluated in mandible anatomical model with 
periodontal defect. 
 
7.4 Conclusions 
In this chapter, a process for bi-layered membrane preparation based on the assembly of 
previously prepared compact and porous layers was developed, and preliminary 
characterizations of the bi-layered absorbable membrane were carried out. The assembly 
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process was based on the insertion of an intermediate adhesive layer composed of a PVP/PEG 
blend. 
Blending PVP and PEG through a solvent casting process generated a PAS system already 
employed in biomedical field. Results from physico-chemical characterizations showed an 
increase in surface hydrophilicity with increasing PEG content. The miscibility between the two 
components in PVP/PEG blends was verified through DSC analysis. In detail, the temperature 
difference between the Tgs of the blend components markedly decreased with increasing PEG 
content. The analysis of the behaviour of blend component Tgs suggested the formation of 
hydrogen bonds between PEG terminal hydroxyl groups and carbonyl groups of PVP repeating 
units. 
The Lap shear strength test allowed the evaluation of PVP/PEG blend adhesive properties. 
Superior adhesiveness was found for PVP/PEG 70/30 blend that was thus selected for the 
assembly of the bi-layered device. The assembly process developed in this chapter did not 
change the morphology of both compact and porous layer and led to a device with good 
manageability. Further characterizations need to be carried out in order to evaluate membrane 
stability in physiological conditions and biocompatibility. However, the preliminary results 
obtained in this work are promising for a future use of the bi-layered membrane in GTR/GBR 
applications. 
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8 
Final discussion and conclusions 
 
8.1 General discussion 
Periodontal diseases are highly prevalent and can affect up to 90% of the worldwide population. 
These diseases may be of developmental, inflammatory, traumatic, neoplastic, genetic, or 
metabolic origin [1, 2]. However, the term periodontal disease usually refers to the common 
inflammatory disorders of gingivitis and periodontitis that are caused by pathogenic microflora 
in the biofilm or dental plaque that forms adjacent to the teeth on a daily basis [3]. 
Gingivitis, the mildest form of periodontal disease, is highly prevalent and readily reversible by 
simple, effective oral hygiene. It affects 50-90% of adults worldwide [3]. Inflammation that 
extends deep into the tissues and causes loss of supporting connective tissue and alveolar bone 
is known as periodontitis. It results in the formation of soft tissue pockets or deepened crevices 
between the gingival and tooth root. Severe periodontitis can result in loosening of teeth, 
occasional pain and discomfort, and impaired mastication [4]. 
Treatments of gingivitis and periodontitis include various non-surgical and surgical therapies, 
depending on the specific treatment objective [4]. The different strategies of periodontal therapy 
aim to (1) reduce and/or eliminate inflamed tissues caused by bacterial plaque, (2) correct 
defects or anatomical problems due to the disease, and (3) regenerate new periodontal tissues 
[5, 6]. A number of different treatments have been developed to promote periodontal 
regeneration since the mid-1980s; they include bone replacement grafts, root surface 
biomodifications, guided tissue/bone regeneration (GTR/GBR), and delivery of growth factors 
or gene therapies [7]. Among them, GTR and GBR have become the most promising therapies 
and were widely used in clinical treatment for their convenience and effectiveness [8, 9]. 
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GTR/GBR treatments of periodontitis are surgical procedures to implant a regeneration 
membrane that specifically aims to restore the periodontal tissues supporting the teeth. It is 
commonly found that the epithelial and gingival connective tissues migrate rapidly into the 
wound, preventing periodontal regeneration [9]. In these therapies, the ideal regeneration 
membrane plays a key role to work both as a barrier to prevent epithelial and gingival 
connective cells growing into periodontal defects and as a favorable niche to maximize the 
migration and proliferation of periodontal ligament cells and osteoblasts within the periodontal 
defects to promote the reconstruction of the supporting tissue [10]. In order to achieve better 
clinical outcomes in dental implantology, barrier membranes should fulfill some fundamental 
requirements, such as good biocompatibility and biodegradability, suitable adhesiveness 
between the membrane and surrounding bone tissues to prevent the movement of the 
membrane, high flexibility to provide surgical facility, and sufficient mechanical strength to 
maintain their barrier function long enough for bone regeneration [11, 12]. In addition, a further 
improvement in the GTR/GBR techniques can be achieved by using a bioactive membrane 
capable of accelerating bone formation while minimizing the influence of bacterial 
contamination on regenerative outcome [4, 13]. 
Different non-resorbable and resorbable membranes have been developed and are currently 
available on the market. The so-called “gold standard” non-resorbable membranes for 
GTR/GBR procedures are currently based on polytetrafluoroethylene (PTFE). However, they 
have different disadvantages such as non-resorbability and the need for a second surgical 
operation to repair dehiscence [10]. Although membranes based on biodegradable synthetic 
polymers, such as polylactic acid (PLA), poly(D,L-lactide-co-glycolide) (PLGA) and poly(DL-
lactide-co-ε-caprolactone) (PLCL), avoid a second surgical operation, they show drawbacks 
concerning their capacity of space maintenance, early/late absorption, mechanical properties 
and bacterial infection during degradation. On the other hand, collagen membranes have 
additional advantages related to biological properties of collagen itself but are characterized by 
low mechanical strength [14, 15]. 
The “ideal” membrane for use in periodontal regenerative therapy has yet to be developed. 
Based on the State of the Art analysis, research efforts were addressed to the preparation of (i) 
composites consisting of osteoconductive calcium phosphate ceramics and biodegradable 
polymers, (ii) multi-component membranes with specific properties at the interface between the 
implant and alveolar bone and epithelial tissues, and (iii) surface modification of synthetic 
polymers to graft bioactive proteins or biomolecules. The introduction of specific cell-adhesion 
molecules should lead to a specific tissue response on the membrane surfaces, the delivery or 
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incorporation of antimicrobial substances might minimize the influence of bacterial 
contamination on regenerative outcome and the growth factor release from membranes should 
stimulate a better bone regeneration. 
In this contest, the thesis was aimed at the development of biologically active products for 
GTR/GBR procedures, with improved osteoconductive and antimicrobial properties. In the first 
part of the work, a commercially available membrane based on PTFE was surface modified to 
tailor the surface properties, allowing rapid bone re-growth (Chapter 2) and exerting 
antimicrobial action (Chapter 3). In the second part, an innovative bi-layered bioabsorbable 
membrane was developed (Chapter 7), by the assembly of a compact (Chapter 4 and 5) and a 
porous layer (Chapter 6). 
A mussel-inspired coating method, involving the application of a thin film coating of 3,4-
dihydroxy-DL-phenylalanine (DOPA) on a substrate via dip-immersion and oxidative 
polymerization, was employed to surface modify PTFE films. This versatile method was first 
proposed by Lee at al. [16]. The thickness of the adherent polymer film (polyDOPA) is a 
function of the immersion time and the polymerization temperature. Moreover, to avoid non-
specific microparticle formation on surfaces, stirring and/or vertical sample orientation is 
necessary. The polyDOPA coating is able to form on virtually all types of material surfaces. 
Then, it can further support a variety of secondary reactions, leading to tailoring of the coating 
for diverse functional uses. 
Guided by these findings, we applied a hydroxyapatite nanoparticles (HAp) coating on PTFE 
film through one-step DOPA/HAp application process in order to promote the bone re-growth 
properties of PTFE membranes. In our strategy, HAp coating on polymer films occurred by 
simultaneous binding of DOPA during its polymerization, to the HAp nanoparticles and to the 
PTFE substrates. Thus, the immobilization of HAp nanoparticles on PTFE surface was achieved 
by their entrapment and/or conjugation with polyDOPA. It was found that the polyDOPA/HAp 
coating covered the entire surface of the films, producing a very rough surface with improved 
wettability properties. The coating was characterized by a 3D-structure, able to enhance protein 
absorption and osteoblast proliferation. Indeed, in vitro cell tests with pre-osteoblast MC3T3-E1 
cells confirmed these observations. Cells proliferated on the modified PTFE substrate over 3 
days. They were extremely well spread and formed long filopodia with firm attachment to the 
surface. 
The surface multifunctional groups on the polyDOPA layer (catechol and amine functional 
groups) were also reported to be able to spontaneously reduce noble metal nanoparticles, 
without using a reducing agent, surfactants, or energy-consuming steps [17, 18]. In this contest, 
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the polyDOPA was applied to produce silver nanoparticles (AgNPs) on PTFE film surfaces in 
order to exert antimicrobial action against pathogens in the periodontal treated site. 
Physicochemical and morphological analyses demonstrated that the polyDOPA coating 
deposited on PTFE surface was an effective functional layer for metallization. The AgNPs 
showed a diameter around 68 nm and were homogeneously distributed on the surface. 
Nanoparticles slightly inhibited fibroblasts NIH 3T3 proliferation, without compromising cell 
adhesion and maintaining a good biocompatibility of modified PTFE films. Moreover, the 
antimicrobial efficiency was proved against Gram-negative and Gram-positive bacteria. 
The second part of the thesis followed a highly innovative approach, leading to the development 
of a bi-layered bioabsorbable membrane. The purpose was to combine the approaches identified 
in the scientific literature, developing biologically active, osteoconductive and multi-component 
materials, mimicking native bone and gingival extracellular matrix (ECM). The work was 
divided into three parts: the development of the compact (1) and porous (2) layers and their 
combination onto a bi-layered membrane (3). 
1. Compact layer development 
Physical (morphology, thermal and mechanical properties) and biological (cell adhesion and 
proliferation) properties of films made of blend between PLCL and PLGA (compositions 100/0, 
75/25, 50/50, 25/75, 0/100 wt/wt) were investigated with the aim to select an optimal blend 
composition in terms of compatibility degree between the phases, mechanical properties and 
cell compatibility for our application. PLCL/PLGA 25/75, 50/50 and 75/25 did not show 
evident phase separation, attributed to similar physical properties between blend components. 
The behavior of blend component Tgs suggested some degree of compatibility for PLCL/PLGA 
25/75 and 50/50 blends. Mechanical properties confirmed the limited compatibility for 
PLCL/PLGA 25/75 and 50/50 blends, with superior mechanical properties for PLCL/PLGA 
25/75 blend. In vitro cell tests using mouse embryonic fibroblast NIH 3T3 cells indicated that 
PLCL/PLGA 100/0, 50/50 and 25/75 films supported cellular attachment and proliferation, 
especially on PLCL/PLGA 25/75 blend surface; fibroblasts spread uniformly and extensively 
with the development of lamellopodia. This blend composition was further characterized for its 
stability in physiological medium, evidencing a degradation behavior intermediate between that 
of the pure polymers, in terms of weight loss and molecular weight changes, becoming similar 
to those of pure PLGA after 6 weeks incubation in PBS. The cross-section of PLCL/PLGA 
25/75 blends showed pores with a few micron size after 4 weeks of incubation in PBS, probably 
caused by PLCL dissolution and degradation. 
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Layer-by-Layer (LbL) self-assembly technique was investigated to surface engineer 
PLCL/PLGA 25/75 blend films. A chondroitin sulfate/chitosan (CHS/CH) polyelectrolyte 
multilayer coating was deposited on blend films to enhance fibroblast NIH 3T3 cell adhesion, 
proliferation and function, while at the same time conferring antibacterial efficacy. Blend 
sample surface was pre-modified to introduce positively charged groups which are necessary 
for the stable deposition of the first LbL layer. Aminolysis treatment was performed on blend 
films and optimized to finally select the following parameters: C = 0.08 g/mL, t = 8 min and T 
= 37 °C. Then, LbL coating was performed on activated blend films. The success of coating as 
well as the great improvement in surface properties were confirmed by combined techniques. 
QCM-D confirmed the nanometric thickness of the coatings. Contact angle measurements 
suggested a full coverage of the coating after the deposition of at least five layers and, for those 
fully coated surfaces, the surface wettability was dominated by the outmost coating layer. 
Fluorescence microscopy and FTIR-ATR analysis were performed to follow the growth of CHS 
and CH layers on aminolysed blend films. In vitro investigations with fibroblast NIH 3T3 cells 
showed that films incorporated with biomacromolecules exhibited stronger ability to support 
fibroblast cells adhesion and to maintain fibroblast function, in particular for those assembled 
with high number of CHS/CH layers and having a cationic polyelectrolyte layer on top. A 
number of 16 layers was thus selected as optimal number of layers for our application. 
However, no antibacterial activity was observed by the optimized nanocoating. 
2. Porous layer development 
Based on a biomimetic approach, three dimensional sponge-like composite membranes based 
on β-tricalcium phosphate (TCP) and a double cross-linked network of chitosan/gelatin (CH/G) 
were obtained and investigated, having a similar composition to that of natural bone. The 
double cross-linking method was based on a covalent and ionic cross-linker, genipin (GP) and 
dibasic sodium phosphate salt (DSP) respectively. The cross-linking process did not 
significantly influence sample morphology and thermal stability. An optimal interconnected 
porous network for bone repair, with pores size within 100–200 μm range, was obtained for all 
membranes. Lower sized pores were also present in order to favor protein adhesion and thus 
cells attachment on the membrane, and to allow the flow of nutrients to cells within the 
substrate. On the contrary, the double cross-linking process and the addition of TCP increased 
the mechanical properties (both in dry and wet conditions), the membrane stability in contact 
with water media, and the cell response of CH/G network. In fact, Young’s modulus and 
maximum tensile strength increased, while deformability of CH/G membranes decreased by 
cross-linking, as a consequence of a stiffening effect by the cross-linkers and TCP. The water 
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absorption degree and the dissolution rate were markedly reduced in cross-linked samples. 
Finally, viability of MG-63 cells seeded onto CH/G+GP-DSP and CH/G/TCP+GP-DSP 
membranes was significantly higher than for CH/G samples. SEM micrographs after 72 h 
showed that MG-63 cells had a high affinity for CH/G/TCP+GP-DSP samples, displaying the 
typical spindle-like shape, with a stretched elongated shape and a spread morphology. 
3. Bi-layered membrane development 
The assembly process was based on the insertion of an intermediate adhesive layer composed of 
a polyvinylpyrrolidone (PVP)/polyethylene glycol (PEG) blend. PVP/PEG blends are pressure-
sensitive adhesives (PSAs), which are commonly used in a variety of applications because of 
their ease of application, low toxicity, and versatility [19]. PSAs combine a liquid-like 
character, which allows a good molecular contact under a light applied pressure, and a solid-like 
character, that resists an applied stress once the bond has been formed. In particular, PVP/PEG 
blends display interesting PSA properties only in a fairly narrow window of compositions 
(between 30 and 40 wt% PEG) [20]. The Lap shear strength test allowed the evaluation of 
PVP/PEG blends adhesive properties. Better results were found for blend with PVP/PEG 70/30 
composition that was selected for the assembly of the final device. Preliminary characterization 
of the bi-layered membrane showed that the assembly process did not change the morphology 
of both compact and porous layer and led to a device with good manageability and mechanical 
properties. 
8.2 Conclusions and future developments 
In this thesis work, synthetic and natural polymeric materials and nanostructured coatings were 
designed for the fabrication and coating of membranes for GTR/GBR applications in 
periodontal diseases. 
The coating strategies adopted to surface modified non-resorbable PTFE membranes led to the 
development of PTFE substrates with improved osteoconductive and antibacterial properties. 
Such an improvement in PTFE is not only promising for the treatment of periodontal diseases 
but also for many other pathologies requiring improved surface properties of PTFE. 
In the future, the ability of substrates coated with HAp nanoparticles to support Mouse 
preosteoblast MC3T3-E1 cells differentiation will be evaluated, while more extensive 
antibacterial tests will be performed (i.e. antimicrobial activity assay in liquid through viable 
cell counting method) on PTFE films enriched with AgNPs, using also periodontal pathogens 
(i.e. Porphyromonas gingivalis, Actinobacillus actinomycetemcomitans). 
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Regarding the development of the bi-layered bioabsorbable membrane, the selected materials 
for compact and porous layers introduced improvements in the biomaterial field for Tissue 
Engineering (TE) applications. 
In detail, blend for the compact layer (PLCL/PLGA 25/75) combined the deformability of 
PLCL with the higher mechanical stiffness, the cell adhesion properties and the slowly 
degradation rate of PLGA, leading to a tough material with similar degradation rate to PLGA 
and superior cell adhesion and proliferation. The surface modifications of PLCL/PLGA 25/75 
blend films (aminolysis treatment and LbL coating) were carried out with success and 
optimized. The introduction of CHS and CH onto blend surface improved biocompatibility 
properties. However, in the future, further improvements will be introduced in the optimized 
CHS/CH multilayer nanocoatings in terms of antimicrobial activity. In this context, different 
strategies can be compared. Firstly, extensive antibacterial tests can be performed (i.e. 
antimicrobial activity assay in liquid through viable cell counting method) using also 
periodontal pathogens, to verify if the absence of antibacterial activity is related to the amount 
of CH into the nanocoating. Secondly, AgNPs, antimicrobial drugs (e.g. metronidazole) or both 
agents can be introduced onto the LbL nanocoating and membranes will be further 
characterized. 
The composite material for the porous layer (CH/G/TCP+GP-DSP) was demonstrated to be 
suitable candidate as osteoconductive layer. In the future, its bioactivity and its ability to 
support osteoblast cells differentiation needs to be evaluated. Moreover, to better mimic bone 
ECM matrix, the freeze-drying process adopted in this thesis can be replaced by electrospinning 
in order to obtain biomimetic nanofibrous mats. 
Finally, the assembly process based on the application of an adhesive layer (PVP/PEG 70/30) 
between compact and porous component led to the development of membranes with preserved 
morphology of the two components, good mechanical properties and manageability. These 
preliminary results were promising for a future application of the bi-layered membrane in 
GTR/GBR applications. In the future, further characterizations are required in order to evaluate 
membrane stability in physiological conditions (water uptake and dissolution tests) and 
biocompatibility (in vitro cell tests using both osteoblast and fibroblast cells). 
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